(STCC) Lausanne Assemblée Annuelle Commune 2016

Assemblée Annuelle commune 2016 Gemeinsame Jahrestagung 2016 Société Suisse de Cardiologie (SSC) Société Suisse de Chirurgie Cardiaque et Vasculaire Thoracique (SSCC) Société Suisse de Pneumologie (SSP)

15–17 juin 2016 SwissTech Convention Center (STCC) Lausanne

SOCIETES HOTES Société Suisse d’Hypertension (SSH) Société Suisse sur l’Hypertension Pulmonaire (SSHP) Société Suisse de Cardiologie Pédiatrique (SSCP) Société Suisse de Pneumologie Pédiatrique (SSPP) Société Suisse des Perfusionistes (SSdP) Société Suisse de Chirurgie Thoracique (SSCT) Association pour les Sciences Infirmières (APSI) – Société scientifique des soins dans le domaine cardiovasculaire Swiss Cardiovascular Therapists (SCT)

www.swisscardio.ch1

Table of Contents

Societies...... 3 Committees...... 5 Welcome...... 6 Exhibitors and Sponsors...... 8

Programme Overview Wednesday, 15 June ...... 12 Thursday, 16 June ...... 14 Friday, 17 June ...... 16

Scientific Programme Wednesday, 15 June ...... 19-30 Thursday, 16 June ...... 31-69 Friday, 17 June ...... 71-88 Posters...... 89 Moderator List...... 128 Abstract Author Index...... 131 Reviewers List ...... 150 Publication and Accreditation...... 151 Prizes...... 152 Information for Authors and Speakers ...... 153 General Information...... 154 Society Evenings...... 157 Congress Centre Map...... 159 Poster & Exhibition Layout...... 160 Piazza Layout...... 161 List of Exhibitors and Sponsors...... 162 Public Lecture, Swiss Heart Foundation...... 164 General Assembly Programme...... 165

Mit den in diesem Programm enthaltenen Be- Les termes dans ce programme représentes grifflichkeiten sind immer sowohl weibliche toujours des personnes féminins et également als auch männliche Personen gemeint . masculins .

1 SSC, SSCS and SSP Joint Annual Meeting 2016 Mobile App Download it now! Jetzt downloaden:Jetzt downloaden: Die SGK/SGHC– Mobile – Mobile App App Die SGK/SGHC• Quickly navigate through the programme and the abstracts • Synchronize Navigieren your Siefavorites schnell undwith einfach your durchcalendar das Programm und zu den  NavigierenAbstracts Sie schnell und einfach durch das Programm und zu den Abstracts • Search forSynchronisieren speakers, chairs Sie Ihre or ausgewählten abstract authors Programmteile mit Ihrem Kalender  Synchronisierenand mark Sie your Ihre favorites ausgewählten Programmteile mit Ihrem Kalender  Lokalisieren Sie die Aussteller und erhaltenInformationen Sie mehr Informationen Lokalisierenzu denSie dieausstellenden Aussteller Firmenund erhalten Sie mehr  zu den ausstellenden Firmen Scan the QR-Code and download the SSC, SSCS Scannenand SSP JointSie den Annual QR-Code Meeting und 2016laden App Sie die App bequem herunter. Scannen Sie den QR-Code und laden Sie die App bequem herunter.

iOs iOs

Android iOs/Android Die App ist gesponsert von

Android

Die App ist gesponsert von

Produziert in Zusammenarbeit mit

Societies

Societies Schweizerische Gesellschaft für Kardiologie (SGK) Jetzt downloaden: Société Suisse de Cardiologie (SSC) www .swisscardio .ch – Mobile App Schweizerische Gesellschaft für Herz- und thorakale Die SGK/SGHC Gefässchirurgie (SGHC) Société Suisse de Chirurgie Cardiaque et Vasculaire Thoracique (SSCC) www .swisscardiac .org  Navigieren Sie schnell und einfach durch das Programm und zu den Abstracts Schweizerische Gesellschaft für Pneumologie (SGP) Société Suisse de Pneumologie (SSP) Synchronisieren Sie Ihre ausgewählten Programmteile mit Ihrem  www .pneumo .ch Kalender Informationen Lokalisieren Sie die Aussteller und erhalten Sie mehr  zu den ausstellenden Firmen Guest Societies Behandlungsplan Behandlungsziel Antihypertensivawahl bei Zusatzproblemen Checkliste bei pharmakotherapieresistenter Hypertonie

I. Nicht-medikamentöse Massnahmen beachten. Problem Bevorzugte Antihypertensiva Mögliche Ursachen Evaluation Massnahme Lebensstil verbessern. • Nikotinabstinenz Koronare Herzkrankheit Betablocker, RAAS-Blocker, Fehlmessung des Manschette, Messtechnik Messfehler beheben ++ Blutdruckes • Alkoholeinschränkung Ca -Antagonist • Ernährung: Schweizer Hypertonie Gesellschaft (SHG) Weisskittelhypertonie Ambulante BD- Überbehandlung vermeiden – reich an Früchten und Gemüse Herzinsuffi zienz RAAS-Blocker, Diuretikum, Betablocker, Messung, Selbstmessung – «salzarm» (≤ 6 g NaCl/Tag = 24-h-UrinNa+ < 100 mmol) Generell Blutdruck Aldosteron-Antagonist • Körpertraining: Gehen, Laufen, Radfahren, Schwimmen, Langlaufen, … Schlafapnoe Anamnese, 24h-BD- Gewichtsreduktion < 140/90 mmHg Asthma und chronisch obstruktive RAAS-Blocker, Ca++-Antagonist, Diuretika Messung (non-dipper), bei Übergewicht, • Gewichtskontrolle Lungenkrankheit Schlafstudie spezialärztliche Abklärung -Code und laden Sie ➔ Diese Massnahmen begleiten jede Pharmakotherapie Société Suisse d’Hypertension (SSH) Dyslipidämie RAAS-Blocker, Ca++-Antagonist Alkohol, Hormone, Anamnese Pressorische / Scannen Sie den QR II. Falls Blutdruck nach Lebensstil-Verbesserung Diabetiker und nichtsteroidale antagonistische Antirheumatika, Lakritze Substanzen absetzen ≥ 140/90 mmHg: Nierenpatienten Proteinurie, Mikroalbuminurie, RAAS-Blocker diabetische Nephropathie Antihypertensiva < 140/85 mmHg Mangelhafte Antihypertensiva- Verordnung optimieren, www .swisshypertension .ch Medikamentenverordnung Kombination? Dosierung? Diuretikum? RAAS-Blocker Ca++-Antagonist die App bequem herunter. Gestörte Glukosetoleranz RAAS-Blocker, Ca++-Antagonist Unvollständige Anamnese Patienten aufklären, Isolierte systolische Medikamenteneinnahme: häufi ge Kontrollen, ABPM, Diabetes RAAS-Blocker, Ca++-Antagonist, Nebenwirkungen BD-Selbstmessung, Hypertonie* < 150 mmHg Betablocker Fixdosen-Kombination

Schwangerschaft Keine RAAS-Blocker Adipositas Ernährungsanamnese, Gewichtskontrolle, ß-Blocker Diuretikum Manschette anpassen körperliche Aktivität α-Methyldopa, Labetalol, Betablocker, Schweizerische Gesellschaft für Pulmonale++ Hypertonie (SGPH) * gilt auch für Betagte bei fehlender Orthostase Ca -Antagonist (Dihydropiridin), Dihydralazin. + Antihypertensiva erster Wahl Übermässige 24-h-Urin-Na Salzeinschränkung, CAVE: Diuretika Salzzufuhr (> 6 g/d) (>100 mmol/24h) Diuretika Antihypertensiva für alternative Initialtherapie Hyperkinetische Zirkulation, Tremor, Betablocker

Migräne + Na -H2O-Retention Klinischer Status, Kontrolle der Nieren- www.swisshypertension.ch Société Suisse sur l’Hypertension Pulmonaire (SSHP)Na+-retinierende funktion, salzretinierende Medikamente (NSAR*), Medikamente absetzen Risikostufe systolisch 140–159 systolisch ≥ 160 und/oder Therapieresistente Hypertonie Niereninsuffi zienz und/oder diastolisch diastolisch ≥ 100 mmHg ARTERIELLE 90–99 mmHg Defi nition: Blutdruckwerte in der Praxis >140 / 90mmHg mit einer Sekundäre Hypertonie Siehe oben, Gezielt behandeln ausdosierten 3-er Therapie inkl. Diuretikum (Pseudo- gezielt suchen www .sgph .ch Resistenz mittels 24h-ABPM ausgeschlossen) Leicht bis mässig Monotherapie Monotherapie oder HYPERTONIE Kombinationstherapie *NSAR: Nichtsteroidale Antirheumatika Behandlung: mangelnde Compliance ausschliessen, medikamentöse Therapie anpassen Empfehlungen für Ärzte Hoch oder Monotherapie oder Kombinationstherapie Renale Denervation Expertenmeinung ohne Haftung sehr hoch Kombinationstherapie und Barorefl ex-Stimulation: noch nicht etabliert; nur in Referenzzentren und Schweizerische Gesellschaft fürim Rahmen Pädiatrische klinischer Studien Kardiologie (SGPK) Bei Resistenz zu einer Therapie mit einem Hemmer des Renin-Angiotensin-Systems, einem Diuretikum und einem Kalzium-Antagonisten, zusätzlich die Gabe eines Betablockers, eines Alphablockers oder eines zentralwirkenden Sympatholytikum evaluieren. 2015 Cave: Kontraindikation und medikamentöse Interaktionen berücksichtigen Société Suisse de Cardiologie Pédiatrique (SSCP) Niedrig dosierte Diuretika verwenden (Hypokaliämie!) SchweizeriScher Verein www .pediatriccardiology .ch für PflegewiSSenSchaft iOs Schweizerische Gesellschaft für Pädiatrische Pneumologie (SGPP) Société Suisse de Pneumologie Pédiatrique (SSPP) www .sgpp-sspp .ch

Schweizerische Gesellschaft für Perfusionstechniken (SGfP) Société Suisse des Perfusionistes (SSdP) www .swissperfusion .ch Android Schweizerische Gesellschaft für Thoraxchirurgie (SGT) Société Suisse de Chirurgie Thoracique (SSCT) Die App ist gesponsert von www thoraxchirurgie. .ch Schweizerischer Verein für Pflegewissenschaft (VfP) – Akademische Fachgesellschaft für Kardiovaskuläre Pflege Association pour les Sciences Infirmières (APSI) – Société scientifique des soins dans le domaine cardiovasculaire www .pflegeforschung-vfp .ch

Produziert in Zusammenarbeit mit Swiss Cardiovascular Therapists (SCT) www .SwissCardioTherapists .ch

3 COMPRIMÉ EN CAS D’HYPERTENSION

VASCORD® C : Combinaison olmésartan médoxomil/amlodipine (sous forme de bésilate d’amlodipine) : Cps à 20 mg/5 mg, 40 mg/5 mg et 40 mg/10 mg. I : Traitement de l’hypertension artérielle essentielle chez des patients insuffisamment contrôlés par une monothérapie. P : 1 cps 1 x par jour, à jeun ou après un repas. Adaptation de la posologie en cas d’insuffisance hépatique modérée. CI : Deuxième et troisième trimestre de la grossesse, allaitement, obstructions biliaires, insuffisance rénale sévère et hépatique sévère. PC : Hypovolémie ou une hyponatrémie, états avec stimulation du système rénine-angiotensine-aldostérone, hypertension d’origine rénovasculaire, insuffisance rénale et transplantation rénale, insuffisance hépatique, hyperkaliémie, lithium, sténose mitrale ou aortique, cardiomyopathie hypertrophique obstructive, hyperaldosté¬ronisme primaire, insuffisance cardiaque. IA : Principes actifs qui influencent l’équilibre potassium, lithium, AINS, inhibiteurs ou inducteurs du CYP3A4, sildénafil. IE Fréquents : vertiges, céphalées, œdèmes, fatigue ; occasionnels : hyperkaliémie, diminution de la libido, léthargie, paresthésies, hypoest- hésies, palpitations, tachycardie, hypotension,dyspnée, toux, troubles GI, rougeurs, pollakiurie, dysfonction érectile, asthénie. Très rare : entéropathie. P : 28*, 98* (*admis par les caisses-maladie). Liste : B. Pour les informations détaillées consultez SVP www.swissmedicinfo.ch. A. Menarini SA, 8052 Zurich. V.02.

VASCORD HCT® C : Combinaison olmésartan médoxomil/amlodipine (sous forme de bésilate d’amlodipine)/hydrochlorothiazide comprimés pelliculés à 20/5/12,5 mg, 40/5/12,5 mg, 40/10/12,5 mg, 40/5/25 mg und 40/10/25 mg. I : Traitement de l’hypertension artérielle essentielle chez des patients dont la pression artérielle est contrôlée par une combinaison d’olmésartan, d’amlodipine et de hydrochlorothiazide ou lors de contrôle insuffisant. P : Adultes : 1 comprimé pelliculé 1 x par jour, à jeun ou après un repas. Adaptation de la posologie en cas d’insuffisance hépatique modérée.CI : Insuffisance rénale sévère, insuffisance hépatique sévère, angiooedème héréditaire, choc, insuffisance cardiaque instable. PC : Hypovolémie ou hyponatrémie, états avec stimulation du système RAAS, hypertension d’origine rénovasculaire, insuffisance rénale et transplantation rénale, insuffisance hépatique, sténose mitrale ou aortique, cardiomyopathie hypertrophique obstructive, hyperaldosté¬ronisme primaire, effets métaboliques et endocriniens, troubles électrolytiques, hyperkaliémie, lithium, insuffisance cardiaque, variabilité ethnique. IA : Principes actifs qui influencent l’équilibre potassique, lithium, AINS, anticholinergiques, échangeurs d’anions, inhibiteurs ou inducteurs du CYP3A4, metformine, sildénafil et autres, voir information professionnelle. EI (combinaison fixe) Fréquents : infections des voies respiratoires ou urinaires, vertiges, céphalées, hypotension, troubles GI, crampes musculaires, pollakiurie, œdème périphérique, flushing, fatigue, élévation de la créatinine et de l’acide urique dans le sang. Très rare : entéropathie. P : 28*, 98* (B) * admis par les caisses-maladies. Pour les informations détaillées consultez SVP www.swissmedicinfo.ch. A. Menarini SA, 8052 Zurich. V.03. P-2858_01/16_f. Committees

Congress Presidents Laurent Nicod, Lausanne Hans Rickli, St . Gallen

Joint Scientific Committee SSP/SSC/SSCS Martin Brutsche, St . Gallen François Mach, Geneva Esther Frey, Bern Laurent Nicod, Lausanne Martin Frey, Barmelweid Hans Rickli, St . Gallen Paola Gasche Soccal, Geneva Marjam Rüdiger-Stürchler, Basel Michele Genoni, Zurich Silvia Ulrich Somaini, Zurich Urs Kaufmann, Bern Michael Zellweger, Basel

Scientific Committee Members SSC/SSCS Christine Attenhofer Jost, Zurich Urs Kaufmann, Bern Alexander Breitenstein, London François Mach, Geneva Cornelia Bläuer, Basel Romy Mahrer Imhof, Winterthur Stefano di Bernardo, Lausanne Franco Muggli, Vezia Judith Bouchardy, Lausanne Hans Rickli, St . Gallen Harran Burry, Geneva Marco Roffi, Geneva Jolanda Consiglio, Bern Nathalie Rosenblatt, Geneva Simon Costabile, Zurich Marjam Rüdiger-Stürchler, Basel Arnold von Eckardstein, Zurich Jean-Paul Schmid, Bern Michele Genoni, Zurich Francesco Siclari, Lugano Matthias Greutmann, Zurich Gaby Stoffel, Zurich Martin Gsponer, Kilchberg Thomas Suter, Bern Gudrun Haager, St . Gallen Michael Zellweger, Basel Christoph Huber, Geneva Nicole Zigan, Winterthur

Scientific Committee Members SSP Constance Barazzone, Geneva Raphael Heinzer, Lausanne Martin Brutsche, St . Gallen Laurent P . Nicod, Lausanne André Dutly, St . Gallen Isabelle Rochat, Lausanne Martin Frey, Barmelweid Thomas Rothe, Zurich Esther Frey, Bern Daiana Stolz, Basel Paola Gasche-Soccal, Geneva Silvia Ulrich Somaini, Zurich Jürg Hammer, Basel

5 Welcome

Liebe Kolleginnen, liebe Kollegen

Unsere Jahrestagung 2016, welche vom 15 .-17 . Juni in Lausanne stattfindet, wird dieses Jahr sehr speziell sein . Nach 10 Jahren, ist dies zum ersten Mal wieder eine gemeinsame Jahresta- gung der Schweizerischen Gesellschaft für Kardiologie (SGK), der Schweize- rischen Gesellschaft für Herz- und thorakale Gefässchirurgie (SGHC) und der Schweizerischen Gesellschaft für Pneumologie (SGP) und deren Gastgesell- schaften . Dieses Mal benutzen wir das brandneue SwissTech anstatt des MCH Beau lieu . Zudem steht eine gemeinsame Session mit der École Polytechnique Fédérale de Lausanne (EPFL) auf dem Programm . All diese Elemente erfreuen uns und wir blicken mit Vorfreude und Enthusi- asmus auf ein interessantes und vielversprechendes Programm . Es gibt eine Vielzahl interessanter Themen wie Atemnot, Pulmonale Hyperto- nie und Lungenembolie, Herzinsuffizienz, kardiovaskuläre Risikofaktoren und deren Auswirkungen . Die am ESC/ERS 2015 publizierten Guidelines werden uns von hochkarätigen Vertretern der Guidelines Committees vorgestellt . Und besonders gespannt sind wir natürlich auf die im Frühjahr 2016 erschei- nenden Guidelines zur Lipidtherapie sowie zur Herzinsuffizienz, welche wir in einer separaten Session thematisieren .

Wir freuen uns, Sie im SwissTech in Lausanne begrüssen zu dürfen .

Mit herzlichen Grüssen

Prof . Dr . med . Hans Rickli Prof . Dr . med . Paola Gasche Soccal Kongresspräsident SGK / SGHC Präsidentin SGP

Prof . Dr . med . Laurent Nicod Dr . med . Urs Kaufmann Kongresspräsident SGP Präsident SGK

Prof . Dr . med . Michele Genoni Präsident SGHC

6 Welcome

Chers collègues,

Notre réunion annuelle 2016, qui se déroulera du 15–17 juin à Lausanne, sera une occasion spéciale . Après 10 ans, c’est la première Assemblée Annuelle commune de la Société Suisse de Cardiologie (SSC), de la Société Suisse de Chirurgie Cardiaque et Vasculaire Thoracique (SSCC) et de la Société Suisse de Pneumologie (SSP) ainsi que de leurs sociétés hôtes . Pour cette occasion, nous utilisons le tout nouveau SwissTech à la place du MCH Beaulieu . Il y aura aussi une session commune avec l’École Polytech- nique Fédérale de Lausanne (EPFL) au programme . Tous ces éléments nous réjouissent et nous sommes impatients du programme très prometteur . Nous espérons que vous aussi puissiez-vous réjouir des diverses possibilités que cet évènement commun aura à vous offrir . Il y a une multitude de thèmes intéressants tels que les problèmes respiratoires, l’hypertension pulmonaire, les insuffisances cardiaques et les facteurs de risques cardiovasculaires . Les directives ESC, publiées en 2015 ainsi que celles publiées au printemps 2016 seront naturellement aussi mises en évidence . Le comité des directives de l’ESC nous donnera une perspicacité des importantes recommendations .

Nous nous réjouissons de vous accueillir au SwissTech à Lausanne .

Prof . Dr méd . Hans Rickli Prof . Dr méd . Paola Gasche Soccal Président du congrès SSC / SSCC Présidente SSP

Prof . Dr méd . Laurent Nicod Dr méd . Urs Kaufmann Président du congrès SSP Président SSC

Prof . Dr méd . Michele Genoni Président SSCC

7 Exhibitors and Sponsors

We would like to thank the following companies for their precious support

8 Exhibitors and Sponsors

9 Exhibitors and Sponsors

10 Exhibitors and Sponsors

11 Programme Overview Wednesday, June 15

Wednesday, 15.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

07:15 07:15 07:30 07:30 07:45 07:45 08:00 08:00 08:15 07:30-10:00 08:15 08:30 Assembly 08:30 08:45 Board meeting Swiss Society of Cardiac and 08:30-10:00 08:45 09:00 Vascular Thoracic Surgery Assembly 09:00 09:15 08:30-11:15 Board meeting Swiss Society of Cardiology 09:15 08:30-11:15 09:30 Pre-Meeting 09:30 08:30-11:35 Pre-Meeting 09:45 Swiss Fellow Course Interventional 09:00-11:30 09:00-11:15 09:45 Pre-Meeting Postgraduate Course Heart failure 10:00 Cardiology Assembly Assembly 10:00 Postgraduate Course in Imaging (p.19) (p.20) Board meeting Working group pacemaker Board meeting Working group AGLA 10:15 (p.19 & 21) 10:15 10:15-11:15 and electrophysiology 10:30 Assembly 10:30 10:45 10:45 10:30-12:00 Scientific program committee 2017 Session 11:00 11:00-11:45 11:00 Young Swiss Cardiac Surgeons Session Assembly 11:15 (p.21) 11:15 11:30 Working Group SCOT 11:30 11:45 11:45-12:30 11:45 11:45-12:30 11:45-12:30 11:45-12:30 11:45-12:30 12:00 Assembly 12:00 12:00-13:00 Assembly Assembly Assembly Assembly Working Group Pace maker and General assembly SCOT Working Group AGLA Working Group Heart failure Working Group WATCH WG Echocardiography and Cardiac Imaging 12:15 electrophysiology 12:15

12:30 12:30-13:00 12:30 12:30-13:30 12:45 Assembly SCOT-YSCS 12:45-13:30 12:45 12:45-13:30 Assembly Assembly 13:00 Assembly, Working Group Echocardiography General assembly Swiss Society of Cardiac 13:00 Swiss Working Group Interventional + Cardiac imaging Surgery 13:15 Cardiology 13:15

Thursday 16.06.2016 Side MeetingsAuditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor 07:15 07:15-08:00 07:15 Track Nursing and Satellite Symposium SSCS Track 07:30 Allied Professionals 07:30 07:45 The Medicines Company (p.31) 07:45 08:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00 Time 08:00-09:00 Room Who 08:00-09:00 08:00-09:00 08:00-09:00 08:15 Workshop SS Hypertension Workshop Workshop SCOT Workshop 08:15 Joint Session Workshop Working group Rhythmology Workshop Workshop The patient with heartfailure, renal failure Complicated parapneumonic effusion: Electronic tools and aids for patients and health Thoracovertebral malformations: 08:30 High altitude In-depth: 2015 ESC guidelines on ventricular Tobacco prevention and e-cigarette facts ILD and systemic diseases 08:30 and hypertension: what strategy? surgery or drainage care professionals cardiopulmonary consequences and (p.31) arrhythmia and sudden cardiac death (p.33) (p.33) (p.32) 08:30–11:3008:45 E Postgraduate Course in Cardiac(p.32) Imaging, SGK(p.33) 2016: (p.32) treatment (p.33) 08:45 09:00 09:00 09:15 09:15 Multimodality imaging 09:15-10:45approach in aortic stenosis 09:15-10:45 09:15-10:45 09:30 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:30 Workshop and Abstract Session Basic Science Scientific Session Nursing and allied professions Abstract Session SSC/SSCS 09:45 Main Session Workshop AGLA Abstract Session SSC/SSCS Session SSCS Quiz 09:45 Basic research in cardiology: clinical Adherence after lung transplantation – Struggling ventricles in congenital heart Chronic dyspnea Lipids Heart failure at it's best Endocarditis Swiss pulmonary challenge 10:00 perspectives Enhancing patients’ self-care abilities disease 10:00 08:30–11:30(p.37) F Postgraduate(p.40) Course in Cardiac Imaging, SGK(p.34) 2016: (p.37) (p.38) 10:15 (p.39) (p.38) (p.35) 10:15 10:30 10:30 10:45 Multimodality imaging approach in aortic stenosis 10:45 11:00 11:00 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:15 11:00-12:30 11:00-12:30 11:15 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint Session Joint Session Scientific Session Nursing and allied professions Rapid Fire Abstract Session SSC/SSCS Free communications 1 SPP 11:30 Joint Session Free communications 2 SSP 11:30 08:30–11:30Session: Pearls of the ESC/ERSG Guidelines ManagementPostgraduate of chronic thromboembolic Course in SarcoidosisCardiac Imaging, SGK 2016: Patients with obstructive sleep apnea (OSAS): Heart failure and beyond - modern treatment Clinical studies in COPD and related 11:45 Cardiovascular risk factors Pulmonary cell biology 11:45 2015 disease (p.47) implications for nursing practice concepts obstructive disorders (p.48) (p.45) 12:00 (p.47) (p.48) (p.49) (p.43) (p.40) 12:00 12:15 Multimodality imaging approach in aortic stenosis 12:15 12:30-12:45 (p.49) 12:30 12:30 Tuberculosis Research Prize Ceremony 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 08:30–11:3012:45 H Postgraduate Course in Cardiac Imaging, SGK 2016: 12:45 13:00 13:00 13:15-14:15 13:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15 Multimodality imaging approach in aortic stenosis Assembly 13:15-14:15 Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:30 General assembly Working group Poster Walks SSC/SSCS & SSP 13:30 Novartis Sanofi Aventis Suisse SA PneumRx/PulmonX Actelion Pharma Schweiz AG Medela 13:45 13:15-14:45 Cardiovascular nursing and allied (p.49 & p.89) 13:45 (p.52) (p.51) (p.51) (p.50) (p.53) General Assembly Swiss Society of Pediatric 14:00 professionals 14:00 08:30–11:30 I Postgraduate Course in Cardiac Imaging, SGK 2016: Pneumology 14:15 14:15 14:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30 14:30-16:00 14:30-15:30 14:45 Workshop MultimodalitySatellite Symposium imagingSatellite approach Symposium in aorticSatellite stenosis Symposium Satellite Symposium 14:45 Joint Session Poster Walks SSC/SSCS & SSP ECG-Quiz Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG SERVIER (Suisse) SA 15:00 ECMO Therapy: What do healthcare (p.53 & p.89) 15:00 15:15 (p.57) (p.56) (p.55) (p.55) professionals need to know about ECMO (p.57) 15:15 15:30 and how to care for these patients? 15:30 15:45 (p.54) 15:45 15:45-17:15 15:45-17:15 15:45-17:15 16:00 15:45-17:15 15:45-17:15 15:45-17:15 15:45-17:15 16:00 Abstract Session SSC/SSCS Abstract Session SSC/SSCS Free communications 3 SSP 16:15 Main Session Workshop Joint Session SSPP Session 16:15 16:15-17:15 Beneficial and adverse of cardiometabolic Challenges in ischemic, valvular and Physiopathology and mechanisms of Ventilation and heart failure Facing the challenge of TAVI 2016 Pulmonary hypertension Pediatric Grand Rounds 16:30 Nursing and allied professionals on- and off-target effects congenital heart disease diseases 16:30 (p.63) (p.64) (p.63) (p.57) 16:45 Presentation of clinical scientific projects (p.61) (p.58) (p.60) 16:45 17:00 (p.64) 17:00 17:15 17:15 17:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:15 17:30-18:30 17:30 1217:45 17:30-19:00 Assembly Satellite Symposium Satellite Symposium Workshop Abstract Session SSC/SSCS Abstract Session SSC/SSCS Satellite Symposium 17:45 18:00 Assembly General Assembly Swiss Society of Thoracic Zoll Johnson&Johnson AG, Biosense Webster SSC Quiz Clinical Cases: Miscellaneous I Clinical Cases: miscellaneous II (p.65) LivaNova & Sorin 18:00 18:15 General Assembly Swiss Society of Surgery (p.68) (p.68) (p.67) (p.66) (p.69) 18:15 18:30 Pneumology 18:30 18:45 18:45 19:00 19:00 19:15 19:15 19:30 19:30 19:45 19:30 Society evening, Lausanne Palace 19:30 Society evening, Lausanne Palace 19:45 20:00 20:00

Friday 17.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

07:15 07:15 07:30 SCT/SAKR Track WATCH Track 07:30 07:45 07:45 08:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00 08:00-09:30 08:00-09:30 08:00-09:30 08:00-09:30 08:15 Workshop Workshop Workshop Workshop 08:15 Joint Session Workshop Rhythmology Joint Session Joint Session New lung function standards Cardiopulmonary pediatric challenges of altitude Indication and outcome in lung Swiss recommendations for adult patients 08:30 NOACs and antiplatelet therapy - Update What the general cardiologist should know From gadgets to evidence based Cardiopulmonary exercise testing (CPET): 08:30 (p.72) (p.71) transplantation (p.72) with cystic fibrosis (p.72) 08:45 2016 about rhythmology telemedicine interactive case discussion 08:45 09:00 (p.71) (p.73) (p.71) (p.71) 09:00 09:15 09:15

09:30 09:15-10:45 09:30 - 09:45 Coffee break at Piazza and Exhibition 09:30 Main Session 09:15-11:00 09:45 09:45 News in oncology of the Lung 09:45-11:15 09:45-11:15 09:45-11:15 Main Session 10:00 09:45-11:15 09:45-11:15 09:45-11:15 10:00 (p.73) Workshop Joint Session Abstract Session SSC/SSCS Paediatric Pulmonology Science Session 10:15 Main Session Debate Abstract Session SSC/SSCS 10:15 Hot topics in heart failure and mitral valve Rehabilitation for cardiac and pulmonary Leads and leadless systems: the good, the (p.74) Pulmonary embolism Hole - Leave it or correct it Surgical particularities 10:30 disease patients bad and the ugly 10:30 (p.78) (p.77) (p.74) 10:45 (p.79) (p.78) (p.76) 10:45 11:00 11:00 11:15 11:00-12:30 11:15 11:30 11:30-12:30 Main Session 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30 11:45 Workshop Swiss WG Interventional Cardiology Asthma Joint EPFL- SSC/SSCS/SSP-Session Practical Workshop Scientific Session Joint Session Workshop FMH Insurances 11:45 12:00 2015 ESC NSTE-ACS guidelines in-depth (p.79) Innovation and Competitive of Research in Respiratory physiotherapy Complications in CHD - with a little help from our Evaluation of right heart function 11:30 – 13:00 Medical centres and surgeries – present 12:00 12:15 (p.81) Switzerland (p.80) (p.82) friends (p.81) (p.80) Assembly and future (p.82) 12:15 Working Group home ventilation 12:30 12:30 12:30-13:00 Lunch at Piazza and Exhibition 12:30-13:00 Lunch at Piazza and Exhibition 12:30-13:00 Lunch at Piazza and Exhibition 12:45 12:30-14:00 12:45 Assembly 13:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00 General Assembly Swiss Society of Pediatric Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:00-14:00 13:15 Cardiology 13:15 13:30 Vertex Pharmaceuticals (CH) GmbH GSK Mundipharma Medical Company Boston Scientific AG Boston Scientific AG SSC/SSCS-Boards & Industry CEO Meeting 13:30 (p.82) (p.84) (p.82) (p.83) (p.84) 13:45 13:45 14:00 14:00 14:15 14:15-15:00 14:15 Workshop SS Hypertension 14:15-15:00 14:15-15:45 14:30 14:15-15:45 14:15-15:45 14:15-15:45 13:00-17:00 14:30 Therapy of hypertension in patients with Assembly Abstract Session SSC/SSCS Workshop Main Session Joint Session Hands-on Course 14:45 coronary heart disease Working Group Cardiac rehabilitation From PCI to electrophysiology/pacemaker 14:45 Best Swiss articles of the year 2015 Respiratory infections PAH and congenital heart disease BLS/AED Refresher 15:00 (p.88) implantation 15:00 (p.87) (p.87) (p.86) (p.82) 15:15 (p.85) 15:15 15:30 15:30 Programme Overview Wednesday, June 15

Wednesday, 15.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

Thursday 16.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

07:15 07:15-08:00 07:15 Track Nursing and Satellite Symposium SSCS Track 07:30 Allied Professionals 07:30 07:45 The Medicines Company (p.31) 07:45 08:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00 08:00-09:00 08:00-09:00 Time Room Who 08:00-09:00 08:00-09:00 08:15 Workshop SS Hypertension Workshop Workshop SCOT Workshop 08:15 Joint Session Workshop Working group Rhythmology Workshop Workshop The patient with heartfailure, renal failure Complicated parapneumonic effusion: Electronic tools and aids for patients and health Thoracovertebral malformations: 08:30 High altitude In-depth: 2015 ESC guidelines on ventricular Tobacco prevention and e-cigarette facts ILD and systemic diseases 08:30 and hypertension: what strategy? surgery or drainage care professionals cardiopulmonary consequences and (p.31) arrhythmia and sudden cardiac death (p.33) (p.33) (p.32) 08:45 (p.32) (p.33) 11:30–12:30(p.32) E AMIS Plus Registry Meeting treatment (p.33) 08:45 09:00 09:00 09:15 09:15 09:15-10:45 09:15-10:45 09:15-10:45 09:30 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:30 Workshop and Abstract Session Basic Science 11:30–12:30Scientific Session Nursing and alliedG professions Réunion projet MitraSWISS Abstract Session SSC/SSCS 09:45 Main Session Workshop AGLA Abstract Session SSC/SSCS Session SSCS Quiz 09:45 Basic research in cardiology: clinical Adherence after lung transplantation – Struggling ventricles in congenital heart Chronic dyspnea Lipids Heart failure at it's best Endocarditis Swiss pulmonary challenge 10:00 perspectives Enhancing patients’ self-care abilities disease 10:00 (p.37) (p.40) (p.34) (p.37) (p.38) 10:15 (p.39) (p.38) (p.35) 10:15 10:30 12:45–13:30 F Arbeitsgruppe Herzschrittmacher Sitzung 10:30 10:45 10:45 11:00 11:00 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 mit den11:00-12:30 Stiftungsratsmitgliedern11:00-12:30 11:15 11:00-12:30 11:00-12:30 11:15 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint Session Joint Session Scientific Session Nursing and allied professions Rapid Fire Abstract Session SSC/SSCS Free communications 1 SPP 11:30 Joint Session Free communications 2 SSP 11:30 Session: Pearls of the ESC/ERS Guidelines Management of chronic thromboembolic Sarcoidosis Patients with obstructive sleep apnea (OSAS): Heart failure and beyond - modern treatment Clinical studies in COPD and related 11:45 Cardiovascular risk factors Pulmonary cell biology 11:45 2015 disease (p.47) implications for nursing practice concepts obstructive disorders (p.48) (p.45) 12:00 (p.47) (p.48) 13:30–14:30(p.49) E Swiss (p.43)TAVI Meeting (p.40) 12:00 12:15 12:15 12:30-12:45 (p.49) 12:30 12:30 Tuberculosis Research Prize Ceremony 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:45 12:45 13:00 13:00 13:15-14:15 13:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15 Assembly 13:15-14:15 Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:30 General assembly Working group Poster Walks SSC/SSCS & SSP 13:30 Novartis Sanofi Aventis Suisse SA PneumRx/PulmonX Actelion Pharma Schweiz AG Medela 13:45 13:15-14:45 Cardiovascular nursing and allied (p.49 & p.89) 13:45 (p.52) (p.51) (p.51) (p.50) (p.53) General Assembly Swiss Society of Pediatric 14:00 professionals 14:00 Pneumology 14:15 14:15 14:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30 14:30-16:00 14:30-15:30 14:45 Workshop Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 14:45 Joint Session Poster Walks SSC/SSCS & SSP ECG-Quiz Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG SERVIER (Suisse) SA 15:00 ECMO Therapy: What do healthcare (p.53 & p.89) 15:00 15:15 (p.57) (p.56) (p.55) (p.55) professionals need to know about ECMO (p.57) 15:15 15:30 and how to care for these patients? 15:30 15:45 (p.54) 15:45 15:45-17:15 15:45-17:15 15:45-17:15 16:00 15:45-17:15 15:45-17:15 15:45-17:15 15:45-17:15 16:00 Abstract Session SSC/SSCS Abstract Session SSC/SSCS Free communications 3 SSP 16:15 Main Session Workshop Joint Session SSPP Session 16:15 16:15-17:15 Beneficial and adverse of cardiometabolic Challenges in ischemic, valvular and Physiopathology and mechanisms of Ventilation and heart failure Facing the challenge of TAVI 2016 Pulmonary hypertension Pediatric Grand Rounds 16:30 Nursing and allied professionals on- and off-target effects congenital heart disease diseases 16:30 (p.63) (p.64) (p.63) (p.57) 16:45 Presentation of clinical scientific projects (p.61) (p.58) (p.60) 16:45 17:00 (p.64) 17:00 17:15 17:15 17:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:15 17:30-18:30 17:30 17:45 17:30-19:00 Assembly Satellite Symposium Satellite Symposium Workshop Abstract Session SSC/SSCS Abstract Session SSC/SSCS Satellite Symposium 13 17:45 18:00 Assembly General Assembly Swiss Society of Thoracic Zoll Johnson&Johnson AG, Biosense Webster SSC Quiz Clinical Cases: Miscellaneous I Clinical Cases: miscellaneous II (p.65) LivaNova & Sorin 18:00 18:15 General Assembly Swiss Society of Surgery (p.68) (p.68) (p.67) (p.66) (p.69) 18:15 18:30 Pneumology 18:30 18:45 18:45 19:00 19:00 19:15 19:15 19:30 19:30 19:45 19:30 Society evening, Lausanne Palace 19:30 Society evening, Lausanne Palace 19:45 20:00 20:00

Friday 17.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

09:00 09:00 09:15 09:15 09:15-10:45 09:15-10:45 09:15-10:45 09:30 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:30 Workshop and Abstract Session Basic Science Scientific Session Nursing and allied professions Abstract Session SSC/SSCS 09:45 Main Session Workshop AGLA Abstract Session SSC/SSCS Session SSCS Quiz 09:45 Basic research in cardiology: clinical Adherence after lung transplantation – Struggling ventricles in congenital heart Chronic dyspnea Lipids Heart failure at it's best Endocarditis Swiss pulmonary challenge 10:00 perspectives Enhancing patients’ self-care abilities disease 10:00 (p.37) (p.40) (p.34) (p.37) (p.38) 10:15 (p.39) (p.38) (p.35) 10:15 10:30 10:30 10:45 10:45 11:00 11:00 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:15 11:00-12:30 11:00-12:30 11:15 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint Session Joint Session Scientific Session Nursing and allied professions Rapid Fire Abstract Session SSC/SSCS Free communications 1 SPP 11:30 Joint Session Free communications 2 SSP 11:30 Session: Pearls of the ESC/ERS Guidelines Management of chronic thromboembolic Sarcoidosis Patients with obstructive sleep apnea (OSAS): Heart failure and beyond - modern treatment Clinical studies in COPD and related 11:45 Cardiovascular risk factors Pulmonary cell biology 11:45 2015 disease (p.47) implications for nursing practice concepts obstructive disorders (p.48) (p.45) 12:00 (p.47) (p.48) (p.49) (p.43) (p.40) 12:00 12:15 12:15 12:30-12:45 (p.49) 12:30 12:30 Tuberculosis Research Prize Ceremony 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:45 12:45 13:00 13:00 13:15-14:15 13:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15 Assembly 13:15-14:15 Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:30 General assembly Working group Poster Walks SSC/SSCS & SSP 13:30 Novartis Sanofi Aventis Suisse SA PneumRx/PulmonX Actelion Pharma Schweiz AG Medela 13:45 13:15-14:45 Cardiovascular nursing and allied (p.49 & p.89) 13:45 (p.52) (p.51) (p.51) (p.50) (p.53) General Assembly Swiss Society of Pediatric 14:00 professionals 14:00 Pneumology 14:15 14:15 14:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30 14:30-16:00 14:30-15:30 14:45 Workshop Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 14:45 Joint Session Poster Walks SSC/SSCS & SSP ECG-Quiz Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG SERVIER (Suisse) SA 15:00 ECMO Therapy: What do healthcare (p.53 & p.89) 15:00 15:15 (p.57) (p.56) (p.55) (p.55) professionals need to know about ECMO (p.57) 15:15 15:30 and how to care for these patients? 15:30 15:45 (p.54) 15:45 15:45-17:15 15:45-17:15 15:45-17:15 16:00 15:45-17:15 15:45-17:15 15:45-17:15 15:45-17:15 16:00 Abstract Session SSC/SSCS Abstract Session SSC/SSCS Free communications 3 SSP 16:15 Main Session Workshop Joint Session SSPP Session 16:15 16:15-17:15 Beneficial and adverse of cardiometabolic Challenges in ischemic, valvular and Physiopathology and mechanisms of Ventilation and heart failure Facing the challenge of TAVI 2016 Pulmonary hypertension Pediatric Grand Rounds 16:30 Nursing and allied professionals on- and off-target effects congenital heart disease diseases 16:30 (p.63) (p.64) (p.63) (p.57) 16:45 Presentation of clinical scientific projects (p.61) (p.58) (p.60) 16:45 17:00 (p.64) 17:00 17:15 17:15 17:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:15 17:30-18:30 17:30 17:45 17:30-19:00 Assembly Satellite Symposium Satellite Symposium Workshop Abstract Session SSC/SSCS Abstract Session SSC/SSCS Satellite Symposium 17:45 18:00 Assembly General Assembly Swiss Society of Thoracic Zoll Johnson&Johnson AG, Biosense Webster SSC Quiz Clinical Cases: Miscellaneous I Clinical Cases: miscellaneous II (p.65) LivaNova & Sorin 18:00 18:15 General Assembly Swiss Society of Surgery (p.68) (p.68) (p.67) (p.66) (p.69) 18:15 18:30 Pneumology 18:30 18:45 18:45 19:00 19:00 19:15 19:15 19:30 19:30 19:45 19:30 Society evening, Lausanne Palace 19:30 Society evening, Lausanne Palace 19:45 20:00 20:00

Friday 17.06.2016

Side MeetingsAuditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor 07:15 07:15 07:30 SCT/SAKR Track WATCH Track 07:30 07:45 07:45 08:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00-09:00 08:00 08:00-09:30 08:00-09:30 08:00-09:30 08:00-09:30 08:15 Workshop Workshop Workshop Workshop 08:15 Time Joint Session Room Who Workshop Rhythmology Joint Session Joint Session New lung function standards Cardiopulmonary pediatric challenges of altitude Indication and outcome in lung Swiss recommendations for adult patients 08:30 NOACs and antiplatelet therapy - Update What the general cardiologist should know From gadgets to evidence based Cardiopulmonary exercise testing (CPET): 08:30 (p.72) (p.71) transplantation (p.72) with cystic fibrosis (p.72) 08:45 2016 about rhythmology telemedicine interactive case discussion 08:45 11:15–12:0009:00 (p.71) E SGPP Restricted Board Members(p.73) (p.71) (p.71) 09:00 09:15 09:15 09:30 09:15-10:45 09:30 - 09:45 Coffee break at Piazza and Exhibition 09:30 Main Session 09:15-11:00 09:45 09:45 12:30–13:30 E SéanceNews in oncology informative of the Lung pour09:45-11:15 la constitution 09:45-11:15 09:45-11:15 Main Session 10:00 09:45-11:15 09:45-11:15 09:45-11:15 10:00 (p.73) Workshop Joint Session Abstract Session SSC/SSCS Paediatric Pulmonology Science Session 10:15 Main Session Debate Abstract Session SSC/SSCS 10:15 Hot topics in heart failure and mitral valve Rehabilitation for cardiac and pulmonary Leads and leadless systems: the good, the (p.74) Pulmonary embolism Hole - Leave it or correct it Surgical particularities 10:30 du “swiss Concil for Cardiologydisease Practice” SCCP,patients bad and the ugly 10:30 (p.78) (p.77) (p.74) 10:45 (p.79) (p.78) (p.76) 10:45 11:00 un nouveau Groupe de travail de la SSC, 11:00 11:15 11:00-12:30 11:15 11:30 11:30-12:30 Main Session 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30 11:45 Workshop Swiss WG Interventional Cardiology pour lesAsthma praticiens Jointcardiologues EPFL- SSC/SSCS/SSP-Session libérauxPractical Workshop Scientific Session Joint Session Workshop FMH Insurances 11:45 12:00 2015 ESC NSTE-ACS guidelines in-depth (p.79) Innovation and Competitive of Research in Respiratory physiotherapy Complications in CHD - with a little help from our Evaluation of right heart function 11:30 – 13:00 Medical centres and surgeries – present 12:00 12:15 (p.81) Switzerland (p.80) (p.82) friends (p.81) (p.80) Assembly and future (p.82) 12:15 Working Group home ventilation 12:30 12:30 12:30–13:15 F Kommission12:30-13:00 Fortbildung Lunch at Piazza and Exhibition SGP 12:30-13:00 Lunch at Piazza and Exhibition 12:30-13:00 Lunch at Piazza and Exhibition 12:45 12:30-14:00 12:45 Assembly 13:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00 General Assembly Swiss Society of Pediatric Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:00-14:00 14:30–15:3013:15 E Expertengruppe Lungenkarzinom-Screening SGP Cardiology 13:15 13:30 Vertex Pharmaceuticals (CH) GmbH GSK Mundipharma Medical Company Boston Scientific AG Boston Scientific AG SSC/SSCS-Boards & Industry CEO Meeting 13:30 (p.82) (p.84) (p.82) (p.83) (p.84) 13:45 13:45 14:30–15:3014:00 F SSC Tarife Commission 14:00 14:15 14:15-15:00 14:15 Workshop SS Hypertension 14:15-15:00 14:15-15:45 14:30 14:15-15:45 14:15-15:45 14:15-15:45 13:00-17:00 14:30 Therapy of hypertension in patients with Assembly Abstract Session SSC/SSCS Workshop Main Session Joint Session Hands-on Course 14:45 coronary heart disease Working Group Cardiac rehabilitation From PCI to electrophysiology/pacemaker 14:45 15:45–17:15Best Swiss articles of theE year 2015 GroupeRespiratory infectionsde travail prévention et réadaptation PAH and congenital heart disease BLS/AED Refresher 15:00 (p.88) implantation 15:00 (p.87) (p.87) (p.86) (p.82) 15:15 de section cardiologie du sport (p.85) 15:15 15:30 15:30

14 Wednesday, 15.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

13:30 13:30-14:00 Welcome reception at the Exhibition Area 13:30-14:00 Welcome reception at the Exhibition Area 13:30 13:45 13:45 14:00 14:00 14:15 14:00-15:30 14:00-15:30 14:00-15:30 14:00-15:30 14:15 14:15-15:30 14:30 Main Session Workshop WATCH Abstract Session SSC/SSCS Abstract Session SSC/SSCS 14:00-16:00 14:00-16:00 14:30 Senning Lecture & SSCS Medtronic Young 14:45 Assessment of acute dyspnea What happened to our difficult cases News in catheter ablation of arrhythmias Methods for assessment and monitoring of risk Hands-on Hands-on 14:45 Investigators Prize Lecture 14:00-17:00 (p.25) (p.26) (p.22) (p.23) Interstitial lung disease Thorax drainage 15:00 Wednesday, 15.06.2016(p.26) Workshop 15:00 15:15 Swiss Society for Perfusion Techniques (p.25) (p.25) 15:15 Auditorium B 15:30 Room 5AB Room 1AB Room 3C Room 1C Room 5C Quality parametersRoom in 2C extracorporeal Room 4C Foyer Ground Floor 15:30 circulation 07:15 15:45 07:15 15:45 15:45-17:15 15:45-17:15 15:45-17:15 15:45-17:00 (p.26) 16:00 15:45-17:15 16:00 07:30 Main Session Workshop WG Rhythmology Workshop Imaging + SSCS Abstract Session SSC/SSCS 07:30 16:15 Workshop WG Interventional Cardiology 16:15 07:45 Hot news from heart failure and dyslipidemia New devices in current practice and on the Diagnosis and treatment of pericardial Clinical pearls in rhythmology 07:45 Update on Stents 08:00 16:30 guidelines horizon effusion (p.27) 08:00 16:30 (p.29) 08:15 16:45 (p.28) 07:30-10:00(p.28) (p.29) 08:15 16:45 08:30 17:00 Assembly 08:30 17:00 16:15-18:15 17:15 Board meeting Swiss Society of Cardiac and 17:15 08:45 08:30-10:00 Hands-on 08:45 09:00 17:30 Vascular Thoracic Surgery 17:30-18:15 WorkshopAssembly SS Hypertension 09:00 17:30 17:30-18:00-18:20 Polysomnography and polygraphy 16:15-19:15 17:45 IsolatedBoard systolic meeting hypertension: Swiss Society same of Cardiologysignificane 17:00 - 19:00 17:45 09:15 08:30-11:15 Andreas Grüntzig Lecture & Prize Ceremony (p.29) Hands-on 09:15 08:30-11:15 and same treatment in the young and old? Assembly 09:30 Pre-Meeting SSC/SHF Bodyplethysmography 09:30 18:00 08:30-11:35 Pre-Meeting (p.30) Board meeting Swiss Society of Pneumology 18:00 09:45 Swiss Fellow Course Interventional 09:00-11:30 09:00-11:15 09:45 Pre-Meeting(p.30) Postgraduate Course Heart failure (p.30) 10:00 18:15 Cardiology Assembly Assembly 10:00 18:15 Postgraduate Course in Imaging (p.19) 10:15 18:30 (p.20) Board meeting Working group pacemaker Board meeting Working group AGLA 10:15 18:30 18:30-19:45(p.19 & 21) 10:15-11:15 18:45 and electrophysiology 18:45 10:30 Assembly Assembly 10:30 10:45 19:00 10:45 19:00 General assembly Swiss Society of 10:30-12:00 Scientific program committee 2017 Session 11:00 11:00-11:45 19:15 19:00-20:30 11:00 19:15 Cardiology Young Swiss Cardiac Surgeons Session Programme Overview Assembly 19:30 Public lecture 19:30 11:15 (p.21) 11:15 11:30 Working Group SCOT 19:45 Swiss Heart Foundation 11:30 19:45 11:45 20:00 11:45-12:30 11:45 20:00 11:45-12:30 11:45-12:30 11:45-12:30 11:45-12:30 12:00 Assembly 20:00-22:00 Get together SSP/SSC 20:00-22:00 Get together SSP/SSC 12:00 12:00-13:00 Assembly Assembly Assembly Assembly Thursday, June 16 Working Group Pace maker and General assembly SCOT Working Group AGLA Working Group Heart failure Working Group WATCH WG Echocardiography and Cardiac Imaging 12:15 electrophysiology 12:15

12:30 12:30-13:00 Thursday 16.06.2016 12:30 12:30-13:30 12:45 Assembly SCOT-YSCS 12:45-13:30 12:45 12:45-13:30 Assembly Assembly Wednesday, 15.06.2016 13:00 Assembly, WorkingAuditorium Group Echocardiography B Room 5AB General assemblyRoom Swiss 1AB Society of Cardiac Room 3C Room 1C Room 5C Room 2C Room 4C 13:00 Foyer Ground Floor Swiss Working Group Interventional Auditorium B + CardiacRoom imaging5AB Room 1AB RoomSurgery 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor 13:15 Cardiology 13:15 13:3007:15 07:15 07:15-08:00 13:3007:15 07:15 13:30-14:00 Welcome reception at the Exhibition Area Track Nursing13:30-14:00 and Welcome reception at the Exhibition Area 07:30 Satellite Symposium SSCS Track 07:30 13:45 07:30 Allied Professionals 13:45 07:30 07:45 07:45 14:00 07:45 The Medicines Company (p.31) 14:00 07:45 08:00 08:00 14:15 14:00-15:30 08:00 14:00-15:30 14:00-15:30 08:00-09:00 08:00-09:0014:00-15:30 08:00-09:00 08:00-09:00 14:15 08:00 08:15 08:00-09:00 08:00-09:00 07:30-10:0014:15-15:30 08:00-09:00 08:00-09:00 08:15 14:30 Main Session 08:15 Workshop WATCH Abstract Session SSC/SSCS Workshop SS Hypertension AbstractWorkshop Session SSC/SSCS Workshop SCOT 14:00-16:00 14:00-16:00 Workshop 14:30 08:15 08:30 Joint Session Workshop Working group Rhythmology Senning Lecture Assembly& SSCS Medtronic Young Workshop Workshop 08:30 14:45 Assessment of acute dyspnea What happened to our difficult cases News in catheter ablation of arrhythmias The patient with heartfailure, renal failure MethodsComplicated for assessment parapneumonic and monitoring effusion: of riskElectronic tools and aids14:00-17:00 for patients and health Hands-on Hands-on Thoracovertebral malformations: 14:45 08:30 High altitude In-depth: 2015 ESC guidelines on ventricular Board meetingInvestigators Swiss Society Prize Lecture of Cardiac and Tobacco prevention and e-cigarette facts ILD and systemic diseases 08:30 15:0008:45 (p.25) (p.26) (p.22) and hypertension: what strategy? surgery or(p.23) drainage care professionals08:30-10:00Workshop Interstitial lung disease Thorax drainage cardiopulmonary consequences and 15:0008:45 (p.31) arrhythmia and sudden cardiac death (p.33) Vascular Thoracic(p.26) Surgery (p.33) (p.32) 15:1509:00 08:45 (p.32) (p.33) Swiss Society (p.32)forAssembly Perfusion Techniques (p.25) (p.25) treatment (p.33) 15:1509:00 08:45 Board meeting Swiss Society of Cardiology 15:3009:15 08:30-11:15 Quality parameters in extracorporeal 15:3009:15 09:00 08:30-11:15 09:00 15:4509:30 Pre-Meeting circulation 15:4509:30 09:15 08:30-11:35 Pre-Meeting 09:15 09:45 15:45-17:15 Swiss Fellow Course Interventional 15:45-17:15 15:45-17:15 15:45-17:00 (p.26) 09:45 16:00 15:45-17:15 09:15-10:45 09:15-10:45 09:00-11:30 09:00-11:15 09:15-10:45 16:00 09:30 Pre-Meeting Postgraduate Course Heart failure 09:15-10:45 09:30 10:00 Main Session 09:15-10:45Cardiology Workshop09:15-10:45 WG Rhythmology Workshop Imaging + SSCS Abstract09:15-10:45 Session SSC/SSCS 09:15-10:45Assembly Assembly 10:00 16:15 Workshop WG Interventional Cardiology Postgraduate Course in Imaging Workshop and Abstract Session Basic Science (p.19) Scientific Session Nursing and allied professions Abstract Session SSC/SSCS 16:15 Hot news from heart failure and dyslipidemia09:45 Main(p.20) Session New devices inWorkshop current practiceAGLA and on the Diagnosis and treatment of pericardial AbstractClinical Sessionpearls in SSC/SSCS rhythmology Board meetingSession Working SSCS group pacemaker Board meeting WorkingQuiz group AGLA 09:45 16:3010:15 Update on Stents (p.19 & 21) Basic research in cardiology: clinical Adherence after lung transplantation – Struggling ventricles in congenital heart 16:3010:15 guidelines 10:00 Chronic dyspnea horizonLipids effusion Heart failure(p.27) at it's best 10:15-11:15 Endocarditis Swiss pulmonary challenge 10:00 10:30 perspectives Enhancing patients’ self-care abilities and electrophysiology disease 10:30 16:45 (p.29)(p.37) (p.40) (p.34) Assembly (p.37) (p.38) 16:45 (p.28) 10:15 (p.28) (p.29)(p.39) (p.38) (p.35) 10:15 17:0010:45 17:0010:45 10:30 10:30-12:00 Scientific program committee 2017 Session 10:30 11:00 11:00-11:45 16:15-18:15 11:00 17:15 Young Swiss Cardiac Surgeons Session 17:15 Assembly 10:45 Hands-on 10:45 17:3011:15 (p.21) 17:30-18:15 Workshop SS Hypertension 17:3011:15 Working Group SCOT 11:00 17:30-18:00-18:20 Polysomnography and polygraphy 16:15-19:15 11:00 17:4511:30 11:00-12:30 11:00-12:30 11:00-12:30 Isolated systolic hypertension: same significane 11:00-12:3017:00 - 19:00 11:00-12:30 11:00-12:30 17:4511:30 11:15 Andreas Grüntzig Lecture & Prize Ceremony 11:00-12:30 (p.29) Hands-on 11:00-12:30 11:15 11:45 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint11:45-12:30 Session Joint Session and same treatment in the young and old? Scientific Session NursingAssembly and allied professions Rapid Fire Abstract Session SSC/SSCS Free communications 1 SPP 11:45 11:30 11:45-12:30SSC/SHF Joint11:45-12:30 Session 11:45-12:30 11:45-12:30 Bodyplethysmography Free communications 2 SSP 11:30 12:0018:00 Session: Pearls of the ESC/ERS Guidelines Management of Assemblychronic thromboembolic Sarcoidosis (p.30) PatientsBoard with meeting obstructive Swiss Society sleep apnea of Pneumology (OSAS): Heart failure and beyond - modern treatment Clinical studies in COPD and related 12:0018:00 12:00-13:00 11:45 Assembly(p.30) CardiovascularAssembly risk factors Assembly Assembly (p.30) Pulmonary cell biology 11:45 2015 Working Groupdisease Pace maker and (p.47) implications for nursing practice concepts obstructive disorders 18:15 General assembly SCOT Working Group AGLA Working Group Heart failure Working Group WATCH WG Echocardiography and Cardiac Imaging 18:15 12:15 12:00 electrophysiology (p.48) (p.45) 12:15 12:00 18:30 (p.47) (p.48) (p.49) (p.43) (p.40) 18:30 12:15 18:30-19:45 12:15 18:4512:30 12:30-13:00 18:4512:30 Assembly 12:30-13:30 12:45 Assembly SCOT-YSCS 12:45-13:30 12:30-12:45 (p.49) 12:45 19:00 12:30 General assembly12:45-13:30 Swiss Society of Assembly 19:00 12:30 Assembly Tuberculosis Research Prize Ceremony 19:1513:00 19:00-20:30 Assembly, WorkingCardiology Group 12:30-13:15Echocardiography Lunch at Piazza and Exhibition General assembly Swiss Society of Cardiac 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 19:1513:00 12:45 12:45 19:30 Public lecture Swiss Working Group Interventional 19:30 13:15 + Cardiac imaging Surgery 13:15 13:00 Cardiology 13:00 19:45 Swiss Heart Foundation 19:45 13:30 13:15-14:15 13:30 20:00 13:15 13:30-14:00 Welcome reception at the Exhibition13:15-14:15 Area 13:15-14:15 13:15-14:15 13:15-14:1513:30-14:00 Welcome reception at the Exhibition Area13:15-14:15 20:00 13:15 Assembly 13:15-14:15 13:45 20:00-22:00Satellite Get Symposium together SSP/SSC Satellite Symposium Satellite Symposium Satellite Symposium20:00-22:00 Get together SSP/SSCSatellite Symposium 13:45 13:30 General assembly Working group Poster Walks SSC/SSCS & SSP 13:30 14:00 Novartis Sanofi Aventis Suisse SA PneumRx/PulmonX Actelion Pharma Schweiz AG Medela 14:00 13:45 13:15-14:45 Cardiovascular nursing and allied (p.49 & p.89) 13:45 14:15 14:00-15:30 14:00-15:30 14:00-15:30(p.52) (p.51) 14:00-15:30(p.51) (p.50) (p.53) General Assembly Swiss Society of Pediatric 14:15 14:00 14:15-15:30 professionals 14:00 14:30 Main Session Workshop WATCH Abstract Session SSC/SSCS Abstract Session SSC/SSCS 14:00-16:00 14:00-16:00 14:30 Senning Lecture & SSCS Medtronic Young Thursday 16.06.2016 Pneumology 14:45 Assessment of acute dyspnea14:15 What happened to our difficult cases News in catheter ablation of arrhythmias Methods for assessment and monitoring of risk Hands-on Hands-on 14:45 14:15 Investigators Prize Lecture 14:00-17:00 (p.25) 14:30 14:30-15:30(p.26) 14:30-15:30(p.22) 14:30-15:30 14:30-15:30(p.23) 14:30-16:00 Interstitial14:30-15:30 lung disease Thorax drainage 14:30 15:00 (p.26) Workshop 15:00 14:30-15:30 14:45 Workshop Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 14:45 15:15 Auditorium B Room 5AB Room 1AB Room 3C Room 1C Swiss SocietyJoint forRoom Session Perfusion 5C Techniques Room(p.25) 2C Room(p.25) 4C Foyer Ground Floor 15:15Poster Walks SSC/SSCS & SSP 15:00 ECG-Quiz Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG ECMO Therapy: What do healthcare SERVIER (Suisse) SA 15:00 15:30 Quality parameters in extracorporeal 15:30 (p.53 & p.89) (p.57) (p.56) (p.55) (p.55) professionals need to know about ECMO (p.57) 15:45 15:15 circulation 15:45 15:15 07:15 15:45-17:15 15:30 15:45-17:15 15:45-17:1507:15-08:00 15:45-17:00 and how to care for(p.26) these patients? 07:15 15:30 16:00 15:45-17:15 Track Nursing and 16:00 07:30 Main Session Workshop WG Rhythmology WorkshopSatellite Imaging Symposium + SSCS Abstract Session SSC/SSCS SSCS(p.54) Track 07:30 16:15 15:45 Workshop WG Interventional Cardiology Allied Professionals 16:15 15:45 Hot news from heart failure and dyslipidemia New devices in current practice and on the DiagnosisThe Medicines and treatment Company of pericardial (p.31) Clinical pearls in rhythmology 15:45-17:15 15:45-17:15 15:45-17:15 07:45 16:00 Update15:45-17:15 on Stents 15:45-17:15 15:45-17:15 15:45-17:15 07:45 16:00 16:30 guidelines horizon effusion (p.27) Abstract Session SSC/SSCS Abstract Session SSC/SSCS Free communications 3 SSP 16:30 08:00 16:15 Main(p.29) Session 08:00-09:00Workshop Joint08:00-09:00 Session SSPP08:00-09:00 Session 16:15-17:15 08:00-09:00 08:00 16:15 16:45 08:00-09:00(p.28) 08:00-09:00 (p.28) (p.29) 08:00-09:00 Beneficial and adverse08:00-09:00 of cardiometabolic Challenges in ischemic, valvular and Physiopathology and mechanisms of 16:45 08:15 16:30 Ventilation and heart failure FacingWorkshop the challenge SS Hypertension of TAVI 2016 PulmonaryWorkshop hypertension PediatricWorkshop Grand RoundsSCOT Nursing and allied professionals Workshop 08:15 16:30 17:00 Joint Session Workshop Working group Rhythmology Workshop on- and Workshopoff-target effects congenital heart disease diseases 17:00 (p.63) The patient with heartfailure,(p.64) renal failure Complicated parapneumonic(p.63) effusion: Electronic tools and(p.57) aids for patients and health Presentation of clinical scientific projects 16:15-18:15 Thoracovertebral malformations: 17:1508:30 High altitude 16:45 In-depth: 2015 ESC guidelines on ventricular Tobacco prevention and e-cigarette facts ILD and systemic(p.61) diseases (p.58) (p.60) 17:1508:30 16:45 and hypertension: what strategy? surgery or drainage care professionals (p.64) Hands-on cardiopulmonary consequences and 17:30 (p.31) 17:00 arrhythmia and sudden cardiac death (p.33) 17:30-18:15 Workshop SS Hypertension (p.33) (p.32) 17:30 17:00 08:45 17:30-18:00-18:20 (p.32) (p.33) (p.32) Polysomnography and polygraphy treatment16:15-19:15 (p.33) 08:45 17:45 17:15 Isolated systolic hypertension: same significane 17:00 - 19:00 17:45 17:15 Andreas Grüntzig Lecture & Prize Ceremony (p.29) Hands-on 09:00 17:30 17:30-18:30 17:30-18:30 and same treatment17:30-18:30 in the young and old? 17:30-18:30Assembly 17:30-18:30 17:30-18:15 17:30-18:30 09:00 17:30 18:00 SSC/SHF Bodyplethysmography 18:00 09:15 17:45 17:30-19:00 Assembly Satellite Symposium Satellite Symposium(p.30) Board meeting SwissWorkshop Society of Pneumology Abstract Session SSC/SSCS Abstract Session SSC/SSCS Satellite Symposium 09:15 17:45 (p.30) (p.30) 18:00 Assembly General Assembly09:15-10:45 Swiss Society of Thoracic Zoll Johnson&Johnson09:15-10:45 AG, Biosense Webster SSC Quiz Clinical Cases: Miscellaneous I Clinical Cases:09:15-10:45 miscellaneous II (p.65) LivaNova & Sorin 18:00 18:1509:30 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 18:1509:30 Workshop and AbstractSurgery Session Basic Science (p.68) Scientific Session Nursing(p.68) and allied professions (p.67) (p.66) Abstract Session SSC/SSCS (p.69) 09:45 Main Session 18:15 General AssemblyWorkshop Swiss AGLA Society of Abstract Session SSC/SSCS Session SSCS Quiz 09:45 18:15 18:30 Basic research in cardiology: clinical Adherence after lung transplantation – Struggling ventricles in congenital heart 18:30 Chronic dyspnea 18:30 Pneumology18:30-19:45Lipids Heart failure at it's best Endocarditis Swiss pulmonary challenge 18:30 18:4510:00 18:4510:00 Assembly perspectives Enhancing patients’ self-care abilities disease 10:15 (p.37) 18:45 (p.40) (p.34) (p.37) (p.38) 10:15 18:45 19:00 General assembly Swiss Society of (p.39) (p.38) (p.35) 19:00 10:30 19:00 10:30 19:00 19:15 19:00-20:30 Cardiology 19:15 19:15 19:15 19:3010:45 Public lecture 19:3010:45 19:30 19:30 19:4511:00 Swiss Heart Foundation 19:4511:00 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:15 19:45 19:30 Society evening, Lausanne Palace11:00-12:30 19:30 Society evening, Lausanne Palace11:00-12:30 11:15 19:45 20:00 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint Session Joint Session Scientific Session Nursing and allied professions Rapid Fire Abstract Session SSC/SSCS Free communications 1 SPP 20:00 11:30 20:00 Joint Session Free communications 2 SSP 11:30 20:00 Session: Pearls of the ESC/ERS Guidelines Management of chronic thromboembolic 20:00-22:00Sarcoidosis Get together SSP/SSC Patients with obstructive sleep apnea (OSAS): Heart failure and beyond -20:00-22:00 modern treatment Get together ClinicalSSP/SSC studies in COPD and related 11:45 Cardiovascular risk factors Pulmonary cell biology 11:45 2015 disease (p.47) implications for nursing practice concepts obstructive disorders (p.48) (p.45) 12:00 (p.47) (p.48) (p.49) Friday 17.06.2016(p.43) (p.40) 12:00 12:15 Thursday 16.06.2016 12:15 12:30-12:45 (p.49) 12:30 12:30 Auditorium B Tuberculosis ResearchRoom 5AB Prize Ceremony Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor Auditorium12:30-13:15 B Lunch at Piazza and ExhibitionRoom 5AB Room 1AB 12:30-13:15 LunchRoom at Piazza 3C and Exhibition Room 1C Room12:30-13:15 5C Lunch at Piazza and Exhibition Room 2C Room 4C Foyer Ground Floor 12:45 12:45 07:15 07:15 13:00 13:00 07:30 SCT/SAKR Track WATCH Track 07:30 07:15 07:15-08:00 13:15-14:15 07:15 13:15 07:45 13:15-14:15 13:15-14:15 13:15-14:15 Track13:15-14:15 Nursing and 13:15-14:15 13:15 07:45 07:30 Satellite Symposium SSCS Track Assembly 13:15-14:15 07:30 13:30 08:00 Satellite Symposium Satellite08:00-09:00 Symposium Satellite Symposium AlliedSatellite Professionals Symposium Satellite08:00-09:00 Symposium 08:00-09:00 08:00-09:00 13:30 08:00 07:45 08:00-09:30 The Medicines08:00-09:30 Company (p.31) 08:00-09:30 08:00-09:30 General assembly Working group Poster Walks SSC/SSCS & SSP 07:45 13:45 08:15 Novartis Sanofi AventisWorkshop Suisse SA PneumRx/PulmonX Actelion Pharma Schweiz AG WorkshopMedela 13:15-14:45 Workshop Workshop 13:45 08:15 Joint Session Workshop Rhythmology Joint Session Joint Session Cardiovascular nursing and allied (p.49 & p.89) 08:00 (p.52) New lung function(p.51) standards (p.51) (p.50) Cardiopulmonary pediatric(p.53) challenges of altitude General Assembly Swiss Society of Pediatric Indication and outcome in lung Swiss recommendations for adult patients 08:00 14:00 08:30 08:00-09:00 08:00-09:00 08:00-09:00 professionals08:00-09:00 14:00 08:30 08:15 08:00-09:00 NOACs and antiplatelet08:00-09:00 therapy - Update What the general cardiologist should know From gadgets to evidence based 08:00-09:00 Cardiopulmonary08:00-09:00 exercise testing (CPET): 08:15 08:45 Workshop SS(p.72) Hypertension Workshop Workshop SCOT (p.71) Pneumology transplantation Workshop (p.72) with cystic fibrosis (p.72) 08:45 14:15 Joint Session Workshop Working2016 group Rhythmology about rhythmology telemedicine Workshop interactiveWorkshop case discussion 14:15 The patient with heartfailure, renal failure Complicated parapneumonic effusion: Electronic tools and aids for patients and health Thoracovertebral malformations: 08:30 High altitude 09:00 In-depth: 2015 ESC guidelines(p.71) on ventricular (p.73) (p.71) Tobacco prevention and e-cigarette facts ILD and systemic(p.71) diseases 08:30 09:00 14:30 14:30-15:30 14:30-15:30 and hypertension:14:30-15:30 what strategy? surgery14:30-15:30 or drainage care14:30-16:00 professionals 14:30-15:30 cardiopulmonary consequences and 14:30 09:15 14:30-15:30 09:15 14:45 Workshop(p.31) arrhythmia andSatellite sudden Symposium cardiac death (p.33) Satellite Symposium Satellite Symposium Satellite(p.33) Symposium (p.32) 14:45 08:45 (p.32) (p.33) Joint(p.32) Session treatment (p.33) Poster Walks SSC/SSCS & SSP 08:45 ECG-Quiz Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG SERVIER (Suisse) SA 15:00 09:30 09:15-10:45 ECMO Therapy: What09:30 do - 09:45healthcare Coffee break at Piazza and Exhibition (p.53 & p.89) 15:00 09:30 09:00 09:00 15:15 (p.57) (p.56) Main(p.55) Session (p.55) professionals need to know about ECMO (p.57) 09:15-11:00 15:15 09:15 09:45 and how to care for these patients? 09:15 09:45 15:30 News in oncology09:15-10:45 of the Lung 09:45-11:15 09:45-11:1509:15-10:45 09:45-11:15 Main09:15-10:45 Session 15:30 09:30 09:15-10:45 10:00 09:15-10:4509:45-11:15 09:15-10:45 (p.54) 09:45-11:1509:15-10:45 09:15-10:45 09:45-11:15 09:30 10:00 15:45 Workshop and Abstract(p.73) Session Basic Science Workshop Scientific SessionJoint Nursing Session and allied professions Abstract Session SSC/SSCS PaediatricAbstract Pulmonology Session SSC/SSCS Science Session 15:45 09:45 Main Session 10:15 WorkshopMain Session AGLA Abstract Session SSC/SSCS SessionDebate15:45-17:15 SSCS 15:45-17:15Quiz 15:45-17:15 Abstract Session SSC/SSCS 09:45 10:15 16:00 15:45-17:15 15:45-17:15 Basic research15:45-17:15 in cardiology: clinical Hot topics in heart15:45-17:15 failure and mitral valve RehabilitationAdherence forafter cardiac lung transplantation and pulmonary – Leads and leadless systems: the good, the Struggling ventricles(p.74) in congenital heart 16:00 10:00 Chronic dyspnea 10:30 PulmonaryLipids embolism Heart failure at it's best HoleAbstract - LeaveEndocarditis Session it or correct SSC/SSCS it SwissAbstract pulmonary Session SSC/SSCS challenge Free communications 3 SSP Surgical particularities 10:00 10:30 16:15 Main Session Workshop perspectivesJoint Session SSPPdisease Session Enhancing patients’patients16:15-17:15 self-care abilities bad and the ugly disease 16:15 (p.37) (p.40)(p.78) (p.34) Beneficial and adverse(p.77)(p.37) of cardiometabolic Challenges in ischemic,(p.38) valvular and Physiopathology and mechanisms of (p.74) 10:15 Ventilation and heart failure10:45 Facing the challenge of TAVI 2016 Pulmonary(p.39) hypertension Pediatric Grand(p.79) Rounds (p.78)(p.38) (p.76) (p.35) 10:15 10:45 16:30 Nursing and allied professionals on- and off-target effects congenital heart disease diseases 16:30 10:30 (p.63) 11:00 (p.64) (p.63) (p.57) 10:30 11:00 16:45 Presentation of clinical scientific projects (p.61) (p.58) (p.60) 16:45 10:45 11:15 11:00-12:30 10:45 11:15 17:00 (p.64) 17:00 11:00 11:30 11:30-12:30 Main Session 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:00 11:30 17:15 11:00-12:30 11:00-12:30 11:00-12:30Asthma 11:00-12:30 11:00-12:30 11:00-12:30 17:15 11:15 11:45 Workshop Swiss WG Interventional Cardiology Joint EPFL- SSC/SSCS/SSP-Session11:00-12:30 Practical Workshop Scientific Session Joint Session 11:00-12:30 Workshop FMH Insurances 11:15 11:45 17:30 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint17:30-18:30 Session Joint17:30-18:30(p.79) Session 17:30-18:30 Scientific Session Nursing17:30-18:30 and allied professions Rapid Fire Abstract17:30-18:30 Session SSC/SSCS Free communications17:30-18:15 1 SPP 11:3017:30-18:30 – 13:00 17:30 11:30 12:00 2015 ESC NSTE-ACS guidelines in-depth Innovation and JointCompetitive Session of Research in Respiratory physiotherapy Complications in CHD - with a little help from our Evaluation of right heart function Free communications 2 SSP Medical centres and surgeries – present 11:30 12:00 17:45 Session: Pearls 17:30-19:00of the ESC/ERS Guidelines Management of Assemblychronic(p.81) thromboembolic SatelliteSarcoidosis Symposium SatelliteSwitzerland Symposium (p.80) Patients with obstructive(p.82)Workshop sleep apnea (OSAS): Heart failureAbstract andfriends beyondSession (p.81) SSC/SSCS- modern treatment ClinicalAbstract studies Session (p.80)in COPD SSC/SSCS and related SatelliteAssembly Symposium and future (p.82) 17:45 11:45 12:15 Cardiovascular risk factors Pulmonary cell biology 11:45 12:15 18:00 Assembly2015 General Assembly diseaseSwiss Society of Thoracic (p.47)Zoll Johnson&Johnson AG, Biosense Webster implicationsSSC for nursingQuiz practice Clinical Cases:concepts Miscellaneous I Clinical Cases:obstructive miscellaneous disorders II (p.65) WorkingLivaNova Group home & Sorin ventilation 18:00 12:00 12:30 Surgery (p.68) (p.68)(p.48) (p.67) (p.66) (p.45)(p.69) 12:00 12:30 18:15 General Assembly(p.47) Swiss Society of (p.48) 12:30-13:00 Lunch at Piazza and Exhibition (p.49) (p.43) 12:30-13:00 Lunch(p.40) at Piazza and Exhibition 12:30-13:00 Lunch at Piazza and Exhibition 18:15 18:3012:15 Pneumology 12:45 12:30-14:00 18:3012:15 12:45 18:45 12:30-12:45 (p.49) Assembly 18:45 12:30 13:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 12:30 13:00 19:00 Tuberculosis Research Prize Ceremony General Assembly Swiss Society of Pediatric 19:00 12:30-13:1513:15 Lunch at Piazza and ExhibitionSatellite Symposium Satellite Symposium 12:30-13:15Satellite Lunch atSymposium Piazza and Exhibition Satellite Symposium 12:30-13:15 Lunch at Piazza and ExhibitionSatellite Symposium 13:00-14:00 13:15 12:4519:15 Cardiology 12:4519:15 13:30 Vertex Pharmaceuticals (CH) GmbH GSK Mundipharma Medical Company Boston Scientific AG Boston Scientific AG SSC/SSCS-Boards & Industry CEO Meeting 13:30 13:0019:30 (p.82) (p.84) (p.82) (p.83) (p.84) 13:0019:30 13:45 13:45 19:45 19:30 Society evening, Lausanne Palace 19:30 Society evening, Lausanne Palace 13:15-14:15 19:45 13:15 14:00 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15 14:00 20:00 Assembly 13:15-14:15 20:00 13:30 Satellite Symposium Satellite Symposium Satellite14:15-15:00 Symposium Satellite Symposium Satellite Symposium 13:30 14:15 General assembly Working group Poster Walks SSC/SSCS & SSP 14:15 Novartis Sanofi Aventis Suisse SA WorkshopPneumRx/PulmonX SS Hypertension Actelion14:15-15:00 Pharma Schweiz AG Medela 13:15-14:4514:15-15:45 13:45 14:30 14:15-15:45 14:15-15:45 14:15-15:45 Cardiovascular nursing and allied (p.4913:00-17:00 & p.89) 13:45 14:30 (p.52) (p.51) Therapy of hypertension(p.51) in patients with Assembly(p.50) (p.53) General AssemblyAbstract Session Swiss SocietySSC/SSCS of Pediatric 14:00 Workshop Main Session Friday 17.06.2016 Joint Session professionals Hands-on Course 14:00 14:45 coronary heart disease Working Group Cardiac rehabilitation From PCI to electrophysiology/pacemakerPneumology 14:45 14:15 Best Swiss articles of the year 2015 Respiratory infections PAH and congenital heart disease BLS/AED Refresher 14:15 15:00 (p.88) implantation (p.82) 15:00 14:30 14:30-15:30 14:30-15:30(p.87) 14:30-15:30(p.87) 14:30-15:30 14:30-16:00 14:30-15:30(p.86) 14:30 15:15 (p.85) 14:30-15:30 15:15 14:45 AuditoriumWorkshop B SatelliteRoom Symposium 5AB SatelliteRoom Symposium 1AB SatelliteRoom Symposium 3C Room 1C SatelliteRoom Symposium 5C Room 2C Room 4C Foyer Ground Floor 14:45 Joint Session Poster Walks SSC/SSCS & SSP ECG-Quiz 15:30 Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG SERVIER (Suisse) SA 15:30 07:1515:00 ECMO Therapy: What do healthcare (p.53 & p.89) 07:1515:00 (p.57) (p.56) (p.55) (p.55) (p.57) 07:3015:15 SCT/SAKR Track professionalsWATCH need to Track know about ECMO 07:3015:15 and how to care for these patients? 07:4515:30 07:4515:30 (p.54) 08:0015:45 08:00-09:00 08:00-09:00 08:00-09:00 08:00-09:00 08:0015:45 08:00-09:30 08:00-09:30 08:00-09:30 08:00-09:3015:45-17:15 15:45-17:15 15:45-17:15 08:1516:00 15:45-17:15 15:45-17:15Workshop 15:45-17:15 15:45-17:15 Workshop Workshop Workshop 08:1516:00 Joint Session Workshop Rhythmology Joint Session AbstractJoint Session Session SSC/SSCS Abstract Session SSC/SSCS Free communications 3 SSP 16:15 Main Session New lung functionWorkshop standards Joint Session SSPP Session Cardiopulmonary pediatric16:15-17:15 challenges of altitude Indication and outcome in lung Swiss recommendations for adult patients 16:15 08:30 NOACs and antiplatelet therapy - Update What the general cardiologist should know From gadgets to evidence based BeneficialCardiopulmonary and adverse exercise of cardiometabolic testing (CPET): Challenges in ischemic, valvular and Physiopathology and mechanisms of 08:30 16:30 Ventilation and heart failure Facing the challenge(p.72) of TAVI 2016 Pulmonary hypertension Pediatric Grand Rounds Nursing and allied(p.71) professionals transplantation (p.72) with cystic fibrosis (p.72) 16:30 08:45 2016 about rhythmology telemedicine interactiveon- and off-target case discussion effects congenital heart disease diseases 08:45 (p.63) (p.64) (p.63) (p.57) Presentation of clinical scientific projects 09:0016:45 (p.71) (p.73) (p.71) (p.61)(p.71) (p.58) (p.60) 09:0016:45 (p.64) 09:1517:00 09:1517:00 17:15 17:15 09:30 09:15-10:45 09:30 - 09:45 Coffee break at Piazza and Exhibition 09:30 17:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:15 17:30-18:30 17:30 Main Session 09:15-11:00 15 17:4509:45 17:30-19:00 Assembly Satellite Symposium Satellite Symposium Workshop Abstract Session SSC/SSCS Abstract Session SSC/SSCS Satellite Symposium 17:4509:45 News in oncology of the Lung 09:45-11:15 09:45-11:15 09:45-11:15 Main Session 18:0010:00 09:45-11:15Assembly General Assembly Swiss Society of Thoracic Zoll Johnson&Johnson AG, Biosense Webster 09:45-11:15SSC Quiz Clinical Cases: Miscellaneous I Clinical Cases: miscellaneous II (p.65) LivaNova09:45-11:15 & Sorin 18:0010:00 (p.73) Workshop Joint Session Abstract Session SSC/SSCS Paediatric Pulmonology Science Session 10:15 General AssemblyMain Session Swiss Society of Surgery (p.68) (p.68) Debate(p.67) (p.66) Abstract Session(p.69) SSC/SSCS 10:15 18:15 Hot topics in heart failure and mitral valve Rehabilitation for cardiac and pulmonary Leads and leadless systems: the good, the (p.74) 18:15 PulmonaryPneumology embolism Hole - Leave it or correct it Surgical particularities 18:3010:30 disease patients bad and the ugly 18:3010:30 (p.78) (p.77) (p.74) 18:4510:45 (p.79) (p.78) (p.76) 18:4510:45 19:0011:00 19:0011:00 19:1511:15 11:00-12:30 19:1511:15 19:3011:30 11:30-12:30 Main Session 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 19:3011:30 19:4511:45 Workshop Swiss WG Interventional Cardiology Asthma19:30 Society evening, LausanneJoint EPFL- Palace SSC/SSCS/SSP-Session Practical Workshop Scientific Session Joint Session19:30 Society evening, Lausanne Palace Workshop FMH Insurances 19:4511:45 20:0012:00 2015 ESC NSTE-ACS guidelines in-depth (p.79) Innovation and Competitive of Research in Respiratory physiotherapy Complications in CHD - with a little help from our Evaluation of right heart function 11:30 – 13:00 Medical centres and surgeries – present 20:0012:00 12:15 (p.81) Switzerland (p.80) (p.82) friends (p.81) (p.80) Assembly and future (p.82) 12:15 Working Group home ventilation 12:30 12:30 12:30-13:00 Lunch at Piazza and Exhibition Friday 17.06.2016 12:30-13:00 Lunch at Piazza and Exhibition 12:30-13:00 Lunch at Piazza and Exhibition 12:45 12:30-14:00 12:45 Assembly 13:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00 General Assembly Swiss Society of Pediatric SatelliteAuditorium Symposium B SatelliteRoom Symposium 5AB SatelliteRoom Symposium 1AB SatelliteRoom Symposium 3C Room 1C SatelliteRoom Symposium 5C 13:00-14:00Room 2C Room 4C Foyer Ground Floor 13:15 Cardiology 13:15 Vertex Pharmaceuticals (CH) GmbH GSK Mundipharma Medical Company Boston Scientific AG Boston Scientific AG SSC/SSCS-Boards & Industry CEO Meeting 07:1513:30 07:1513:30 (p.82) (p.84) (p.82) (p.83) (p.84) 07:3013:45 SCT/SAKR Track WATCH Track 07:3013:45 07:4514:00 07:4514:00 14:1508:00 08:00-09:00 14:15-15:00 08:00-09:00 08:00-09:00 08:00-09:00 14:1508:00 08:00-09:30 08:00-09:30 08:00-09:30 08:00-09:30 08:15 Workshop Workshop SS Hypertension 14:15-15:00 Workshop 14:15-15:45 Workshop Workshop 08:15 14:30 Joint14:15-15:45 Session 14:15-15:45 Workshop Rhythmology Joint Session 14:15-15:45 Joint Session 13:00-17:00 14:30 New lung function standards Therapy of hypertension in patients with Assembly Cardiopulmonary pediatric challenges of altitude Abstract Session SSC/SSCS Indication and outcome in lung Swiss recommendations for adult patients 08:30 NOACs and antiplateletWorkshop therapy - Update Main Session What the general cardiologist should know From gadgets to evidence based Joint Session Cardiopulmonary exercise testing (CPET): Hands-on Course 08:30 14:45 (p.72) coronary heart disease Working Group Cardiac rehabilitation (p.71) From PCI to electrophysiology/pacemaker transplantation (p.72) with cystic fibrosis (p.72) 14:45 08:45 Best Swiss articles2016 of the year 2015 Respiratory infections about rhythmology telemedicine PAH and congenital heart disease interactive case discussion BLS/AED Refresher 08:45 15:00 (p.88) implantation 15:00 09:00 (p.71)(p.87) (p.87) (p.73) (p.71) (p.86) (p.71) (p.82) 09:00 (p.85) 09:1515:15 09:1515:15 15:30 15:30 09:30 09:15-10:45 09:30 - 09:45 Coffee break at Piazza and Exhibition 09:30 Main Session 09:15-11:00 09:45 09:45 News in oncology of the Lung 09:45-11:15 09:45-11:15 09:45-11:15 Main Session 10:00 09:45-11:15 09:45-11:15 09:45-11:15 10:00 (p.73) Workshop Joint Session Abstract Session SSC/SSCS Paediatric Pulmonology Science Session 10:15 Main Session Debate Abstract Session SSC/SSCS 10:15 Hot topics in heart failure and mitral valve Rehabilitation for cardiac and pulmonary Leads and leadless systems: the good, the (p.74) Pulmonary embolism Hole - Leave it or correct it Surgical particularities 10:30 disease patients bad and the ugly 10:30 (p.78) (p.77) (p.74) 10:45 (p.79) (p.78) (p.76) 10:45 11:00 11:00 11:15 11:00-12:30 11:15 11:30 11:30-12:30 Main Session 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30-12:30 11:30 11:45 Workshop Swiss WG Interventional Cardiology Asthma Joint EPFL- SSC/SSCS/SSP-Session Practical Workshop Scientific Session Joint Session Workshop FMH Insurances 11:45 12:00 2015 ESC NSTE-ACS guidelines in-depth (p.79) Innovation and Competitive of Research in Respiratory physiotherapy Complications in CHD - with a little help from our Evaluation of right heart function 11:30 – 13:00 Medical centres and surgeries – present 12:00 12:15 (p.81) Switzerland (p.80) (p.82) friends (p.81) (p.80) Assembly and future (p.82) 12:15 Working Group home ventilation 12:30 12:30 12:30-13:00 Lunch at Piazza and Exhibition 12:30-13:00 Lunch at Piazza and Exhibition 12:30-13:00 Lunch at Piazza and Exhibition 12:45 12:30-14:00 12:45 Assembly 13:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00-14:00 13:00 General Assembly Swiss Society of Pediatric Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:00-14:00 13:15 Cardiology 13:15 13:30 Vertex Pharmaceuticals (CH) GmbH GSK Mundipharma Medical Company Boston Scientific AG Boston Scientific AG SSC/SSCS-Boards & Industry CEO Meeting 13:30 (p.82) (p.84) (p.82) (p.83) (p.84) 13:45 13:45 14:00 14:00 14:15 14:15-15:00 14:15 Workshop SS Hypertension 14:15-15:00 14:15-15:45 14:30 14:15-15:45 14:15-15:45 14:15-15:45 13:00-17:00 14:30 Therapy of hypertension in patients with Assembly Abstract Session SSC/SSCS Workshop Main Session Joint Session Hands-on Course 14:45 coronary heart disease Working Group Cardiac rehabilitation From PCI to electrophysiology/pacemaker 14:45 Best Swiss articles of the year 2015 Respiratory infections PAH and congenital heart disease BLS/AED Refresher 15:00 (p.88) implantation 15:00 (p.87) (p.87) (p.86) (p.82) 15:15 (p.85) 15:15 15:30 15:30 Wednesday, 15.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

Thursday 16.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

09:00 09:00 09:15 09:15 09:15-10:45 09:15-10:45 09:15-10:45 09:30 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:30 Workshop and Abstract Session Basic Science Scientific Session Nursing and allied professions Abstract Session SSC/SSCS 09:45 Main Session Workshop AGLA Abstract Session SSC/SSCS Session SSCS Quiz 09:45 Basic research in cardiology: clinical Adherence after lung transplantation – Struggling ventricles in congenital heart Chronic dyspnea Lipids Heart failure at it's best Endocarditis Swiss pulmonary challenge 10:00 perspectives Enhancing patients’ self-care abilities disease 10:00 (p.37) (p.40) (p.34) (p.37) (p.38) 10:15 (p.39) (p.38) (p.35) 10:15 10:30 10:30 10:45 10:45 11:00 11:00 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:15 11:00-12:30 11:00-12:30 11:15 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint Session Joint Session Scientific Session Nursing and allied professions Rapid Fire Abstract Session SSC/SSCS Free communications 1 SPP 11:30 Joint Session Free communications 2 SSP 11:30 Session: Pearls of the ESC/ERS Guidelines Management of chronic thromboembolic Sarcoidosis Patients with obstructive sleep apnea (OSAS): Heart failure and beyond - modern treatment Clinical studies in COPD and related 11:45 Cardiovascular risk factors Pulmonary cell biology 11:45 2015 disease (p.47) implications for nursing practice concepts obstructive disorders (p.48) (p.45) 12:00 (p.47) (p.48) (p.49) (p.43) (p.40) 12:00 12:15 12:15 12:30-12:45 (p.49) 12:30 12:30 Tuberculosis Research Prize Ceremony 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:45 12:45 13:00 13:00 13:15-14:15 13:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15 Assembly 13:15-14:15 Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:30 General assembly Working group Poster Walks SSC/SSCS & SSP 13:30 Novartis Sanofi Aventis Suisse SA PneumRx/PulmonX Actelion Pharma Schweiz AG Medela 13:45 13:15-14:45 Cardiovascular nursing and allied (p.49 & p.89) 13:45 (p.52) (p.51) (p.51) (p.50) (p.53) General Assembly Swiss Society of Pediatric 14:00 professionals 14:00 Pneumology 14:15 14:15 14:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30 14:30-16:00 14:30-15:30 14:45 Workshop Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 14:45 Joint Session Poster Walks SSC/SSCS & SSP ECG-Quiz Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG SERVIER (Suisse) SA 15:00 ECMO Therapy: What do healthcare (p.53 & p.89) 15:00 15:15 (p.57) (p.56) (p.55) (p.55) professionals need to know about ECMO (p.57) 15:15 15:30 and how to care for these patients? 15:30 15:45 (p.54) 15:45 15:45-17:15 15:45-17:15 15:45-17:15 16:00 15:45-17:15 15:45-17:15 15:45-17:15 15:45-17:15 16:00 Abstract Session SSC/SSCS Abstract Session SSC/SSCS Free communications 3 SSP 16:15 Main Session Workshop Joint Session SSPP Session 16:15 16:15-17:15 Beneficial and adverse of cardiometabolic Challenges in ischemic, valvular and Physiopathology and mechanisms of Ventilation and heart failure Facing the challenge of TAVI 2016 Pulmonary hypertension Pediatric Grand Rounds 16:30 Nursing and allied professionals on- and off-target effects congenital heart disease diseases 16:30 (p.63) (p.64) (p.63) (p.57) 16:45 Presentation of clinical scientific projects (p.61) (p.58) (p.60) 16:45 17:00 (p.64) 17:00 17:15 17:15 17:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:15 17:30-18:30 17:30 17:45 17:30-19:00 Assembly Satellite Symposium Satellite Symposium Workshop Abstract Session SSC/SSCS Abstract Session SSC/SSCS Satellite Symposium 17:45 18:00 Assembly General Assembly Swiss Society of Thoracic Zoll Johnson&Johnson AG, Biosense Webster SSC Quiz Clinical Cases: Miscellaneous I Clinical Cases: miscellaneous II (p.65) LivaNova & Sorin 18:00 18:15 General Assembly Swiss Society of Surgery (p.68) (p.68) (p.67) (p.66) (p.69) 18:15 18:30 Pneumology 18:30 18:45 18:45 Programme19:00 Overview 19:00 19:15 19:15 19:30 19:30 19:45 19:30 Society evening, Lausanne Palace 19:30 Society evening, Lausanne Palace 19:45 Friday,20:00 June 17 20:00 Friday 17.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

Side Meetings

Time Room Who

11:00–12:15 E Arbeitsgruppe Lungenfunktion SGP

12:30–13:15 F Kommission Weiterbildung SGP

12:30–13:15 G Arbeitsgruppe Asthma

12:45–14:00 E General Assembly SCT

16 Wednesday, 15.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

Thursday 16.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

09:00 09:00 09:15 09:15 09:15-10:45 09:15-10:45 09:15-10:45 09:30 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:15-10:45 09:30 Workshop and Abstract Session Basic Science Scientific Session Nursing and allied professions Abstract Session SSC/SSCS 09:45 Main Session Workshop AGLA Abstract Session SSC/SSCS Session SSCS Quiz 09:45 Basic research in cardiology: clinical Adherence after lung transplantation – Struggling ventricles in congenital heart Chronic dyspnea Lipids Heart failure at it's best Endocarditis Swiss pulmonary challenge 10:00 perspectives Enhancing patients’ self-care abilities disease 10:00 (p.37) (p.40) (p.34) (p.37) (p.38) 10:15 (p.39) (p.38) (p.35) 10:15 10:30 10:30 10:45 10:45 11:00 11:00 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:00-12:30 11:15 11:00-12:30 11:00-12:30 11:15 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Joint Session Joint Session Scientific Session Nursing and allied professions Rapid Fire Abstract Session SSC/SSCS Free communications 1 SPP 11:30 Joint Session Free communications 2 SSP 11:30 Session: Pearls of the ESC/ERS Guidelines Management of chronic thromboembolic Sarcoidosis Patients with obstructive sleep apnea (OSAS): Heart failure and beyond - modern treatment Clinical studies in COPD and related 11:45 Cardiovascular risk factors Pulmonary cell biology 11:45 2015 disease (p.47) implications for nursing practice concepts obstructive disorders (p.48) (p.45) 12:00 (p.47) (p.48) (p.49) (p.43) (p.40) 12:00 12:15 12:15 12:30-12:45 (p.49) 12:30 12:30 Tuberculosis Research Prize Ceremony 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:30-13:15 Lunch at Piazza and Exhibition 12:45 12:45 13:00 13:00 13:15-14:15 13:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15-14:15 13:15 Assembly 13:15-14:15 Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 13:30 General assembly Working group Poster Walks SSC/SSCS & SSP 13:30 Novartis Sanofi Aventis Suisse SA PneumRx/PulmonX Actelion Pharma Schweiz AG Medela 13:45 13:15-14:45 Cardiovascular nursing and allied (p.49 & p.89) 13:45 (p.52) (p.51) (p.51) (p.50) (p.53) General Assembly Swiss Society of Pediatric 14:00 professionals 14:00 Pneumology 14:15 14:15 14:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30-15:30 14:30 14:30-16:00 14:30-15:30 14:45 Workshop Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium 14:45 Joint Session Poster Walks SSC/SSCS & SSP ECG-Quiz Amgen Switzerland AG Daiichi Sankyo (Schweiz) AG ResMed Schweiz AG SERVIER (Suisse) SA 15:00 ECMO Therapy: What do healthcare (p.53 & p.89) 15:00 15:15 (p.57) (p.56) (p.55) (p.55) professionals need to know about ECMO (p.57) 15:15 15:30 and how to care for these patients? 15:30 15:45 (p.54) 15:45 15:45-17:15 15:45-17:15 15:45-17:15 16:00 15:45-17:15 15:45-17:15 15:45-17:15 15:45-17:15 16:00 Abstract Session SSC/SSCS Abstract Session SSC/SSCS Free communications 3 SSP 16:15 Main Session Workshop Joint Session SSPP Session 16:15 16:15-17:15 Beneficial and adverse of cardiometabolic Challenges in ischemic, valvular and Physiopathology and mechanisms of Ventilation and heart failure Facing the challenge of TAVI 2016 Pulmonary hypertension Pediatric Grand Rounds 16:30 Nursing and allied professionals on- and off-target effects congenital heart disease diseases 16:30 (p.63) (p.64) (p.63) (p.57) 16:45 Presentation of clinical scientific projects (p.61) (p.58) (p.60) 16:45 17:00 (p.64) 17:00 17:15 17:15 17:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:30 17:30-18:15 17:30-18:30 17:30 17:45 17:30-19:00 Assembly Satellite Symposium Satellite Symposium Workshop Abstract Session SSC/SSCS Abstract Session SSC/SSCS Satellite Symposium 17:45 18:00 Assembly General Assembly Swiss Society of Thoracic Zoll Johnson&Johnson AG, Biosense Webster SSC Quiz Clinical Cases: Miscellaneous I Clinical Cases: miscellaneous II (p.65) LivaNova & Sorin 18:00 18:15 General Assembly Swiss Society of Surgery (p.68) (p.68) (p.67) (p.66) (p.69) 18:15 18:30 Pneumology 18:30 18:45 18:45 19:00 Programme Overview 19:00 19:15 19:15 19:30 19:30 19:45 19:30 Society evening, Lausanne Palace 19:30 Society evening, Lausanne Palace 19:45 20:00 Friday, June 17 20:00 Friday 17.06.2016

Auditorium B Room 5AB Room 1AB Room 3C Room 1C Room 5C Room 2C Room 4C Foyer Ground Floor

17 Dans l’asthme bronchique1

Ce n’est pas NOUVEAU. C’est juste LOGIQUE!

Première association fixe de propionate de fluticasone + fumarate de formotérol

1 Information professionnelle flutiform® aérosol-doseur (www.swissmedicinfo.ch) Admis aux caisses

FLUTIFORM® aérosol-doseur C: Principes actifs: propionate de fluticasone et fumarate de formotérol dihydraté: aérosol-doseur à50/5μg, 125/5 μg, 250/10 μg. Excipients: apaflurane (HFA 227), cromoglycate de sodium, éthanol.I: Asthme chez l’adulte et l’adolescent âgé de 12 ans et plus lorsque l‘administration d’un produit combiné est indiquée. N’est pas adapté au traitement de première ligne de l’asthme léger. P: L’adulte et l’adolescent âgé de 12 ans et plus: deux inhalations deux fois par jour le matin et le soir de 50/5 μg, 125/5 μg ou, uniquement chez l’adulte, 250/10 μg. Patients souffrant de maladies hépatiques ou rénales: aucune donnée n’est disponible. Patients âgés: il n’y a pas lieu d’ajuster la posologie. Population pédiatrique/adolescente: ne doit pas être utilisé chez l’enfant âgé de moins de 12 ans. FLUTIFORM® 250/10 μg ne doit pas être utilisé chez l’adolescent. La chambre d’inhalation AeroChamber Plus® peut être utilisée. CI: Hypersensibilité à l’un des principes actifs ou à l’un des excipients. PE: N’est pas adapté au traitement des symptômes aigus de l’asthme, de la BPCO ou à la prévention de l’asthme d‘effort. Ne pas interrompre le traitement brusquement; la diminution de la posologie doit s’effectuer progressivement. La précau- tion est de mise lors du traitement des patients présentant un allongement de l‘intervalle QTc, chez les patients atteints de diabète, de tuberculose pulmonaire, de troubles cardiovasculaires sévères, d’hypokaliémie, d’insuffisance surrénalienne, d’insuffisance hépatique sévère ou d’infections chroniques/non-traités. Un bronchospasme paradoxal doit être immédia- tement traité par un bronchodilatateur inhalé d’action rapide. Une détérioration du contrôle des symptômes de l’asthme peut mettre en jeu le pronostic vital et la prescription d’une corticothérapie complémentaire doit être envisagée. Des effets indésirables systémiques peuvent apparaître lors de traitement au long cours avec des doses élevées. IA: Prudence avec les inhibiteurs puissants du CYP3A4 comme la ritonavir ou la kétoconazole et les diurétiques épargneurs de potassium (hypok- aliémie/modifications de l‘ECG) ainsi que la L-Dopa, la L-thyroxine, l’ocytocine et l’alcool. Prudence avec l’administration concomitante d’antagonistes des récepteurs -adrénergiques (-bloquants) et d‘autres médicaments connus pour allonger l‘intervalle QTc tels que les antidépresseurs tricycliques ou les inhibiteurs de la monoamine oxydase. Grossesse/Allaite- ment: Évaluation des bénéfices/risques. Interruption de l‘allaitement ou arrêt du traitement par FLUTIFORM®.EI: Occasionnel: Troubles du sommeil, insomnie, rash, céphalées, tremblements, étourdissements, palpitations, extrasystoles ventriculaires, exacerbation, dysphonie, irritation de la gorge, sécheresse de la bouche. P: 50/5 μg, 125/5 μg, 250/10 μg: emballage de 1 aérosol-doseur à 120 doses unitaires. Catégorie de remise: B. Titulaire de l’autorisation: Mundipharma Medical Company, Hamilton/Bermuda, succursale de Bâle, St. Alban-Rheinweg 74, 4052 Bâle, www.mundipharma.ch. Mise à jour de l’information: Mai 2015. ®: FLUTIFORM est une marque enregistrée. L’information professionnelle complète est publiée sur www.swissmedicinfo.ch.

18 Detailed Programme Wednesday, June 15

Pre-Meeting Room 1AB

08:30–10: 00 Postgraduate course in imaging - Theory of 3D echo 1 Chair: Patric Biaggi (Zürich, CH)

Course introduction 1.1 Patric Biaggi (Zürich, CH)

Grading severity of aortic stenosis: 1.2 simple and easy…? Alain Delabay (Lausanne, CH)

Impact of pressure recovery and energy loss index 1.3 Felix Tanner (Zürich, CH)

Role of 3D (TTE and TEE) to confirm severe AS 1.4 Francesco Faletra (Lugano, CH)

Role of 2D/3D strain imaging in aortic stenosis 1.5 Patric Biaggi (Zürich, CH)

Role of cardiac CT and MR in severe aortic stenosis? 1.6 Pierre Monney (Lausanne, CH)

Q&A

Pre-Meeting Room 1C

08:30–11:15 Postgraduate course heart failure 2 Chairs: Thomas Suter (Bern, CH) Roger Hullin (Lausanne, CH) Otmar Pfister (Basel, CH)

Guidelines 2016 2.1 Matthias Naegele (Zürich, CH)

New Drugs 2.2 Ariane Testuz (Geneva, CH)

HFpEF & acute heart failure 2.3 Jan Vontobel (Zürich, CH)

19 Detailed Programme Wednesday, June 15

Non-pharmacological treatment 2.4 Tobias Höffinghaus (Zürich, CH)

Further devices to monitor & treat heart failure 2.5 Matthias Kirsch (Lausanne, CH)

Left ventricular Non-Compaction 2.6 Simon Stämpfli (Zürich, CH)

Amyloidosis 2.7 Michele Martinelli (Bern, CH)

Myocarditis 2.8 Vilborg Sigurdardottir (Bern, CH)

Imaging in heart failure 2.9 Matthias Paul (Luzern, CH)

Pre-Meeting Room 5AB

08:30–11:15 Swiss fellow course 3 interventional cardiology Chairs: Stéphane Cook (Fribourg, CH) Peter Wenaweser (Zürich, CH)

How to manage access complications? 3.1 Stéphane Noble (Geneva, CH)

How to manage no reflow? 3.2 Marco Roffi (Geneva, CH)

How to manage underexpanded stents? 3.3 Olivier Müller (Lausanne, CH)

How to manage device embolization? 3.4 Amir Fassa (Geneva, CH)

How to perform PCI of stent thrombosis? 3.5 Peter Wenaweser (Zürich, CH)

How to perform rotablation? 3.6 Stéphane Cook (Fribourg, CH)

20 Detailed Programme Wednesday, June 15

How to perform with little radiation? 3.7 Jean-Christophe Stauffer (Fribourg, CH)

Discussion 3.8 Stéphane Cook (Fribourg, CH) Peter Wenaweser (Zürich, CH)

Pre-Meeting Room 1AB

10: 00–11:30 Postgraduate course in imaging - work on your skills: hands on 3D Echo, strain and CT analysis! 4 Chair: Patric Biaggi (Zürich, CH)

Hands on 3D TTE with Philips 4.1 Francesco Faletra (Lugano, CH)

Hands on 3D TTE with GE 4.2 Alain Delabay (Lausanne, CH)

3D volume & strain analysis on Tomtec workstation 4.3 Patric Biaggi (Zürich, CH)

3D volume & strain analysis on GE workstation 4.4 Pierre Monney (Lausanne, CH) Rotations (3 out of 5 options) CT aortic root reconstruction on 3mensio 4.5 workstation Christophe Wyss (Zürich, CH)

Closing remarks 4.6 Patric Biaggi (Zürich, CH)

Workshop Room 3C

10:30–12: 00 Young Swiss Cardiac Surgeons Session 5 Chairs: Diana Reser (Zürich, CH) David Reineke (Bern, CH)

Learning to train smarter 5.1 Jonathan Afoke (Taunton, UK)

Herzchirurgische Ausbildung in Deutschland 5.2 Fabian Emrich (Leipzig, DE)

21 Detailed Programme Wednesday, June 15

Abstract Session Room 1AB

14:00–15:30 News in catheter ablation of arrhythmias 6 Chairs: Tobias Reichlin (Basel, CH) Mehdi Namdar (Geneva, CH)

Radiofrequency catheter ablation of atrial OR01 fibrillation since 2001: did we improve? H. Servatius1, L. Roten1, J. Seiler1, F. Noti1, *, V. N. Tran1, A. Medeiros Domingo1, A. Haeberlin1, A. Lam1, J. Fuhrer1, H. Tanner1 (1Department of Cardiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland)

Reduction of radiation exposure during OR02 cryoballoon ablation of atrial fibrillation M. Kühne1, *, S. Knecht1, T. Reichlin1, A. Mühl1, B. Schaer1, S. Osswald1, C. Sticherling1 (1University of Basel, Basel, Switzerland)

Catheter ablation of ventricular tachycardia OR03 in arrhythmogenic right ventricular cardiomyopathy – experience of a tertiary care center N. Schenker1, *, A. M. Saguner1, S. Mathew1, R. Tilz1, E. Wissner1, A. Metzner1, C. Lemes1, T. Maurer1, C. Heeger1, T. Fink1, F. Santoro1, K. Hayashi1, K.-H. Kuck1, F. Ouyang1 (1Asklepios Klinik St. Georg, Hamburg, Germany)

Propensity-score weighted analysis of irrigated- OR04 tip catheter ablation of typical atrial flutter using standard irrigated platinum-iridium, porous irrigated platinum-iridium and irrigated gold-tip catheters S. Knecht1, F. Burch1, *, A. Mühl1, T. Reichlin1, U. Celikyurt1, B. Schaer1, D. Altmann2, P. Ammann2, S. Osswald1, C. Sticherling1, M. Kühne1 (1Cardiology, University Hospital Basel, Basel, 2Kantonsspital St. Gallen, St. Gallen, Switzerland)

First clinical experience using a novel high- OR05 resolution electroanatomical mapping system for left atrial ablation procedures A. Saguner1, *, C. Sohns1, C. Lemes1, F. Santoro2, F. Ouyang1, K.-H. Kuck1, A. Metzner1

* Presenting author

22 Detailed Programme Wednesday, June 15

(1Asklepios Klinik St. Georg, Hamburg, Germany, 2Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany)

Association between symptomatic burden and OR06 left atrial anatomy in patient with atrial fibrillation S. Knecht1, *, M. Pradella2, A. Mühl1, T. Reichlin1, U. Celikyurt1, B. Stieltjes2, J. Bremerich2, S. Osswald1, C. Sticherling1, M. Kühne1 (1Cardiology, 2Radiology, University Hospital Basel, Basel, Switzerland)

Abstract Session Room 1C

14:00–15:30 Methods for assessment and monitoring of risk 7 Chairs: Walter Riesen (Diessenhofen, CH) Richard James (Geneva, CH)

Prognosis of patients with clinical familial hyper- OR07 cholesterolemia after acute coronary syndrome D. Nanchen1, *, B. Gencer2, O. Muller3, C. M. Matter4, T. F. Lüscher4, S. Windecker5, F. Mach2, N. Rodondi6 (1Policlinique Médicale Universitaire, Lausanne, 2Division of Cardiology, Faculty of Medicine, Geneva University Hospitals, Geneva, 3Service of Cardiology, Lausanne University Hospital, Lausanne, 4Department of Cardiology, University Hospital Zurich, Zurich, 5Department of Cardiology, University Hospital Bern, 6Department of General Internal Medicine, University Hospital of Bern, Bern, Switzerland)

Prognostic value of pcsk9 levels in patients OR08 with acute coronary syndromes B. Gencer1, *, F. Montecucco1, D. Nanchen2, F. Carbone1, R. Klingenberg3, N. Vuilleumier4, S. Aghlmandi5, D. Heg5, L. Räber6, R. Auer7, P. Jüni8, S. Windecker6, T. Lüscher3, C. M. Matter3, N. Rodondi9, F. Mach1 (1Cardiology Division, Geneva University Hospitals, Geneva, 2Department of Ambulatory Care and Community Medicine, Lausanne University, Lausanne, 3Department of Cardiology, University Heart Center, University of Zürich, Zürich, 4Laboratory Medicine Division, Geneva University Hospitals, Geneva, 5Institute of Social and Preventive Medicine, Clinical Trials Unit, Department of Clinical

* Presenting author

23 Detailed Programme Wednesday, June 15

Research, University of Bern, 6Department of Cardiology, University Hospital of Bern, Bern, 7Department of Ambulato- ry Care and Community Medicine, Lausanne University, Lausanne, 8Institute of Primary Health Care, University of Bern, 9Department of General Internal Medicine, University Hospital of Bern, Bern, Switzerland)

Serum uromodulin predicts cardiovascular OR09 events both in patients with and in subjects without type 2 diabetes A. Leiherer1, 2, A. Mündlein2, C. H. Säly1, 2, 3, P. Rein2, 3, A. Vonbank2, 3, E. Kinz1, 2, E.-M. Brandtner2, P. Fraunberger4, A. Mader1, 3, *, H. Drexel1, 2, 3, 5 (1Medicine, Private University of the Principality of Liechten- stein, Triesen, Liechtenstein, 2VIVIT-institute, 3Medicine & Cardiology, 4Medical Central Laboratory Feldkirch, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 5College of Medicine, Drexel University, Philadelphia, United States)

Risk assessment for rupture of ascending aortic OR10 aneurysms. Are we missing something? S. Grego1, *, R. Trunfio1, E. Ferrari1, S. Demertzis1 (1Cardiac surgery, Cardiocentro Ticino, Lugano, Switzerland)

Telementoring of endovascular abdominal OR11 aneurysm repair: resilience against time and geo- graphical setbacks afflicting on-site teaching A. P. Porretta1, M. Alerci2, R. Wyttenbach2, M. Bogen2, M. Toderi2, A. Guerra2, M. Di Valentino2, M. Cattaneo2, C. Limoni3, L. K. Von Segesser1, A. Gallino2, * (1Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, 2Ospedale San Giovanni, Bellinzona, 3University of Applied Sciences and Arts of Southern Switzerland, Lugano, Switzerland)

Iphone-app compared to standard blood OR12 pressure measurement – trial design and pilot data of the iparr trial L. Leonardi1, S. Weber2, R. Birkemeyer3, N. Brasier4, T. Schön5, T. Burkard6, C. Winterhalder4, A. Maseli4, M. Kühne5, D. Conen4, T. Huebner7, A. Seeck7, J. Eckstein4, * (1Department of Internal Medicine, Basel University Hospital, Basel, Switzerland, 2Department of Internal Medicine,

* Presenting author

24 Detailed Programme Wednesday, June 15

University Hospital Regensburg, Regensburg, 3Department of Cardiology, University Hospital Rostock, Rostock, Germany, 4Department of Internal Medicine, Basel University Hospital, 5Department of Cardiology, Basel University Hospital, 6Medical Outpatient Clinic, Basel University Hospital, Basel, Switzerland, 7Preventicus GmbH, Jena, Germany)

Hands-on Room 2C

14:00–16:00 Interstitial lung diseases 8 Speakers: Katrin Hostettler (Basel, CH) Romain Lazor (Lausanne, CH)

Hands-on Room 4C

14:00–16:00 Thorax drainage 9 Speakers: Wolfram Karenovics (Geneva, CH) Lukas Kern (St. Gallen, CH)

Main Session Auditorium B

14:00–15:30 Assessment of acute dyspnea 10 Chairs: Thomas Schmid (Solothurn, CH) Roger Hullin (Lausanne, CH)

Primary assessment of the patient with dyspnea 10.1 on the ED Roland Bingisser (Basel, CH)

Biomarkers in the differentiation of acute dyspnea 10.2 Daiana Stolz (Basel, CH)

Value of cardiac echo in differentiation 10.3 of acute dyspnea Felix Tanner (Zürich, CH)

Prevention and treatment of acute exacerbation 10.4 of COPD Laurent Nicod (Lausanne, CH)

* Presenting author

25 Detailed Programme Wednesday, June 15

Workshop Room 5AB

14:00–15:30 What happened to our difficult cases? 11 Chairs: Alexander Kadner (Bern, CH) Gabriella De Pasquale (Zürich, CH)

Case 1 11.1 Fabienne Schwitz (Bern, CH)

Case 2 11.2 Daniel Tobler (Basel, CH)

Case 3 11.3 Coralie Blanche (Geneva, CH)

Case 4 11.4 Santos Lopes (Zürich, CH)

Workshop Room 5C

14:00–17:00 Quality parameters in extracorporeal circulation 12 Chairs: Hansjörg Jenni (Bern, CH) Simon Costabile (Zürich, CH)

Speakers: Tommaso Aloisio (Milano, IT) Sven Maier (Freiburg, DE) Filip De Somer (Gent, BE) Catherine Reid (Bern, CH)

Award Lecture Room 3C

14:15–15:30 Senning Lecture & SSCS Medtronic Young 13 Investigators Award Prize Lecture Chairs: Michele Genoni (Zürich, CH) Francesco Siclari (Lugano, CH)

Rapidly changing world of cardiac surgery 13.1 Marko Turina (Zürich, CH)

Type A aortic dissection model to improve 13.2 endovascular research and technologies Paul Heinisch (Bern, CH)

26 Detailed Programme Wednesday, June 15

Abstract Session Room 1C

15:45–17: 00 Clinical pearls in rhythmology 14 Chairs: Patrick Monnier (La Chaux-de-Fonds, CH) Martin Kraus (Weinfelden, CH)

Cardiac contractility modulation therapy for OR13 patients with reduced ejection fraction heart failure and normal qrs duration: report of two cases N. Perrin1, S. Cook1, D. Graf1, * (1University and Hospital of Fribourg, Fribourg, Switzerland)

Transient para-aortic hematoma during OR14 transseptal puncture for atrial fibrillation ablation: a characteristic echocardiographic image P. Monney1, *, P. Pascale1, V. Crisinel1, F. Zuercher1, L. Bisch1, J. Schläpfer1, X. Jeanrenaud1, E. Pruvot1 (1Service de Cardiologie, CHUV, Lausanne, Switzerland)

Emergency epicardial-only vt ablation using OR15 image integration in a patient with vt storm B. Berte1, *, L. Dang1, S. Siebert2, F. W. Amman1, C. Scharf1 (1Cardiology, 2Radiology, Herzgefässzentrum Klinik Im Park, Zürich, Switzerland)

Eso-pericardial fistula after pulmonary vein OR16 isolation S. Cochard1, *, C. Beigelman-Aubry2, P. Allemann2, M. Schäfer2, L. Bisch1, P. Pascale1, E. Pruvot1 (1Service de Cardiologie, CHUV, 2CHUV, Lausanne, Switzerland)

Induction of life-threatening arrhythmias OR17 by automatic threshold monitoring by an implantable cardioverter-defibrillator J. Seiler1, *, J. Fuhrer1, H. Tanner1, L. Roten1, F. Noti1, N. Tran1, A. Haeberlin1, A. Lam1, A. Medeiros Domingo1, H. Servatius1 (1Department of Cardiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland)

* Presenting author

27 Detailed Programme Wednesday, June 15

Main Session Auditorium B

15:45–17:15 Hot news from heart failure 15 and dyslipidemia guidelines Chairs: Philippe Meyer (Geneva, CH) Thomas Suter (Bern, CH)

The new heart failure guidelines - 15.1 This session is organ- time for a paradigm shift? ized by the scientific committee . The indus- Frank Ruschitzka (Zürich, CH) try partners are kindly supporting the program without any in- The new dyslipidemia guidelines 15.2 fluence on topic, contents, and speakers . François Mach (Geneva, CH)

Background Studies Preceding Major 15.3 Pharmacologic Advances in Heart Failure Marc Pfeffer (Boston, US)

Workshop Room 1AB

15:45–17:15 New devices in current practice and 16 on the horizon Chairs: Mehdi Namdar (Geneva, CH) Andreas Häberlin (Bern, CH)

Leadless pacemakers 16.1 Tobias Reichlin (Basel, CH)

Subcutaneous ICDs 16.2 Nicolas Dayal (Geneva, CH)

Wearable cardioverter defibrillators 16.3 Sven Reek (Aarau, CH)

Phrenic nerve stimulators 16.4 Angelo Auricchio (Lugano, CH)

CRT 16.5 Richard Kobza (Luzern, CH)

28 Detailed Programme Wednesday, June 15

Workshop Room 1C

15:45–17:15 Diagnosis and treatment of pericardial effusion 17 Chairs: Jürg Schwitter (Lausanne, CH) Christiane Gruner (Zürich, CH)

Echo in pericardial effusion 17.1 Michel Zuber (Othmarsingen, CH)

CT versus CMR in evaluation of pericardial effusion 17.2 Stefano Muzzarelli (Lugano, CH)

Rare etiology of pericardial effusion: Discussion 17.3 of 2 cases Christine Attenhofer Jost (Zürich, CH)

Management of postcardiotomy syndrome 17.4 Stefanos Demertzis (Lugano, CH)

Workshop Room 5AB

15:45–17:15 Update on Stents 18 Chairs: Christian Röthlisberger (Zürich, CH) Christoph Kaiser (Basel, CH)

Now confirmed: new generation DES are superior 18.1 This session is organ- to early generation devices ized by the scientific committee . The indus- Thomas Pilgrim (Bern, CH) try partners are kindly supporting the program without any in- High bleeding risk? No more a contraindication 18.2 fluence on topic, contents, and speakers . for DES Philip Urban (Geneva, CH)

BVS: comparable safety and efficacy to newer 18.3 generation DES Florim Cuculi (Luzern, CH)

Hands-on Room 2C

16:15–18:15 Polysomnography and polygraphy 19 Speakers: Raphaël Heinzer (Lausanne, CH) Werner Strobel (Basel, CH)

29 Detailed Programme Wednesday, June 15

Hands-on Room 4C

16:15–19:15 Bodyplethysmography 20 Speakers: Thomas Sigrist (Barmelweid, CH) Daniela Emmisberger (Barmelweid, CH) Jörg Thoma (Zürich, CH)

This session is organized by the scientific committee . The industry partners are kindly supporting the program without any influence on topic, contents, and speakers .

Award Lecture Room 5AB

17:30–18:20 Andreas Grüntzig Lecture & Prize 21 Ceremony SSC/SHF Chairs: Michael Zellweger (Basel, CH) Urs Kaufmann (Bern, CH)

Energy metabolism in heart disease: 21.1 Is it clinically relevant? René Lerch (Puplinge, CH)

Happy Heart Syndrome: Role of Positive 21.2 Emotional Stress in Takotsubo Cardiomyopathy Jelena-Rima Ghadri (Zürich, CH) Christian Templin (Zürich, CH)

Should we measure PCSK9 in patients with 21.3 acute coronary syndromes? Baris Gencer (Geneva, CH)

Workshop Room 3C

17:30–18:15 Isolated systolic hypertension: 22 same significance and treatment in young and old? Speakers: Isabella Sudano (Zürich, CH) Daniel Hayoz (Fribourg, CH)

30 Detailed Programme Thursday, June 16

Satellite Symposium Room 3C The Medicines Company

07:15–08:00 Taking control of platelet inhibition in PCI 23 Chairs: Erik Eeckhout (CH) Thomas Lüscher (CH)

Welcome and Introduction 23.1 Erik Eeckhout (CH)

Platelet inhibition in coronary interventions- 23.2 needs, choices and limitations Thomas Lüscher (CH)

Cangrelor – the first intravenous P2Y12 inhibitor 23.3 Ulf Landmesser (DE)

Change practice with IV P2Y12 inhibition 23.4 Tobias Geisler (DE)

Discussion 23.5 Erik Eeckhout (CH)

Joint Session Auditorium B

08:00–09:00 High altitude 24 Chairs: Thomas Rothe (Davos Clavadel, CH) Alain Bernheim (Zürich, CH)

Physiological high altitude response 24.1 Marco Maggiorini (Zürich, CH)

Going to high altitude with heart disease 24.2 Stefano Rimoldi (Bern, CH)

Going to high altitude with pulmonary disease 24.3 Konrad Bloch (Zürich, CH)

Pulmonary hypertension at high altitude 24.4 (Prevention, Treatment) Alban Lovis (Lausanne, CH)

31 Detailed Programme Thursday, June 16

Workshop Room 1AB

08:00–09:00 The patient with heartfailure, renal failure 25 and hypertension: what strategy? Speakers: Georg Noll (Zürich, CH) Grégoire Wuerzner (Lausanne, CH)

Workshop Room 1C

08:00–09:00 Electronic tools and aids for patients 26 and health care professionals Chairs: Simon Stämpfli (Zürich, CH) Martin Brutsche (St. Gallen, CH)

Voting Monitoring in heart failure: 26.1 clinicians eyes vs. device Matthias Naegele (Zürich, CH)

New tools in diagnosing arrhythmia 26.2 Hildegard Tanner (Bern, CH)

Apps and Co. – how they are used 26.3 by young cardiologists Christina Deluigi (Bern, CH)

Building a patient-centered, comprehensive 26.4 digital network for COPD Frank Rassouli (St. Gallen, CH)

Discussion

Workshop Room 2C

08:00–09:00 ILD and systemic disease 27 Speakers: Bruno Crestani (Paris, FR) Manuela Funke-Chambour (Bern, CH)

32 Detailed Programme Thursday, June 16

Workshop Room 3C

08:00–09:00 Complicated parapneumonic effusion: 28 surgery or drainage Speakers: Barbara Wildhaber (Geneva, CH) Jürg Hammer (Basel, CH)

Workshop Room 4C

08:00–09:00 Thoracovertebral malformations: 29 cardiopulmonary consequences and treatment Speakers: Beatrix Hoksch (Bern, CH) Daniel Trachsel (Bern, CH)

Workshop Room 5AB

08:00–09:00 In-depth: 2015 ESC guidelines on ventricular 93 arrhythmia and sudden cardiac death Chairs: Jürg Fuhrer (Bern, CH) Firat Duru (Zürich, CH)

Channelopathies 93.1 Carina Blomstrom-Lundqvist (Uppsala, SE)

ICD and WCD indications 93.2 Haran Burri (Geneva, CH)

Catheter ablation of VT 93.3 Christian Sticherling (Basel, CH)

Workshop Room 5C

08:00–09:00 Tobacco prevention and e-cigarette facts 30 Chairs: Macé Schuurmans (Zürich, CH) Jürg Barben (St. Gallen, CH)

Public health perspective of the WHO framework 30.1 convention and proposed new tobacco law Pascal Diethelm (Geneva, CH)

Facts from electronic cigarette research 30.2 Wolfgang Schober (Munich, DE)

33 Detailed Programme Thursday, June 16

Abstract Session Room 3C

09:15–10:45 Heart failure at its best 31 Chairs: Pascal Berdat (Zürich, CH) Thomas Suter (Bern, CH)

Need for support for patients with chronic heart OR20 failure, the development and implementation of self management strategies at home – a qualitative research study in switzerland C. Bläuer1, *, R. Spirig2, W. Schnepp3 (1University Hospital Basel, Basel, 2Universitätsspital Zürich, Zürich, Switzerland, 3Universität Witten/Herdecke, Witten, Germany)

Sustained improvement of mitral regurgitation OR21 and symptoms after mitraclip! – update on the results of the swiss nationwide investigator- initiated prospective registry mitraswiss D. Sürder1, *, G. B. Pedrazzini1, C. Klersy2, T. Moccetti1, S. Toggweiler3, P. Jamshidi3, S. Windecker4, F. Praz4, B. Naegeli5, O. Bertel5, S. Noble6, P. Buser7, R. Jeger7, A. Vuilliomenet8, O. Muller9, O. Gaemperli10, F. Maisano10, J. Grünenfelder11, P. Erne12, R. Corti11 (1Fondazione Cardiocentro Ticino, Lugano, Switzerland, 2IRCCS Fondazione Policlinoco San Matteo, Pavia, Italy, 3Kantonsspital Luzern, Luzern, 4Inselspital Bern, Bern, 5Klinik Im Park, Zürich, 6HUG, Genève, 7Universitätsspital Basel, Basel, 8Kantonsspital Aarau, Aarau, 9CHUV, Lausanne, 10UniversitätsSpital Zürich, 11Herzklinik Hirslanden, Zürich, 12St. Anna Klinik Luzern, Luzern, Switzerland)

Characterization of the natural history and OR22 outcomes of lamin a/c cardiomyopathy over long term follow up: insights from a multi-centre study S. H. Baldinger1, 2, *, S. Kumar2, J.-M. Sellal3, E. Gandjbakhch4, X. D. Waintraub4, P. Maury5, A. Androulakis6, A. Rolin5, P. Richard5, P. Charon4, C. Macintyre7, T. Thompson8, J. Vohra8, J. M. Kalman8, K. Zeppenfeld6, F. Sacher9, N. Lakdawala2, U. B. Tedrow2, W. G. Stevenson2 (1Inselspital, Bern, Switzerland, 2Brigham and Women’s Hospital, Boston, United States, 3Centre Hospitalier

* Presenting author

34 Detailed Programme Thursday, June 16

Universitaire de Nancy, Nancy, 4Hôpital de la Pitié-Salpêtriè- re, Paris, 5Toulouse University Hospital, Toulouse, France, 6Leiden University Medical Center, Leiden, Netherlands, 7Brigham and Women’s Hospital, Boston, United States, 8Royal Melbourne Hospital, Melbourne, Australia, 9Hôpital Haut-Lévêque, Bordeaux, France)

Intermittent scheduled low-dose levosimendan OR23 infusions enhance survival with advanced chronic heart failure: a propensity score matching analysis N. Barras1, *, K. Sotiropoulos2, J. Regamey1, P. Vogt1, R. Hullin1, P. Yerly1 (1Service de Cardiologie, Centre Hospitalier Universitaire Vaudois, Lausanne, 2Herzzentrum, Luzerner Kantonsspital, Luzern, Switzerland)

Prognostic power of probnp in left ventricular OR24 non-compaction cardiomyopathy S. F. Stämpfli1, *, L. Erhart1, N. Hagenbuch2, B. E. Stähli1, C. Gruner1, M. Greutmann1, M. Niemann1, 3, B. A. Kaufmann4, R. Jenni1, L. Held2, F. C. Tanner1 (1Kardiologie, UniversitätsSpital Zürich, 2Biostatistics, University of Zurich, Zurich, Switzerland, 3Faculty Mechanical and Medical Engineering, Furtwangen University, Furtwangen, Germany, 4Kardiologie, Universitätsspital Basel, Basel, Switzerland)

Retinal vessel analysis in heart failure OR25 M. Naegele1, *, I. Sudano1, S. Cantatore1, F. Enseleit1, F. Ruschitzka1, A. J. Flammer1 (1Cardiology, University Hospital Zurich, Zurich, Switzerland)

Abstract Session Room 4C

09:15–10:45 Struggling ventricles in congenital heart disease 32 Chairs: Judith Bouchardy (Geneva, CH) Roland Weber (Zürich, CH)

* Presenting author

35 Detailed Programme Thursday, June 16

Late and very late presenting transposition OR26 of the great arteries: transition from atrial to two-stage arterial switch L. Wannaz1, N. Guedj1, T. Sologashvili1, M. Beghetti2, C. Tissot2, Y. Aggoun2, P. Myers1, * (1Cardiac surgery, 2Pediatric Cardiology, Geneva University Hospitals, Geneva, Switzerland)

Myocardial deformation characteristics of the OR27 systemic right ventricle after atrial switch operation for transposition of the great arteries B. Burkhardt1, 2, *, C. J. Kellenberger1, 3, B. Rücker1, 2, J. Geiger1, 3, E. R. Valsangiacomo Büchel1, 2 (1Children’s Research Center, 2Cardiology, 3Diagnostic Imaging, Children’s Hospital Zurich, Zurich, Switzerland)

Myocardial blood flow and sympathetic OR28 innervation late after arterial switch operation for transposition of the great arteries M. Possner1, *, J. Vontobel1, F. Mikulicic1, 2, C. Gräni1, O. F. Clerc1, 2, D. C. Benz1, B. Hirt-Moch1, J. Stehli1, 2, T. A. Fuchs1, 2, D. Tobler3, D. Stambach4, R. R. Büchel1, P. A. Kaufmann1, M. Greutmann2 (1Nuklearmedizin, 2Kardiologie, UniversitätsSpital Zürich, Zürich, 3Kardiologie, Universitätsspital Basel, Basel, 4Pädiatrische Kardiologie, Ostschweizer Kinderspital St. Gallen, St. Gallen, Switzerland)

Does arterial switch for d-transposition OR29 of the great arteries alter myocardial deformation of the ventricles? B. E. U. Burkhardt1, 2, *, C. J. Kellenberger1, 3, B. Rücker1, 2, J. Geiger1, 3, E. R. Valsangiacomo Büchel1, 2 (1Children’s Research Center, 2Cardiology, 3Diagnostic Imaging, Children’s Hospital Zurich, Zurich, Switzerland)

Prenatal diagnosis of single ventricle physiology OR30 impacts morbidity and mortality R. Weber1, 2, *, B. Stiasny1, 2, B. Rücker1, 3, A. Cavigelli- Brunner1, 2, E. R. Valsangiacomo1, 2 (1Children’s Research Centre, 2Pediatric Heart Center, University Children’s Hospital, Zurich, Switzerland, 3Pediatric Heart Center, University Children’s Hospital Zurich, Zurich, Switzerland) * Presenting author

36 Detailed Programme Thursday, June 16

Biventricular interactions and their impact OR31 on exercise capacity in adults with a systemic right ventricle A. Stauber1, *, C. Wey1, M. Greutmann2, D. Tobler3, K. Wustmann1, A. Wahl4, M. Wilhelm4, M. Schwerzmann1 (1Center for Congenital Heart Disease, Inselspital, Bern, 2Cardiology, University Hospital Zurich, Zurich, 3Cardiology, University Hospital Basel, Basel, 4Cardiology, Inselspital, Bern, Switzerland)

Main Session Auditorium B

09:15–10:45 Chronic dyspnea 34 Chairs: Matthias Wilhelm (Bern, CH) Christophe Uldry (Rolle, CH)

COPD and chronic dyspnea 34.1 Michael Tamm (Basel, CH)

Cardiorespiratory exercise test (CPET) 34.2 Jean-Paul Janssens (Geneva, CH)

Value of echocardiography in chronic dyspnea 34.3 Beat Kaufmann (Bern, CH)

Heart failure with preserved ejection fraction 34.4 (HFpEF) as a cause of dyspnea Hans-Peter Brunner (Maastricht, NL)

Main Session Room 5C

09:15–10:45 Endocarditis

Panel: 35.1 André Vuilliomenet (Aarau, CH), Urs Fischer (Bern, CH), Omer Dzemali (Zürich, CH), Robert Siebenmann (Zürich, CH), Philippe Moreillon (Lausanne, CH), Laurent de Kerchove (Brussels, BE)

* Presenting author

37 Detailed Programme Thursday, June 16

Case 1: Patient with suspected endocarditis 35.2 of aortic valve and massive cerebral emboli but little symptoms Mustafa Cikirikcioglu (Geneva, CH)

Case 2: Patient with endocarditis of prothesis 35.3 and pyarthros of knee prothesis Alicja Zientara (Zürich, CH)

Case 3: Endocarditis of the mitral valve: 35.4 repair vs replacement Tiziano Torre (Lugano, CH)

Closing remarks 35.5 Laurent de Kerchove (Brussels, BE)

Quiz Room 2C

09:15–10:45 Swiss pulmonary challenge 36 Chairs: Thomas Brack (Glarus, CH) Konrad Bloch (Zürich, CH)

Scientific Session Room 1C

09:15–10:45 Adherence after lung transplantation – 37 Enhancing patients’ self-care abilities Chairs: Nicole Zigan (Winterthur, CH) Marcia Leventhal (Pfeffingen, CH)

Tackling nonadherence to immunosuppressive 37.1 drugs: a crucial pathway to improve outcomes in solid organ transplantation Sabina de Geest (Basel, CH)

Practice patterns regarding chronic illness 37.2 management among heart transplant centers in 11 countries - A multicenter cross sectional study Christine Vetter (Zürich, CH)

38 Detailed Programme Thursday, June 16

Self-Management: How can we support patients 37.3 in doing home intravenous therapy? Gabriela Schmid-Mohler (Zürich, CH) Ramona Odermatt (Zürich, CH)

The experience of the spouses during complica- 37.4 tions and hospitalisations of patients with lung transplantation Maisa Omerovic (Zürich, CH)

Workshop Room 1AB

09:15–10:45 Basic research in cardiology: clinical perspectives 38 Chairs: Christian Matter (Zürich, CH) Nathalie Rosenblatt (Lausanne, CH)

Epigenetics and vascular dysfunctions 38.1 Claudio Sartori (Lausanne, CH)

Mitochondrial stress 38.2 Christoph Maack (Homburg, DE)

Silencing of the activated protein-1 OR18 transcription factor jund exacerbates ischemia/ reperfusion-induced cerebral injury M. F. F. Reiner1, *, C. Diaz-Cañestro2, A. Akhmedov1, H. Amstalden1, S. Briand1, A. Semerano3, G. Giacalone3, S. Keller1, G. A. Kullak-Ublick4, M. Sessa5, T. F. Lüscher6, J. H. Beer7, G. G. Camici8 (1Center for Molecular Cardiology, 2Universität Zürich, Schlieren, Switzerland, 3Department of Neurology, San Raffaele Scientific Institute, Milan, Italy,4 Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, 5San Raffaele Scientific Institute, Milan, 6Cardiology, University Heart Center, University Hospital Zurich, Zurich, 7Internal Medicine, Cantonal Hospital Baden, Baden, 8Center for Molecular Cardiology, Universität Zürich, Zürich, Switzerland)

* Presenting author

39 Detailed Programme Thursday, June 16

Phosphodiesterase 5 inhibitor attenuates OR19 pulmonary and right ventricular remodeling due to pulmonary hypertension through an antiproliferative mechanism S. Favre1, *, J. P. Puyal2, L. K. von Segesser1, G. Vassalli3, M. Samaja4, G. Milano1 (1URCV, CHUV, 2DNF, UNIL, Lausanne, 3Fondazione Cardiocentro, Lugano, Switzerland, 4Department of Health Science, University of Milan, Milan, Italy)

Workshop Room 5AB

09:15–10:45 Lipids 39 Chairs: Rubino Mordasini (Bern, CH) Jürg H. Beer (Baden, CH)

This session is organ- Options for intensive lowering of LDL 39.1 ized by the scientific committee . The indus- David Carballo (Geneva, CH) try partners are kindly supporting the program without any in- Statin intolerance and PCSK9 inhibitors 39.2 fluence on topic, contents, and speakers . Ulf Landmesser (Berlin, DE)

Risk of very low LDL 39.3 Walter F. Riesen (Diessenhofen, CH)

Abstract Session Room 2C

11: 00–12:30 Clinical studies in COPD and related 40 obstructive disorders Chairs: Pierre-Olivier Bridevaux (Sion, CH) Sarosh Irani (Aarau, CH)

Lung function in patients with primary ciliary OR32 dyskinesia (pcd): a multinational study F. Halbeisen1, *, M. Goutaki1, E. Maurer1, M. Boon2, C. Casaulta3, A. Clement4, S. Crowley5, E. Haarman6, B. Karadag7, C. Koerner-Rettberg8, H. Mazurek9, L. Morgan10, K. Nielsen11, F. Santamaria12, N. Schwerk13, P. Yiallouros14, P. Latzin15, J. Lucas16, C. Kuehni1

* Presenting author

40 Detailed Programme Thursday, June 16

(1Institute of Social and Preventive Medicine, Bern, Switzer- land, 2Department of Paediatrics, University Hospital Gasthuisberg Leuven, Leuven, Belgium, 3Department of Paediatrics, University Children’s Hospital of Bern, Bern, Switzerland, 4Paediatric Pulmonary Department, Université Pierre et Marie Curie, Paris, France, 5Section for Paediatric Heart, Lung, Allergic Diseases, Rikshospitalet, Oslo, Norway, 6Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, Netherlands, 7Department of Pediatric Pulmonology, Marmara University, School of Medicine, Istanbul, Turkey, 8Department of Paediatric Pneumology, University Children’s Hospital of Ruhr University Bochum, Bochum, Germany, 9Klinika Pneumonologii i Mukowiscydozy, Instytut Gru´zlicy i Chorób Płuc, Rabka-Zdrój, Poland, 10Department of Respiratory Medicine, Concord Hospital Clinical School, University of Sydney, Sydney, Australia, 11Danish PCD Centre Copenhagen, Paediatric Pulmonary Service, Copenhagen University Hospital, Copenhagen, Denmark, 12Department of Translational Medical Sciences, Federico II University, Napoli, Italy, 13Clinic for paediatric pulmonology, allergiology and neonatology, Hannover Medical School, Hannover, Germany, 14Cyprus Interna- tional Institute for Environmental & Public, Cyprus University of Technology, Limassol, Cyprus, 15University Children’s Hospital Basel, Basel, Switzerland, 16PCD Centre, University Hospital Southampton, NHS Foundation Trust and University of Southampton, Southampton)

Altitude related adverse health effects in low- OR33 landers with copd travelling to 3200 m. Randomized trial of preventive dexamethasone treatment M. Furian1, *, M. Lichtblau1, S. S. Aeschbacher1, M. Bisang1, S. E. Hartmann2, M. Poulin2, T. D. Latshang1, S. Ulrich1, A. Aldashev3, T. Sooronbaev4, K. E. Bloch1 (1Pulmonary Division and Sleep Disorders Center, University Hospital of Zurich, Zurich, Switzerland, 2Dept of Physiology & Pharmacology and Hotchkiss Brain Institute, Faculty of Medicine, Calgary, Canada, 3Research Institute for Molecular Biology and Medicine, 4National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyztan)

* Presenting author

41 Detailed Programme Thursday, June 16

Hyaluronic acid and its degrading enzyme OR34 hyaluronidase as systemic biomarkers to predict copd progression and severity E. Papakonstantinou1, 2, I. Bonovolias2, M. Roth1, M. Tamm1, L. Boeck1, A. Scherr1, J. Rakic1, D. Stolz1, * on behalf of Working group, The PROMISE study (1Pneumology, Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland, 2Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece)

A multicentre validation of the 1-minute OR35 sit-to-stand test in patients with chronic obstructive pulmonary disease S. Crook1, *, K. Schultz2, N. Lehbert2, G. Büsching3, D. Jelusic2, S. Keusch4, M. Wittmann2, M. Schuler5, T. Radtke1, M. Puhan1, A. Frei1 (1Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland, 2Klinik Bad Reichenhall, Bad Reichenhall, Germany, 3Klinik Barmelweid, Barmelweid, 4Zürcher Höhenklinik Wald, Wald, Switzerland, 5University of Wuerzburg, Wuerzburg, Germany)

Longitudinal assessment of physical activity OR36 in patients with copd C. F. Clarenbach1, *, N. A. Sievi1, T. Brack2, M. Brutsche3, M. Frey4, S. Irani5, J. Leuppi6, R. Thurnheer7, M. Kohler1 (1Klinik für Pneumologie, UniversitätsSpital Zürich, Zürich, 2Pulmonary Division, Cantonal Hospital of Glarus, Glarus, 3Pulmonary Division, Cantonal Hospital of St. Gallen, St. Gallen, 4Pulmonary Division, Clinic Barmelweid, Barmel- weid, 5Pulmonary Division, Cantonal Hospital of Aarau, Aarau, 6University Clinic of Internal Medicine, Cantonal Hospital Baselland, Basel, 7Pulmonary Division, Cantonal Hospital of Münsterlingen, Münsterlingen, Switzerland)

Therapy with proton-pump inhibitors for OR37 gastroesophageal reflux disease does not reduce the risk of severe exacerbations in copd L. Baumeler1, E. Papakonstantinou1, B. Milenkovic2, A. Lacoma3, R. Louis4, J. G. Aerts5, T. Welte6, K. Kostikas7, F. Blasi8, W. Boersma9, A. Torres10, G. G. Rohde11, L. Boeck12, J. Rakic12, A. Scherr12, M. Tamm1, D. Stolz1, * (1Pneumology, University Hospital Basel, Basel, Switzerland, 2Faculty of Medicine, University of Belgrad, Belgrad, Serbia, * Presenting author

42 Detailed Programme Thursday, June 16

3Department of Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 4Pneumology, University of Liege, Liege, Belgium, 5Department of Pneumology, Amphia Hospital/Erasmus MC, Breda, Netherlands, 6Department of Pneumology, Medizinische Hochschule Hannover, Hannover, Germany, 7Department of Pneumology, University of Thessaly, Medical school , Larissa, Greece, 8Department of Pathophy- siologie and Transplantation, Università degli Studi di Milano, Milano, Italy, 9Department of Pneumology, Medisch Centrum Alkmaar, Alkmaar, Netherlands, 10Department of pneumology, Hospital Clinic, Barcelona, Spain, 11Department of respiratory medicine, Maastrich University Medical Center, Maastrich, Netherlands, 12Department of Pneumology, University Hospital Basel, Basel, Switzerland)

Abstract Session Room 5C

11: 00–12:30 Heart failure and beyond – 41 modern treatment concepts Chairs: Christoph Huber (Geneva, CH) Gabriela Kuster (Basel, CH)

Three-dimensional self-navigated t2 mapping OR44 for the detection of acute cellular rejection after orthotopic heart transplantation R. Hullin1, *, R. van Heeswijk2, D. Piccini2, P. Tozzi3, S. Rotman4, P. Meyer5, J. Schwitter1, M. Stuber2 (1Cardiologie, 2CIBM, CHUV, Lausanne, Switzerland, 3Chirurgie cardiaque, CHUV, Lausanne, Switzerland, 4Pathologie, CHUV, Lausanne, 5Cardiologie, HUG, Genève, Switzerland)

Predictors of procedural outcomes of left OR45 atrial appendage closure in patients with atrial fibrillation K. Koskinas1, *, M. Fürholz1, S. Shakir1, F. Nietlispach2, A. Attinger-Toller2, A. Moschovitis1, P. Wenaweser1, T. Pilgrim1, S. Stortecky1, L. Räber1, S. Windecker1, B. Meier1, S. Gloekler1 (1Bern University Hospital, Bern, 2University Hospital of Zurich, Zurich, Switzerland)

* Presenting author

43 Detailed Programme Thursday, June 16

Iron deficiency based on high soluble transferrin OR46 receptor index identifies patients at the highest risk of death in chronic heart failure patients M. Zurek1, *, B. Wein1, F. Jordan1, S. Rümmler1, O. Pfister1 (1University Hospital Basel, Basel, Switzerland)

Biochemical signatures of frailty predict out- OR47 comes beyond current risk scores in aortic stenosis following transcatheter aortic valve replacement: role of pteridines and tryptophan metabolism A. Csordas1, *, D. Fuchs2, A. Frangieh1, G. Reibnegger3, B. E. Stähli1, M. Cahenzly1, F. Nietlispach1, W. Maier1, F. Maisano4, R. K. Binder1, C. Liebetrau5, W.-K. Kim5, H. Möllmann5, C. Hamm5, T. Lüscher1 (1Department of Cardiology, University Heart Center Zürich, Zürich, Switzerland, 2Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, 3Department of Physiological Chemistry, Medical University of Graz, Graz, Austria, 4Department of Cardiovascular Surgery, University Heart Center Zürich, Zürich, Switzerland, 5Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany)

Prediction of post discharge short-term mortality OR48 after hospitalization for acute heart failure K. Sotiropoulos1, *, P. Yerly2, O. Hugli3, P. Meyer4, R. Hullin5 (1Médecine Interne, 2Cardiologie, 3Urgences, CHUV, Lausanne, 4Cardiologie, HUG, Genève, 5Cardiologie, CHUV, Lausanne, Switzerland)

Renal function post tavi, a significant predictor OR49 of mortality: introducing the acef-7 score S. Obeid1, *, F. Maisano2, M. Taramasso2, A. Csordas1, F. C. Tanner1, T. Luescher1, F. Nietlispach1, E. Holy1 (1Cardiology , 2Vascular and Cardiothoracic Surgery, University Hospital of Zürich, Zürich, Switzerland)

Value of the frontal plane qrs-t angle for OR50 diagnosis and prognosis in patients with symptoms suggestive of acute decompensated heart failure Z. Sabti1, *, S. Shrestha1, I. Strebel1, C. Schumacher1, N. Kozhuharov1, S. Osswald1, C. Müller1, T. Reichlin1

* Presenting author

44 Detailed Programme Thursday, June 16

(1Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, Basel, Switzerland)

First experience with the ozaki technique in OR51 Europe: creating a stentless aortic valve by recon- structing leaflets using autologous pericardium O. Reuthebuch1, *, M. Grapow1, J. Fassl2, F. Eckstein1 (1Clinic for Cardiac Surgery, University Hospital Basel, 2Anesthesiology, University Hospital Basel, Basel, Switzerland)

Predicting right ventricular failure in the era OR52 of continuous flow assist devices: why we are always wrong P. Tozzi1, *, R. Hullin2, G. Siniscalchi1, F. Gronchi3, P. Yerly2, C. Marcucci3, R. Pretre1 (1Service de Chirurgie Cardiaque, 2Service de Cardiologie, 3Service d’Anesthésiologie, CHUV, Lausanne, Switzerland)

Prognostic impact of aortic regurgitation OR53 after tavi: effect of kidney function M. Possner1, 2, *, J. Vontobel1, 2, D. L. Nguyen3, C. Zindel1, E. W. Holy1, S. F. Stämpfli1, M. Zuber1, P. A. Kaufmann2, F. Nietlispach1, F. Maisano4, M. Niemann1, F. C. Tanner1 (1Kardiologie, 2Nuklearmedizin, 3Radiologie, 4Herzchirurgie, UniversitätsSpital Zürich, Zürich, Switzerland)

Abstract Session Room 4C

11: 00–12:30 Pulmonary cell biology 42 Chairs: Eric Bernasconi (Lausanne, CH) TBD

The disease specific effect of adrenomedullin OR38 on epithelial cells in chronic inflammatory lung disease patients: a system biological approach J. Mandal1, *, M. Roth1, E. Papakonstantinou1, L. Bubendorf2, S. Savic2, M. Tamm1, D. Stolz1 (1Pneumologie, 2Pathologie, Universitätsspital Basel, Basel, Switzerland)

* Presenting author

45 Detailed Programme Thursday, June 16

Cell-specific interactions between the novel OR39 myokine irisin and hyaluronic acid in chronic obstructive pulmonary disease E. Papakonstantinou1, M. Roth1, J. Mandal1, M. Tamm1, D. Stolz1, * (1Pneumology, Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland)

Bacterial endotoxin fine-tunes macrophage- OR40 fibroblast tissue remodeling activity S. Mouraux1, *, E. Bernasconi1, J.-D. Aubert1, B. Marsland1, L. Nicod1 (1Département de Médecine, CHUV, Service de Pneumologie, CHUV, Lausanne, Switzerland)

Mesenchymal stem cells isolated from human OR41 lung tissue inhibit proliferation and collagen expression by lung fibroblasts P. Khan1, A. Gazdhar2, S. Savic3, M. Tamm1, D. Lardinois4, M. Roth1, T. Geiser2, K. E. Hostettler1, * on behalf of Interstitial and rare lung diseases (1Department of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, Basel, 2Department of Pulmonary Medicine, University Hospital Bern, Bern, 3Institute for Pathology, 4Division of Thoracic Surgery, University Hospital Basel, Basel, Switzerland)

Virosomes coupled to antigen induce OR42 enhanced specific cd4+ t cell activation compared to liposomes in an in vitro model of pulmonary dendritic cells R. A. M. Blom1, *, M. Amacker2, C. Moser3, R. M. van Dijk4, F. Blank1, C. von Garnier1 (1Departement für Klinische Forschung, University of Bern, Bern, 2Mymetics SA, Epalinges, 3Swiss Federal Institute of Intellectual Property, Bern, 4Functional Neuroanatomy, Institute of Anatomy, University of Zürich, Zürich, Switzerland)

* Presenting author

46 Detailed Programme Thursday, June 16

Metabolite profile differences in exhaled breath OR43 condensate from patients with idiopathic pulmonary fibrosis compared to healthy individuals analyzed by mass spectrometry – a pilot study C. Strebel1, *, B. Rindlisbacher2, S. Guler3, T. Geiser3, C. Bovet2, M. Funke3 (1Internal Medicine, Spital STS AG, Zweisimmen, 2Clinical Metabolomics Facility, 3Pulmonary Medicine, Inselspital, Bern, Switzerland)

Joint Session Auditorium B

11: 00–12:30 Joint ESC/ERS-SSC/SSCS/SSP Guidelines Session: 43 Pearls of the ESC/ERS Guidelines 2015 Chairs: Paola Gasche Soccal (Geneva, CH) Stephan Windecker (Bern, CH)

This session is organized by the scientific Pulmonary hypertension 43.1 committee . The indus- Marc Humbert (Paris, FR) try partners are kindly supporting the program without any influence on topic, con- Infective endocarditis 43.2 tents, and speakers . Bernard Iung (Paris, FR)

NSTEMI 43.3 Marco Roffi (Geneva, CH)

Ventricular arrhythmias and sudden cardiac death 43.4 Carina Blomström-Lundqvist (Uppsala, SE)

Joint Session Room 1AB

11: 00–12:30 Sarcoidosis 44 Chairs: Chan-il Park (Geneva, CH) Thomas Geiser (Bern, CH)

Diagnosis and classification of sarcoidosis 44.1 Christophe von Garnier (Bern, CH)

The heart in sarcoidosis – imaging 44.2 Michael Zellweger (Basel, CH)

The heart in sarcoidosis – electrophysiology 44.3 Etienne Pruvot (Lausanne, CH)

47 Detailed Programme Thursday, June 16

Is there room for biologicals in sarcoidosis - 44.4 Real benefit or just expensive? Martin Brutsche (St. Gallen, CH)

Joint Session Room 3C

11: 00–12:30 Cardiovascular risk factors 45 Chairs: David Nanchen (Lausanne, CH) Thierry Rochat (Geneva, CH)

Smoking and smoking cessation 45.1 Carole Clair Willi (Lausanne, CH)

Sleep apnea as a risk factor for cardiovascular 45.2 disease Malcolm Kohler (Zürich, CH)

Air pollution as a cardiovascular risk factor 45.3 Nicole Probst-Hensch (Basel, CH)

The good and bad of exercise 45.4 Baris Gencer (Geneva, CH)

Joint Session Room 5AB

11: 00–12:30 Management of chronic thromboembolic disease 46 Chairs: John-David Aubert (Lausanne, CH) Daniel Weilenmann (St. Gallen, CH)

Pulmonary endarterectomy 46.1 Isabelle Schmitt-Opitz (Zürich, CH)

Medical management chronic thromboembolic 46.2 disease Otto Schoch (St. Gallen, CH)

Transplantation 46.3 Thorsten Krüger (Lausanne, CH)

Is the percutaneous approach the future? 46.4 Hélène Bouvaist (Grenoble, FR)

48 Detailed Programme Thursday, June 16

Scientific Session Room 1C

11: 00–12:30 Patients with obstructive sleep apnea (OSAS): 47 implications for nursing practice Chairs: Eva Horvath (Zürich, CH) Katrin Vogt (Barmelweid, CH)

Obstructive sleep apnea in patients with heart 47.1 disease: Consequences and treatment options Marco Laures (Suhr, CH)

OSAS: Psychological effects on patients 47.2 Gregory Clark (La Chaux-de-Fonds, CH)

Ambulatory treatment strategies for OSAS 47.3 Hanna Burkhalter (Zürich, CH)

CPAP/BiPAP Therapy: Supporting compliance 47.4 Tsogyal Latshang (Chur, CH)

Joint Session Room 1AB

12:30-12:45 Tuberculosis Research Prize Ceremony 48 Chairs: Laurent Nicod (Lausanne, CH) Jean-Paul Janssens (Geneva, CH)

M. tuberculosis T cell epitope analysis reveals 48.1 paucity of antigene variation and identifies rare variable TB antigens Mireia Coscolla (Basel, CH)

Poster Walk Poster Area

13:15–14:15 Poster Walk SSC/SSCS 1: Cardiovascular biology 49 Chairs: Andrea Banfi (Basel, CH) Stéphane Cook (Fribourg, CH)

13:15–14:15 Poster Walk SSC/SSCS 1: Pacemaker, defibrillator 50 and electrophysiology Chairs: Andreas Müller (Zürich, CH) François Regoli (Lugano, CH)

49 Detailed Programme Thursday, June 16

13:15–14:15 Poster Walk SSC/SSCS 1: Cardiac failure, 51 valvulopathies, cardiomyopathies, pericardiopathies, heart transplantation Chairs: Andreas Flammer (Zürich, CH) Markus Wilhelm (Zürich, CH)

13:15–14:15 Poster Walk SSC/SSCS 1: Epidemiology, risk 52 factors, rehabilitation, thromboembolic disease Chairs: Matthias Hermann (Wald, CH) Werner Deuel (St. Gallen, CH)

13:15–14:15 Poster Walk SSC/SSCS 1: Cardiac imaging, 53 congenital and pediatric cardiology Chairs: Peter Burger (Bern, CH) Tobias Rutz (Lausanne, CH)

13:15–14:15 Poster Walk SSC/SSCS 1: Clinical cases 54 Chairs: Tiziano Schepis (St. Gallen, CH) Mikael Potocki (Dietikon, CH)

13:15–14:15 Poster Walk SSP 1: COPD 55 Chairs: Robert Thurnheer (Münsterlingen, CH) Grégoire Gex (Sion,CH)

13:15–14:15 Poster Walk SSP 1: Pulmonary 56 Hypertension – Transplantation – Biomarkers Chairs: Silvia Ulrich (Zürich, CH) Andrea Azzola (Lugano, CH)

Satellite Symposium Room 1C Actelion Pharma Schweiz AG

13:15–14:15 Pulmonary arterial hypertension: 57 A cardio-pulmonary challenge Chair: Patrick Yerly (CH)

Welcome and Introduction 57.1 Patrick Yerly (CH)

The right ventricle in pulmonary arterial 57.2 hypertension: a cardiologist’s view Jean-Luc Vachiéry (BE)

50 Detailed Programme Thursday, June 16

Multi-disciplinary and patient centric management 57.3 in PAH: a pulmonologist’s view Luke Howard (UK)

Question and answers

Concluding remarks 57.4 Patrick Yerly (CH)

Satellite Symposium Room 1AB Sanofi-Aventis (Suisse) SA

13:15–14:15 Managing Hypercholesterolemia: 58 Beyond current treatment options Chairs: Thomas Lüscher (CH) Stephan Windecker (CH)

Welcome and Introduction 58.1 Thomas Lüscher (CH), Stephan Windecker (CH)

Monoclonal Antibodies: 58.2 Targeting the PCSK9 Pathway Dario Neri (CH)

Familial Hypercholesterolemia: 58.3 Insights from the SPUM-ACS Cohort François Mach (CH)

PCSK9 Inhibition: For which patients? 58.4 Christian Müller (CH)

Questions and answers

Concluding remarks 58.5 Thomas Lüscher (CH), Stephan Windecker (CH)

Satellite Symposium Room 3C PneumRx Ltd / PulmonX

13:15–14:15 Severe COPD / Emphysema: 59 the modern treatment arsenal Chairs: Daniel Franzen (CH) Bernard Egger (CH)

51 Detailed Programme Thursday, June 16

Welcome and introduction 59.1 Daniel Franzen (CH), Bernard Egger (CH)

The medical pulmonologist’s perspective: 59.2 new insights on diagnosis, treatment and prognosis for COPD and emphysema patients Bernard Egger (CH)

The medical pulmonologist’s arsenal: rehabilitation, 59.3 medical treatment. Update on clinical evidence Bernard Egger (CH)

The interventional pulmonologist’s perspective: 59.4 new insights on diagnosis, treatment and prognosis for COPD and emphysema patients Daniel Franzen (CH)

The interventional pulmonologist’s arsenal: 59.5 interventional volume reduction, surgical volume reduction, transplantation. Update on clinical evidence Daniel Franzen (CH)

Discussion 59.6 Bernard Egger (CH), Daniel Franzen (CH)

Satellite Symposium Room 5AB Novartis Pharma Schweiz AG

13:15–14:15 10 years in respiratory - Changing Paradigm 60 in the Treatment of Asthma and COPD Chair: Thomas Geiser (CH)

Paradigm shift in COPD from LABA/ICS 60.1 to Indacaterol/Glycopyrronium Thomas Geiser (CH)

Back to the Future: the exciting IgE journey 60.2 in Asthma continues Christophe von Garnier (CH)

Podium discussion 60.3 Christophe von Garnier (CH), Thomas Geiser (CH), Malcolm Kohler (CH), Laurent Nicod (CH)

52 Detailed Programme Thursday, June 16

Satellite Symposium Room 5C Medela AG

13:15–14:15 Innovation and data driven approaches 61 to optimizing clinical practice in pleural and mediastinal interventions Chair: Frédéric Triponez (CH)

Welcome and introduction 61.1 Frédéric Triponez (CH)

Management of the pleural space after 61.2 minimally invasive cardiac surgery Stefanos Demertzis (CH)

Digital drainage system: a valuable addition 61.3 in fast track thoracic surgery Michel Gonzalez (CH)

Minimal-invasive treatment of pneumothorax 61.4 Martin Brutsche (CH)

Concluding remarks Questions and answers

Poster Walk Poster Area

14:30–15:30 Poster Walk SSC/SSCS 2: Pacemaker, 62 defibrillator and electrophysiology Chairs: Stefano Benussi (Zürich, CH) Peter Ammann (St. Gallen, CH)

14:30–15:30 Poster Walk SSC/SSCS 2: Cardiac failure, 63 valvulopathies, cardiomyopathies, pericardiopathies, heart transplantation Chairs: Micha Maeder (St. Gallen, CH) Roger Hullin (Lausanne, CH)

14:30–15:30 Poster Walk SSC/SSCS 2: ACS, PCI, CABG 64 Chairs: Florim Cuculi (Luzern, CH) Raban Jeger (Basel, CH)

53 Detailed Programme Thursday, June 16

14:30–15:30 Poster Walk SSC/SSCS 2: Epidemiology, risk 65 factors, rehabilitation, thromboembolic disease Chairs: Philippe Meyer (Geneva, CH) Augusto Gallino (Bellinzona, CH)

14:30–15:30 Poster Walk SSC/SSCS 2: Cardiac imaging, 66 congenital and pediatric cardiology Chairs: Kerstin Wustmann (Bern, CH) Simon Koestner (Morges, CH)

14:30–15:30 Poster Walk SSC/SSCS 2: Clinical cases 67 Chairs: Hansjörg Meier (Zofingen, CH) Felix Tanner (Zürich, CH)

14:30–15:30 Poster Walk SSP 2: Sleep disorders – 68 rehab – physiology Chairs: Frédéric Lador (Geneva, CH) Martin Frey (Barmelweid, CH)

14:30–15:30 Poster Walk SSP 2: Bronchoscopy – 69 Cancer – Tobacco Chairs: Alban Lovis (Lausanne, CH) Michael Tamm (Basel, CH)

Joint Session Room 1C

14:30–16: 00 ECMO Therapy: What do healthcare 70 professionals need to know about ECMO and how to care for these patients? Chairs: Lars Englberger (Bern, CH) Gaby Stoffel (Zürich, CH)

An update on ECMO: Benefit for the lungs 70.1 and the heart Martin Schweiger (Zürich, CH)

Advantages and disadvantages of ECMO devices 70.2 Hansjörg Jenni (Bern, CH)

Extracorporeal devices in the operating theater 70.3 Piergiorgio Tozzi (Lausanne, CH)

Caring for patients on ECMO in the ICU 70.4 Carolin Keim (Zürich, CH)

54 Detailed Programme Thursday, June 16

Challenges in caring for the pediatric patient 70.5 on ECMO in the ICU Yvonne Kröger (Zürich, CH) Sebastian Bründler (Zürich, CH)

Satellite Symposium Room 1AB Daiichi Sankyo (Schweiz) AG

14:30–15:30 Mit Edoxaban in die Zukunft 71 Chair: François Mach (CH)

Welcome and introduction 71.1 François Mach (CH)

Considérations importantes sur l’Edoxaban 71.2 dans la pratique quotidienne François Mach (CH)

Thromboembolieprophylaxe bei Vorhofflimmern – 71.3 spezielle Patientengruppen Michael Kühne (CH)

2036. Zukunft der Gesundheit – 71.4 Thesen des Zukunftsforschers Georges T. Roos (CH)

Conclusion remarks 71.5 François Mach (CH)

Satellite Symposium Room 3C ResMed Schweiz AG

14:30–15:30 COPD and home NIV in Switzerland 72 Successful examples across the regions Chair: Sebastian Ott (Bern, CH)

Welcome and Introduction 72.1 Sebastian Ott (Bern, CH)

How to ventilate our COPD patients in 2016 72.2 Christophe Uldry (Rolle, CH)

55 Detailed Programme Thursday, June 16

Management of COPD home ventilation 72.3 in St. Gallen Gabriel Benz (St. Gallen, CH)

Concluding remarks 72.4 Sebastian Ott (Bern, CH)

Questions and answers

Satellite Symposium Room 5AB Amgen Switzerland AG

14:30–15:30 Expert panel round “my first real life 73 experience with Repatha” Chair: Edouard Battegay (CH)

Welcome and introduction 73.1 Edouard Battegay (CH)

The FH patient 73.2 Isabella Sudano (CH)

The CKD patient 73.3 Michel Burnier (CH)

The high risk CHD patient 73.4 Franz Eberli (CH)

Panel discussion lead by Prof. Battegay 73.5 All Speakers

Questions and answers 73.6 Chair & all Speakers

Questions and answers 73.7 Edouard Battegay (CH)

56 Detailed Programme Thursday, June 16

Satellite Symposium Room 5C SERVIER SUISSE S.A.

Hypertension and hypercholesterolemia: a challenge at heart 14:30–15:30 Chairs: François Mach (Geneva, CH) 74 Frank Ruschitzka (Zürich, CH)

Hypertension and hypercholesterolemia: 74.1 a challenge at heart François Mach (Geneva, CH) Frank Ruschitzka (Zürich, CH)

Questions and answers 74.2 François Mach (Geneva, CH) Frank Ruschitzka (Zürich, CH)

Workshop Auditorium B

14:30–15:30 ECG-Quiz 75 Speakers: Jürg Schläpfer (Lausanne, CH) Andrea Menafoglio (Bellinzona, CH) Andreas Müller-Burri (Zürich, CH)

Voting

SSPP Session Room 3C

15:45–17:15 Pediatric grand rounds 76 Chairs: Isabelle Rochat (Geneva, CH) Jürg Hammer (Basel, CH)

A 16yr old boy with skin lesions and fatigue 76.1 Isabella Maschler (St. Gallen, CH)

Air everywhere – severe respiratory distress 76.2 Sophie Yammine (Bern, CH)

Why pneumologists are interested in frogs – 76.3 or not, as the case may be Friederike Kettelhack (Basel, CH) Jürg Hammer (Basel, CH)

57 Detailed Programme Thursday, June 16

Pediatric lung transplantation in a 4 year old: 76.4 successful teamwork Isabelle Rochat (Geneva, CH)

Complex lung malformations: 76.5 random or sequential development? Isabelle Ruchonnet-Metrailler (Geneva, CH)

Debilitating dyspnea on exhaustion – 76.6 a common problem, unveiled by ergospirometry Peter Salfeld (Münsterlingen, CH)

Listen to your lung function technician! 76.7 Andreas Jung (Zürich, CH)

Croup episode not responding to therapy 76.8 Florence Barbey (Zürich, CH)

Abstract Session Room 2C

15:45–17:15 Challenges in ischemic, valvular and 77 congenital heart disease Chairs: Yvan Mivelaz (Lausanne, CH) Markus Schwerzmann (Bern, CH)

Prognostic value and the optimal ischemic OR54 threshold of adenosine stress-perfusion cmr in patients with suspected myocardial ischemia. The experience of the cmr center at University Hospital of Lausanne, Switzerland G. Vincenti1, *, P. Masci1, P. Monney1, T. Rutz1, C. Sierro1, 2, C. Pellaton1, 3, J. Schwitter1 (1Division of Cardiology and Cardiac MR Center, University Hospital of Lausanne (CHUV), Lausanne, Lausanne, 2Division of Cardiology, Centre Hospitalier du Valais Romand (CHVR), Sion, 3Division of Cardiology, Department of Internal Medicine, Neuchâtel, Switzerland)

* Presenting author

58 Detailed Programme Thursday, June 16

Effective orifice area and hemodynamic OR55 performance of the transcatheter edwards sapien 3 prosthesis: short-term and 1 year follow-up M. Külling1, *, J. Külling2, C. Wyss3, D. Hürlimann3, I. Reho3, S. Salzberger3, G. Noll3, J. Grünenfelder3, R. Corti3, P. Biaggi3 (1Universität Zürich, 2ETH Zürich, 3Herzklinik, Klinik Hirslanden, Zürich, Switzerland)

Multimodality imaging causes reclassification OR56 of aortic stenosis severity in patients undergoing tavi: effect on aortic valve area and energy loss index E. W. Holy1, *, H. Lisa1, D. L. Nguyen2, F. Maisano1, T. F. Lüscher1, F. Nietlispach1, F. C. Tanner1 (1Heart Center Zurich, 2Department of Radiology, USZ, Zurich, Switzerland)

Impact of stroke volume assessment OR57 by multimodality imaging on the subtype classification of severe aortic stenosis T. M. Stadler1, *, E. W. Holy1, T. D. L. Nguyen-Kim2, S. Obeid1, L. Hoffelner1, B. Stähli1, F. Maisano1, T. F. Lüscher1, F. Nietlispach1, F. C. Tanner1 (1Cardiology, University Heart Center, 2Radiology, Institute of Diagnostic and Interventional Radiology, Zurich, Switzerland)

Medication taking – a specific challenge OR58 for teenagers? Y. Liebert-Keller1, *, K. van Holten2, G. Stoffel3 (1Kalaidos Fachhochschule, 2Careum, 3Kinderspital Zürich, Zürich, Switzerland)

Swiss adult congenital heart disease registry OR59 (sacher) – rationale, design and patient characteristics D. Tobler1, *, M. Schwerzmann2, K. Wustmann2, R. Engel3, D. Stambach3, T. Rutz4, J. Bouchardy4, C. Attenhofer Jost5, G. De Pasquale5, A. Oxenius5, T. Seeliger5, F. Bonassin5, M. Greutmann5 (1Cardiology, University Hospital Basel, Basel, 2Cardiology, Inselspital, Bern, 3Cardiology, Kantonsspital St. Gallen, St. Gallen, 4Cardiology, CHUV, Lausanne, 5Cardiology, University Hospital Zurich, Zurich, Switzerland)

* Presenting author

59 Detailed Programme Thursday, June 16

Quality of life, general self-efficacy and health OR100 status in adults with congenital heart disease C. Thomet1, *, M. Schwerzmann1, E. Oechslin2, A. Kovacs2 (1Zentrum für angeborene Herzfehler, Kardiologie, Inselspital Bern, Bern, Switzerland, 2Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network and University of Toronto, Toronto, Canada)

Abstract Session Room 4C

15:45–17:15 Physiopathology and mechanisms of diseases 78 Chair: Peter Grendelmeier (Basel, CH) TBD

Telemetrically triggered interventions in the first OR60 month of cpap treatment – a prospective, randomized controlled intervention trial in patients with a new diagnosis of obstructive sleep apnea syndrome O. D. Schoch1, G. Benz1, *, F. Baty2, J. Niedermann1, M. H. Brutsche2 (1Kantonsspital St.Gallen, Center for Sleep Medicine, 2Kantonsspital St.Gallen, Pneumologie, St.Gallen, Switzerland)

Dexamethasone reduces pulmonary artery OR61 pressure in lowlanders with copd travelling to 3200m. Randomized, placebo-controlled trial M. Lichtblau1, *, M. Furian1, S. Aeschbacher1, M. Bisang1, S. Hartmann2, S. Ulrich1, T. Latsang1, A. Aldashev3, E. Mirrakhimov4, T. Soronbaev4, K. E. Bloch1, S. Ulrich1 (1Pneumology, University Hospital Zurich, Zurich, Switzer- land, 2Departments of Physiology and Pharmacology, University of Calgary, Calgary, Canada, 3Research Institute for Molecular Biology and Medicine, 4National Centers for Cardiology and Internal Medicine, Bishkek, Kyrgyztan)

Exercise pulmonary hemodynamics in systemic OR62 sclerosis patients – implications for outcome A. Stamm1, *, S. Saxer1, M. Lichtblau1, L. C. Huber1, O. Distler2, R. Speich1, K. E. Bloch1, S. Ulrich1 (1Pneumologie, 2Rheumatologie, UniversitätsSpital Zürich, Zürich, Switzerland)

* Presenting author

60 Detailed Programme Thursday, June 16

Asa score and preoperative icu admission are OR63 the only predictors of mortality after surgical biopsy for interstitial lung disease K. Furrer1, *, C. Nebiker2, L. Junker3, S. Lazdinyte1, S. Savic4, K. Hostettler3, D. Schumann1, J. Halter5, M. Tamm3, D. Lardinois1 (1Thoracic Surgery, 2Visceral Surgery, 3Pneumology, 4Pathology, 5Haematology, University Hospital Basel, Basel, Switzerland)

Online bronchoscopy atlas: OR64 an open access educational tool for pulmonologists A. Koutsokera1, N. Liechti1, C. Daccord1, M. Bernasconi1, V. Garelli1, A. Valenti1, D. Keller1, S. Lahzami1, N. Leslie1, A. Ogna1, A. Pasche1, N. Petitpierre1, D. Hinchliffe1, S. Perret Bakhouy1, M. Prella1, R. Manzoni1, A. Lenoir1, J.-D. Aubert1, L. P. Nicod1, J.-W. Fitting1, A. Lovis1, * (1Division of Respiratory Medicine, University Hospital of Lausanne, Lausanne, Switzerland)

Recurrent hypercapnia and hypoxemia in OR65 congenital central hypoventilation syndrome (undine syndrome) likely acts as endothelial preconditioning D. Hutter1, *, L. Rovina2, S. Rimoldi1, C. Sartori3, R. Chetany1, R. Soria1, U. Scherrer1, E. Rexhaj1 (1Cardiology, Inselspital, Bern, Switzerland, 2Cardiology, Inselspital, Bern, Switzerland, 3Medicine interne, CHUV Lausanne, Lausanne, Switzerland)

Abstract Session Room 5C

15:45–17:15 Beneficial and adverse cardiometabolic on- 79 and off-target effects Chairs: Jürg Beer (Baden, CH) David Nanchen (Lausanne, CH)

Marijuana consumption is associated with OR66 higher pcsk9 levels in hiv-infected patients naïve of statin therapy B. Gencer1, *, N. Vuilleumier2, C. Delhumeau-Cartier3, C. Meier4, S. Bavamian3, F. Montecucco1, F. Mach1, A. Calmy3

* Presenting author

61 Detailed Programme Thursday, June 16

(1Cardiology Division, Geneva University Hospitals, 2Laboratory Medicine Division, Geneva University Hospitals, 3Division of Infectious Diseases, HIV Unit, Geneva University Hospitals, Geneva, 4Department of Internal Medicine, Triemli Hospital, University of Zurich, Zürich, Switzerland)

Endothelial protective properties of hdl improve OR67 early after roux-en-y gastric bypass but not after diet-induced weight loss: the superior cardiometabolic benefits of rygb E. Osto1, *, P. Doytcheva1, M. Charakida2, L. Van Gaal3, J. Deanfield2, T. Lüscher1 (1Centre for Molecular Cardiology, University of Zurich, Schlieren-Zurich, Switzerland, 2Institute of Cardiovascular Sciences, London, United Kingdom, 3Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Antwerp, Belgium)

Arterial hypertension in long-term survivors OR68 after hematopoietic stem cell transplantation C. Arranto1, *, T. Burkard2, O. Pfister2, J. Halter1 (1Hematology, 2Cardiology, University Hospital Basel, Basel, Switzerland)

Selective heart rate reduction with ivabradine OR69 increases central blood pressure in stable coronary artery disease D. Cerny1, *, F. Messerli1, S. Laurent2, C. Seiler1, S. Rimoldi1 (1Department of Cardiology and Clinical Research, Insel spital, Bern, Switzerland, 2Department of Pharmacology, European Georges Pompidou Hospital, University Paris Descartes, Paris, France)

The prevalence of and relationships between OR70 complex needs, self-care, healthcare utilization and vulnerable profiles in individuals with heart failure: preliminary results of an ongoing cross-sectional study P. Schäfer-Keller1, *, G. Santos1, K. Vasserot2, C. Augereau2, H. Villeneuve2, O. Raccanello2, D. Graf2, N. Aubort2, M. Vona3, C. Moses Passini4, D. Richards5, A. Strömberg6 (1School of Health Sciences Fribourg – HEdS-FR , University of Applied Sciences and Arts Western

* Presenting author

62 Detailed Programme Thursday, June 16

Switzerland HESO, 2Cardiology, 3Cardiac and pulmonary rehabilitation, Cantonal Hospital Fribourg, 4School of Health Sciences Fribourg – HEdS-FR / HES-SO, University of Applied Sciences and Arts Western Switzerland, Fribourg, Switzerland, 5Psychology, University of Exeter medical school, Exeter, United Kingdom, 6Department of Medical and Health Sciences, Linköpings University, Linköping, Sweden)

Effect of permanent internal mammary artery OR71 occlusion on extracardiac coronary collateral supply M. Stoller1, *, R. Kurmann1, R. Grossenbacher1, C. Tschannen1, C. Seiler1 (1Department of Cardiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland)

Joint Session Room 1AB

15:45–17:15 Pulmonary hypertension 80 Chairs: Andrea Azzola (Lugano, CH) André Linka (Winterthur, CH)

Hemodynamic evaluation of PH 80.1 Frédéric Lador (Geneva, CH)

Case-based discussion of PH due to lung diseases 80.2 Silvia Ulrich (Zürich, CH)

Case-based discussion of PH due to left heart 80.3 diseases Patrick Yerly (Lausanne, CH)

New and upfront therapies in pulmonary 80.4 hypertension Marc Humbert (Paris, FR)

Main Session Auditorium B

15:45–17:15 Ventilation and Heart Failure 81 Chairs: Andreas Flammer (Zürich, CH) Robert Thurnheer (Münsterlingen, CH)

* Presenting author

63 Detailed Programme Thursday, June 16

Epidemiology and diagnosis of sleep apnea 81.1 Raphaël Heinzer (Lausanne, CH)

Sleep apnea and heart failure 81.2 Micha Maeder (St. Gallen, CH)

Treatment of sleep apnea in heart failure 81.3 patients considering after SERVE HF results Martin Cowie (London, UK)

Non invasive ventilation in acute heart failure 81.4 Jochen Rüdiger (Basel, CH)

Discussion

Workshop Room 5AB

15:45–17:15 Facing the challenge of TAVI 2016 82 Chairs: Peter Wenaweser (Zürich, CH) Enrico Ferrari (Lugano, CH)

Pitfalls in the severity assessment of aortic 82.1 stenosis by echocardiography Hajo Müller (Geneva, CH)

This session is organized by the scientific Extension to medium and low risk patients? 82.2 committee . The industry partners are kindly Pro: Stéphane Noble (Geneva, CH) supporting the program without any in- Con: Friedrich Eckstein (Basel, CH) fluence on topic, contents, and speakers . Surgical standby still necessary? 82.3 Con: Hans Rickli (St. Gallen, CH) Pro: Thierry Carrel (Bern, CH)

Nurse Session Room 1C

16:15–17:15 Presentation of clinical scientific projects 83 Chairs: Verena Cattilaz-Langenauer (St. Gallen, CH) Marianne Schärli (Zürich, CH)

Phases of restlessness in newborn and infants 83.1 with reduced heart function Chantal Costan (Zürich, CH) Jasmina Robl (Zürich, CH)

64 Detailed Programme Thursday, June 16

Information on assist device implantation 83.2 for patients with on the intensive care ward and their relatives Iris Weber (Zürich, CH)

Medication intake of adolescents with heart 83.3 disease - recommendations for practice Yvonne Liebert-Keller (Kirchdorf, CH)

Need for support for patients with chronic heart 83.4 failure, the development and implementation of self management strategies at home Cornelia Bläuer (Basel, CH)

Abstract Session Room 2C

17:30–18:45 Clinical cases: miscellaneous II 84 Chairs: Piergiorgio Tozzi (Lausanne, CH) Jacqueline Landolt (Morges, CH)

Unrestrictive aortopulmonary window: OR77 extreme presentation as non-eisenmenger in a 30 year-old patient P. Myers1, 2, *, F. Lador2, A.-L. Hachulla2, J. Jolou1, J. Bouchardy2, S. Noble2, M. Licker2, M. Beghetti2 (1Cardiac surgery, 2Pulmonary hypertension program, Geneva University Hospitals, Geneva, Switzerland)

Bilateral subclavian artery aneurysm in a patient OR78 with marfan’s syndrome N. F. Sipahi1, *, C. Mueller1, C. Hagl1, M. Pichlmaier1 (1Cardiac Surgery, University Hospital Munich, Ludwig- Maximilian-University, Munich, Germany)

Left ventricular non-compaction cardiomyopathy OR79 mimicking a myocardial infarction J. Sztajzel1, *, B. Veragut-Davies1, M. Roffi2 (1Clinique de Carouge, 2Service de Cardiologie, Genève, Switzerland)

* Presenting author

65 Detailed Programme Thursday, June 16

Livedo reticularis and iris flocculi would have OR80 predicted the risk of aortic dissection during pregnancy P. Banerjee1, *, C. Dovifat1, M. Ziaki1, M. Gabor1, F. Eckstein1, P. Matt1 (1Cardiac Surgery, University Hospital Basel, Basel, Switzerland)

First neonatal cardiac transplantation OR81 in Switzerland M. Schweiger1, 2, *, B. Stiasny1, 3, A. Cavigelli-Brunner1, 3, V. Cannizzaro1, 4, M. Schmiady1, 2, C. Bürki1, 5, O. Kretschmar1, 3, M. Hübler1, 2 (1Children’s Research Centre, 2Department for congenital cardiovascular surgery, 3Division of Pediatric Cardiology , 4Department of Intensive Care and Neonatology , 5Department of Anesthesiology, Children’s Hospital Zurich, Zurich, Switzerland)

Abstract Session Room 5C

17:30–18:45 Clinical cases: miscellaneous I 85 Chairs: Philipp Weiss (Basel, CH) André Plass (Zürich, CH)

Genetic testing in sudden cardiac death: OR72 never give up J. Schläpfer1, *, F. Fellmann2, M.-O. Roussianos3, H. Fodstad2, Z. A. Bhuiyan2 (1Cardiologie, 2Génétique, CHUV, 3Cardiologie, Lausanne, Switzerland)

A rare manifestation of right heart endocarditis OR73 of the chiari network in a patient with iv drug abuse diagnosed and followed up by transthoracic echocardiography (tte) and treated in an unconventional way D. Weber1, *, M. Fechter2, K. Weber1, J. Gubler2, T. Fischer1 (1Kardiologie, 2Medizinische Klinik, Kantonsspital Winterthur, Winterthur, Switzerland)

* Presenting author

66 Detailed Programme Thursday, June 16

Transapical aortic and mitral valve implantation OR74 with severe left ventricular outflow tract obstruction and complete retraction of the repositionable lotus® valve system in mitral position P. P. Heinisch1, *, F. Praz2, M. Mihalj1, B. Winkler1, S. Windecker2, T. Carrel1, C. Huber1 (1Department of Cardiovascular Surgery, University Hospital, Bern, 2Department of Cardiology, University Hospital, Bern, Switzerland)

Vasopastic angina: OR75 a forgotten acute coronary syndrome F. Rey1, *, F. Rigamonti1 (1Médecine interne / Cardiology, Hôpitaux Universitaire de Genève ( HUG), Genève, Switzerland)

Complete regression of liver cirrhosis after OR76 heart transplantation in a patient with prior fontan surgery for complex congenital heart disease J. Bouchardy1, 2, *, P. Meyer2, P. Yerly1, R. Hullin1, E. Giostra3, L. Rubbia-Brandt4, N. Sekarski5, R. Prêtre6, M. Beghetti7 (1Cardiologie, CHUV, Lausanne, 2Cardiologie, 3Gastro- entérologie, 4Pathologie, HUG, Genève, 5Cardiologie pédiatrique, 6Chirurgie cardiaque, CHUV, Lausanne, 7Cardiologie pédiatrique, HUG, Genève, Switzerland)

Quiz Room 1C

17:30–18:30 SSC-Quiz 86 Chair: Franz Messerli (New-York, USA)

Team Cardiocentro Lugano 86.1 Giulia Montrasio (Lugano, CH) Alessandra Chiodini (Lugano, CH) Stefano Svab (Lugano, CH)

against

Team Stadtspital Triemli Zürich 86.2 Peter Dietrich (Zürich, CH) Armin Zürcher (Zürich, CH) Flurina Arquint (Zürich, CH) * Presenting author

67 Detailed Programme Thursday, June 16

Satellite Symposium Room 1AB Zoll

17:30–18:30 The Wearable Cardioverter Defibrillator: 87 Protecting Patients from the Risk of Sudden Cardiac Death Chairs: Frank Ruschitzka (CH) Sven Reek (CH)

Welcome and introduction 87.1 Sven Reek (CH)

Patients at high risk of sudden cardiac death 87.2 and indications for a Wearable Cardioverter Defibrillator (WCD) Jan Steffel (CH)

A WCD: what is it and how does it work? 87.3 Giulia Dominichini (CH)

A new therapeutic tool for the Swiss cardiologist 87.4 and how to integrate it into daily practice Michael Kühne (CH)

Panel Discussion 87.5 Frank Ruschitzka (CH)/Faculty

Concluding remarks 87.6 Frank Ruschitzka (CH)

Satellite Symposium Room 3C Johnson&Johnson AG, Biosense Webster

17:30–18:30 Catheter ablation of ventricular 88 arrhythmias: The state of the art Chairs: Etienne Pruvot (CH) Tobias Reichlin (CH)

Welcome and introduction 88.1 Etienne Pruvot (CH), Tobias Reichlin (CH)

68 Detailed Programme Thursday, June 16

Ultrasound Integration in 3D Mapping system: 88.2 clinical benefits in VT mapping and ablation Antonio Dello Russo (IT)

The pace-mapping technique to unmask VT 88.3 isthmuses in post-infarct patients Christian De Chillou (FR)

Discussion

Satellite Symposium Room 4C LivaNova – Sorin Group International SA

17:30–18:30 New approaches in device therapy for HF 89 Chairs: Christian Sticherling (Basel, CH) Vincent Ganière (Pompaples, CH)

Welcome and introduction 89.1 Christian Sticherling (Basel, CH) Vincent Ganière (Pompaples, CH)

Sleep Apnea: A significant risk factor 89.2 for HF patients – treatable by pacing Haran Burri (Geneva, CH)

Automatic device based CRT optimization: 89.3 SonR technology David Hürlimann (Zürich, CH)

Clinical benefits from frequent CRT optimization: 89.4 results from the large scale RESPOND CRT trial François Regoli (Lugano, CH)

Conclusion & questions/answers all

69 Gemeinsame Jahrestagung 2017 Gemeinsame Jahrestagung 2017 Jahrestagung Gemeinsame Gemeinsame Jahrestagung 2017 Bild: shutterstock Bild: shutterstock Bild: shutterstock 7.– 9. Juni 2017 Trafo Baden Trafo Baden Trafo 2017 Juni 9. 7.– 7.– 9. Juni 2017 Trafo Baden Gemeinsame Jahrestagung Gemeinsame Jahrestagung Gemeinsame SchweizerischeGemeinsame Gesellschaft Jahrestagung für Kardiologie (SGK) Schweizerische Gesellschaft für Kardiologie (SGK) Kardiologie für Gesellschaft Schweizerische SchweizerischeSchweizerische Gesellschaft Gesellschaft für für Herz- Kardiologie und thorakale (SGK) Gefässchirurgie (SGHC) Schweizerische Gesellschaft für Herz- und thorakale Gefässchirurgie (SGHC) Gefässchirurgie thorakale und Herz- für Gesellschaft Schweizerische Schweizerische Gesellschaft für Herz- und thorakale Gefässchirurgie (SGHC) Gastgesellschaften Gastgesellschaften SchweizerischeGastgesellschaften Gesellschaft für Pädiatrische Kardiologie (SGPK) Schweizerische Gesellschaft für Pädiatrische Kardiologie (SGPK) Kardiologie Pädiatrische für Gesellschaft Schweizerische SchweizerischeSchweizerische Hypertonie Gesellschaft Gesellschaft für Pädiatrische (SHG) Kardiologie (SGPK) Schweizerische Hypertonie Gesellschaft (SHG) Gesellschaft Hypertonie Schweizerische SwissSchweizerische Cardiovascular Hypertonie Therapists Gesellschaft (SCT) (SHG) Swiss Cardiovascular Therapists (SCT) Therapists Cardiovascular Swiss SchweizerischerSwiss Cardiovascular Verein Therapistsfür Pflegewissenschaften (SCT) (VfP) Schweizerischer Verein für Pflegewissenschaften (VfP) Pflegewissenschaften für Verein Schweizerischer SchweizerischeSchweizerischer Gesellschaft Verein für Pflegewissenschaftenfür Notfall- und Rettungsmedizin (VfP) (SGNOR) Schweizerische Gesellschaft für Notfall- und Rettungsmedizin (SGNOR) Rettungsmedizin und Notfall- für Gesellschaft Schweizerische SchweizerischeSchweizerische Gesellschaft Gesellschaft für für Perfusionstechniken Notfall- und Rettungsmedizin (SGfP) (SGNOR) Schweizerische Gesellschaft für Perfusionstechniken (SGfP) Perfusionstechniken für Gesellschaft Schweizerische Schweizerische Gesellschaft für Perfusionstechniken (SGfP) 70

Gemeinsame Jahrestagung 2017 Bild: shutterstock 7.– 9. Juni 2017 Trafo Baden

Gemeinsame Jahrestagung Schweizerische Gesellschaft für Kardiologie (SGK) Schweizerische Gesellschaft für Herz- und thorakale Gefässchirurgie (SGHC)

Gastgesellschaften Schweizerische Gesellschaft für Pädiatrische Kardiologie (SGPK) Schweizerische Hypertonie Gesellschaft (SHG) Swiss Cardiovascular Therapists (SCT) Schweizerischer Verein für Pflegewissenschaften (VfP) Schweizerische Gesellschaft für Notfall- und Rettungsmedizin (SGNOR) Schweizerische Gesellschaft für Perfusionstechniken (SGfP) Detailed Programme Friday, June 17

Joint Session Room 5C

08:00–09:30 Cardiopulmonary exercise testing (CPET): Interactive case discussion

Panel: 90.1 Otmar Pfister (Basel, CH) Pierre-Olivier Bridevaux (Sion, CH) Susanna Stöhr (Basel, CH) Voting

Cardiologist’s point of view 90.2 Lukas Trachsel (Bern, CH)

Pneumologist’s point of view 90.3 Jörg Leuppi (Liestal, CH)

The surgical need for CPET 90.4 Markus Furrer (Chur, CH)

Joint Session Room 3C

08:00–09:30 From gadgets to evidence based telemedicine 91 Chairs: Arno Schmidt-Trucksäss (Basel, CH) Martin Brutsche (St. Gallen, CH)

How will runtastic, polar, garmin & Co. influence 91.1 rehabilitation in the future? Christoph Schmidt (Barmelweid, CH)

Minimal medical standards for actigraphy 91.2 Milo Puhan (Zürich, CH)

Monitored rehab or unsupervised daily physical 91.3 activity? Christel Kamani (Geneva, CH)

Joint Session Auditorium B

08:00–09:30 NOACs and antiplatelet therapy – Update 2016 92 Chairs: Rolf Inderbitzi (Zürich, CH) Giovanni Pedrazzini (Lugano, CH)

71 Detailed Programme Friday, June 17

This session is organ- Non-vitamin K oral anticoagulants (NOACs) 92.1 ized by the scientific committee . The indus- Jan Steffel (Zürich, CH) try partners are kindly supporting the program without any in- Dual-platelet therapy 92.2 fluence on topic, contents, and speakers . Giovanni Pedrazzini (Lugano, CH)

Antiplatelet therapy in the periinterventional 92.3 situation Mario Togni (Fribourg, CH)

Major lung resection in the presence 92.4 of antiplatelet therapy Hans-Beat Ris (Lausanne, CH)

Workshop Room 1C

08:00–09:00 Cardiopulmonary pediatric challenges of altitude 94 Speakers: Isabelle Rochat (Geneva, CH) Damian Hutter (Bern, CH)

Workshop Room 5AB

08:00–09:00 New lung function standards 95 Speakers: Jean-Marc Fellrath (Neuchâtel, CH) Thomas Sigrist (Barmelweid, CH)

Workshop Room 2C

08:00–09:00 Indication and outcome in lung transplantation 96 Speakers: John-David Aubert (Lausanne, CH) Ilhan Inci (Zürich, CH)

Workshop Room 4C

08:00–09:00 Swiss recommendations for adult patients 97 with cystic fibrosis Speakers: Alain Sauty (Lausanne, CH) Reta Fischer (Bern, CH)

72 Detailed Programme Friday, June 17

Workshop Room 1AB

08:00–09:30 What the general cardiologist should know 98 about rhythmology Chairs: Marianne Zimmerli (Thun, CH) Stefan Osswald (Basel, CH)

Frequent ventricular premature beats/ 98.1 ventricular tachycardia Jens Seiler (Bern, CH)

Frequent atrial premature beats/atrial 98.2 tachycardia Etienne Delacretaz (Lausanne, CH)

Stroke prevention in AF 98.3 Peter Ammann (St. Gallen, CH)

Bradycardia and pacing 98.4 Patrice Carroz (Lausanne, CH)

Main Session Room 5AB

09:15–10:45 News in oncology of the lung 99 Chairs: Sandor Györik (Bellinzona, CH) Hans-Beat Ris (Lausanne, CH)

Lung CT scan: 99.1 diagnostic approach of pulmonary nodules Catherine Beigelman-Aubry (Lausanne, CH)

Early stage surgery in NSCLC radiotherapy 99.2 vs. surgery Walter Weder (Zürich, CH) Alexandros Papachristofilou (Basel, CH)

New personalized therapy 99.3 Hasna Buchaab (Lausanne, CH)

73 Detailed Programme Friday, June 17

Main Session Room 2C

09:15–11: 05 Paediatric Pulmonology Science Session 100 Chairs: Philip Latzin (Basel, CH) Constance Barazzone (Geneva, CH)

Pediatric ILD 100.1 Matthias Griese (Munich, DE)

Swiss-wide studies and registries results 100.2 of the ILD survey Isabelle Rochat (Lausanne, CH)

Swiss pediatric asthma study (SPAC) 100.3 Claudia Kuehni (Bern, CH)

Congenital lung malformations 100.4 Isabelle Ruchonnet Métrailler (Geneva, CH)

Closing up discussion

Abstract Session Room 4C

09:45–11:15 Surgical particularities 101 Chairs: Stephane Noble (Geneva, CH) Omer Dzemali (Zürich, CH)

Fast-track management: dexmedetomidine OR82 provides effective pain modulation and rapid extubation in patients after off-pump coronary artery bypass grafting A. Zientara1, *, S. Matter-Ensner2, S. Mariotti2, K. Graves1, O. Dzemali1, M. Genoni1 (1Cardiac Surgery, 2Anesthesiology/Intensive Care, Stadtspital Triemli, Zürich, Switzerland)

* Presenting author

74 Detailed Programme Friday, June 17

Skeletonized bima grafts in cabg surgery: OR83 a single centre fifteen-year experience T. Torre1, *, D. Corsi1, E. Caporali1, F. Armato1, E. Ferrari1, G. Franciosi1, S. Demertzis1 (1Cardiac Surgery, Cardiocentro Ticino, Lugano, Switzerland)

Heart string reduces stroke rate and enables OR84 complete revascularization in off pump coronary artery bypass graft surgery D. Odavic1, *, A. Haeussler1, H. Loeblein1, A. Zientara1, K. Graves1, D. Berdajs1, O. Dzemali1, M. Genoni1 (1Herzchirurgie, Stadtspital Triemli, Zürich, Switzerland)

Sternal healing in asymptomatic patients OR85 and potential influencing factors H. Rodriguez1, S. H. Sündermann2, M. Y. Emmert1, H. Alkhadhi3, M. Genoni1, F. Maisano1, A. Plass4, * (1Cardiovascular Surgery, UniversitätsSpital Zürich, Zürich, Switzerland, 2Cardiovascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany, 3Radiology, 4UniversitätsSpital Zürich, Zürich, Switzerland)

Hybrid coronary artery revascularization OR86 D. Reser1, *, M. van Hemelrijck2, A. Plass1, S. Benussi1, A. Weber1, F. Maisano1 (1Herzchirurgie, UniversitätsSpital Zürich, 2Universität Zürich, Zürich, Switzerland)

Single center experience of miniaturized OR87 extracorporeal circulation circuits in a large patient cohort G. Zuk1, B. Winkler1, *, P. P. Heinisch1, B. Gahl1, K. Zuk1, F. Schönhoff1, H. Most1, E. Roost1, D. Reineke1, A. Kadner1, L. Englberger1, C. Huber1, T. Carrel1 (1Department of Cardiovascular Surgery, University Hospital, Bern, Switzerland)

* Presenting author

75 Detailed Programme Friday, June 17

Abstract Session Room 5C

09:45–11:15 Leads and leadless systems: 102 the good, the bad and the ugly Chairs: Jan Steffel (Zürich, CH) Patrizio Pascale (Lausanne, CH)

Preliminary results of the rally-x4 study OR88 on performance of straight and spiral multipolar coronary sinus leads H. Burri1, *, P. Defaye2, P. Ammann3, E. Pruvot4, T. Kayser5, C. Leclercq6, M. Biffi7 (1Cardiology, University Hospital of Geneva, Geneva, Switzerland, 2CHU Michalon, Grenoble, France, 3Kantonsspital, St. Gallen, 4CHUV, Lausanne, Switzerland, 5Boston Scientific, Vienna, Austria,6 Cardiology, CHU Rennes, Rennes, France, 7University Hospital, Bologna, Italy)

The torpedo-pacemaker – towards blood flow OR89 driven lead – and batteryless right ventricular outflow tract pacing Y. Gugler1, 2, A. Zurbuchen1, 2, L. Bereuter1, 2, S. Frey1, S. E. Jahren1, J. Seiler2, F. Noti2, N. Tran2, H. Servatius2, A. Medeiros-Domingo2, A. Lam2, L. Roten2, H. Tanner2, D. Obrist1, R. Vogel3, J. Fuhrer2, A. Haeberlin1, 2, * (1ARTORG Center University of Bern, 2Department of Cardiology, Bern University Hospital, Bern, 3Department of Cardiology, Solothurner Spitäler AG, Solothurn, Switzerland)

Transcatheter leadless pacemaker (micra®) – OR90 real-world safety and efficacy V. Valiton1, *, E. Pruvot2, S. Cook1, L. Bisch2, P. Carroz2, D. Graf1 (1University and Hospital Fribourg, Fribourg, 2CHUV, Lausanne, Switzerland)

* Presenting author

76 Detailed Programme Friday, June 17

Pericardial effusion during transvenous lead OR91 extraction: not always the same story F. Regoli1, *, M. L. Caputo1, G. Conte1, S. Svab1, G. D’Ambrosio1, C. Klersy2, T. Moccetti1, A. Auricchio1 (1Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland, 2Servizio di Biometria e Statistica, Direzione Scientifica, HRCCS Osp. S Matteo, Pavia, Italy)

Lead failure rate and failure manifestation of OR92 the biotronik linox lead compared to the st jude medical riata lead and the medtronic sprint fidelis lead A. Lam1, *, S. Bühler1, F. Noti1, H. Servatius1, J. Seiler1, A. Haeberlin1, A. Medeiros-Domingo1, V. N. Tran1, J. Fuhrer1, H. Tanner1, L. Roten1 (1Department of Cardiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland)

Biotronik linox and linox smart defibrillator OR93 lead performance A. Lam1, *, F. Noti1, S. Bühler1, J. Seiler1, H. Servatius1, A. Haeberlin1, A. Medeiros-Domingo1, V. N. Tran1, J. Fuhrer1, H. Tanner1, L. Roten1 (1Department of Cardiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland)

Debate Room 1C

09:45–11:15 Hole - Leave it or correct it 103 Chairs: Tornike Sologashvili (Geneva, CH) Kerstin Wustmann (Bern, CH)

Case 1: TGA with atrial switch and moderate- 103.1 large baffle leak – native valve conduit stenosis or leakage – how can the interventionist help? Case Presentation: Ophélie Loup (Bern, CH) Discussant “leave it”: Dominik Stambach (St. Gallen, CH) Discussant “correct it”: Peter Ewert (Munich, DE)

* Presenting author

77 Detailed Programme Friday, June 17

Case 2: AVSD requiring re-do surgery 103.2 Case Presentation: Martin Schmiady (Zürich, CH) Discussant “leave it”: Francesca Bonassin (Zürich, CH) Discussant “correct it”: René Prêtre (Lausanne, CH)

Joint Session Room 3C

09:45–11:15 Rehabilitation for cardiac and pulmonary patients

Panel: 104.1 Martin Frey (Barmelweid, CH) Arturo Bernardo (Gais, CH) Martin Gsponer (Kilchberg, CH)

COPD and heart disease – Training modalities 104.2 in rehabilitation Bernard Egger (Rolle, CH)

Alternative rehabilitations methods and novel 104.3 indications in cardiac patients Jean-Paul Schmid (Bern, CH)

Alternative rehabilitation methods and novel 104.4 indications in pulmonary patients Alexander Turk (Wald, CH)

Discussion: does one size fit all?

Main Session Auditorium B

09:45–11:15 Pulmonary embolism 105 Chairs: Stefano Benussi (Zürich, CH) Thomas Hess (Winterthur, CH)

Epidemiology, diagnosis and risk assessment 105.1 Marc Righini (Geneva, CH)

In-house vs. ambulatory management: 105.2 strategy and medication Drahomir Aujesky (Bern, CH)

78 Detailed Programme Friday, June 17

Severe pulmonary embolism: surgical aspects 105.3 Oliver Reuthebuch (Basel, CH)

Severe pulmonary embolism: Catheter based 105.4 thrombolysis and medical treatment Rolf Engelberger (Fribourg, CH)

Workshop Room 1AB

09:45–11:15 Hot topics in heart failure and mitral regurgitation 106 Chairs: Giorgio Moschovitis (Lugano, CH) David Reineke (Bern, CH)

Where and how to quantify MI: 106.1 Echolab, cathlab or MRI? My best tips and tricks Philipp Haager (St. Gallen, CH)

Durability of mitral valve surgery: 106.2 Repair, replacement or simply a clip? Christoph Huber (Geneva, CH)

Bad LV and severe MR: how to proceed and how 106.3 to predict LV improvement? Jan Vontobel (Zürich, CH)

Clip it, band it or leave it 106.4 Maurizio Taramasso (Zürich, CH)

Main Session Room 5AB

11: 00–12:30 Asthma 107 Chairs: Laurent Nicod (Lausanne, CH) Alexander Möller (Zürich, CH)

The origine of asthma in children – 107.1 from the hygiene hypothesis to the microbiota Gaudenz Hafen (Lausanne, CH)

Impact of biomarkers on phenotypes 107.2 Kian Fan Chung (London, UK)

79 Detailed Programme Friday, June 17

Biologic agents or thermoplasty 107.3 in severe asthma Pascal Chanez (Marseille, FR)

Betablockers in asthma – which yes, which no? 107.4 Lars Huber (Bern, CH)

Joint Session Room 1AB

11:30–12:30 Innovation and competitiveness of research in Switzerland

Panel: 108.1 Thomas Lüscher (Zürich, CH) Michael Tamm (Basel, CH) Hans Rickli (St. Gallen, CH)

Input-Referat 108.2 Alexander Breitenstein (Zürich, CH)

The gap between basic and clinical science 108.3 Patrick Aebischer (Lausanne, CH)

Swiss clinical trials organization 108.4 Gregor Zünd (Zürich, CH)

The state secretary for education, research 108.5 and innovation’s view Mauro Dell’Ambrogio (Bern, CH)

Discussion

Joint Session Room 5C

11:30–12:30 Evaluation of right heart function 109 Chairs: Hans Stricker (Locarno, CH) Peter Buser (Basel, CH)

Is an echo the best right heart catheter? 109.1 Bernhard Herzog (Luzern, CH)

80 Detailed Programme Friday, June 17

Right heart catheterization 109.2 Franz Eberli (Zürich, CH)

Exercise test 109.3 Philipe Herve (Paris, FR)

MRI 109.4 Emanuela Valsangiacomo Büchel (Zürich, CH)

Scientific Session Room 1C

11:30–12:30 Complications in CHD – with a little help 110 from our friends Chairs: Birgit Donner (Basel, CH) Tobias Rutz (Lausanne, CH)

Ventricular arrhythmias – 110.1 how can the electrophysiologist help? Dipen Shah (Geneva, CH)

Native valve conduit stenosis or leakage? – 110.2 how can the interventionalist help? Peter Ewert (München, DE)

Systemic ventricular failure – how can the 110.3 surgeon help? Assist device or transplantation? Michael Hübler (Zürich, CH)

Workshop Auditorium B

11:30–12:30 2015 ESC NSTE-ACS guidelines in-depth 111 Chairs: Marco Roffi (Geneva, CH) Alberto Weber (Zürich, CH)

Diagnosis and risk assessment 111.1 Christian Müller (Basel, CH)

Antithrombotic treatment? 111.2 Marco Valgimigli (Bern, CH)

Invasive assessment and revascularisation 111.3 Stephan Windecker (Bern, CH)

81 Detailed Programme Friday, June 17

Workshop Room 4C

11:30–12:30 Medical centres and surgeries – present and future 112 Speaker: Patrick Tuor (CH)

Practical workshop Room 3C

11:30–12:30 Respiratory physiotherapy 113 Speaker: Anja Raab (Luzern, CH)

Hands-on Room 4C

13:00–17:00 BLS/AED refresher 114 Speaker: Stefan Müller (Geneva, CH)

Satellite Symposium Auditorium B Vertex Pharmaceuticals (CH) GmbH

13:00–14:00 CFTR modulation: advances in the treatment 115 of cystic fibrosis Chair: Alexander Möller (CH)

Welcome and introduction 115.1 Alexander Möller (CH)

How CFTR modulation targets the basic defect 115.2 of cystic fibrosis Jane C. Davies (UK)

Emerging treatment options based on CFTR 115.3 modulation Jane C. Davies (UK) Lars Huber (Zürich, CH)

Discussion

Satellite Symposium Room 1AB Mundipharma Medical Company

13:00–14:00 Asthma therapy: Is it really that easy? 116 Chair: Malcom Kohler (CH)

82 Detailed Programme Friday, June 17

Welcome and introduction 116.1 Malcom Kohler (CH)

Non – Adherence: missed opportunity 116.2 to reach better asthma therapy? Isabelle Arnet (CH)

Is it asthma or is it COPD ? 116.3 Pierre Olivier Bridevaux (CH)

Concluding remarks 116.4 Questions and answers Malcom Kohler (CH)

Satellite Symposium Room 3C Boston Scientific AG

13:00–14:00 Beyond standard therapies 117 Chairs: Haran Burri (Geneva, CH) Angelo Auricchio (Lugano, CH) Christian Sticherling (Basel, CH)

Challenges in contemporary ICD therapy 117.1 Haran Burri (Geneva, CH)

Questions and answers 117.2 Haran Burri (Geneva, CH)

Simplicity and sophistication in subcutaneous 117.3 ICD therapy Angelo Auricchio (Lugano, CH)

Questions and answers 117.4 Angelo Auricchio (Lugano, CH)

Treatment of paroxysmal atrial fibrillation 117.5 Christian Sticherling (Basel, CH)

Questions and answers 117.6 Christian Sticherling (Basel, CH)

83 Detailed Programme Friday, June 17

Satellite Symposium Room 5AB GSK

13:00–14:00 Mepolizumab – Anti-IL5 in the treatment 118 of severe eosinophilic asthma Chair: Christian Baumgartner (CH)

Welcome and introduction 118.1 Christian Baumgartner (CH)

The journey to personalised care within 118.2 severe asthma: mepolizumab Neil Martin (UK)

Questions and answers

Satellite Symposium Room 5C Boston Scientific AG

13:00–14:00 It’s time to breathe: bronchial thermoplasty; 119 long term solution for severe asthma patients Chairs: Pascal Chanez (Marseille, FR) Franco Quadri (Bellinzona, CH)

Welcome and introduction 119.1 Paola Gasche Soccal (Geneva, CH)

Scientific evidence on bronchial thermoplasty 119.2 Michel Aubier (Paris, FR)

When, for whom and how? Bronchial 119.3 thermoplasty – the swiss experience Daiana Stolz (Basel, CH)

Video presentation: 5 minutes 119.4 Daiana Stolz (Basel, CH)

Questions and answers

84 Detailed Programme Friday, June 17

Abstract Session Room 5C

14:15–15:45 From PCI to electrophysiology/ 120 pacemaker implantation Chairs: Marianne Zimmerli (Thun, CH) Fabian Noti (Bern, CH)

High-intensity statin therapy stabilizes OR97 vulnerable plaques in patients after st-elevation myocardial infarction patients (ibis-4): a serial multivessel optical coherence tomography study (oct) L. Räber1, *, S. Zaugg2, K. Yamaji1, M. Roffi3, A. Moschovitis1, G. Pedrazzini4, C. M. Matter5, S. Noble3, K. K. Koskinas1, T. F. Lüscher5, M. Taniwaki1, S. Windecker6 (1Interventional Cardiology, Bern University Hospital, 2Clinical Trials Unit, University of Bern, Bern, 3Interventional Cardiology, Geneva University Hospital, Geneva, 4Interventional Cardiology, Cardiocentro Lugano, Lugano, 5Cardiology, Zurich University Hospital, Zurich, 6Cardiology, Bern University Hospital, Bern, Switzerland)

Gender differences in the outcome of primary OR95 preventive implantable defibrillator therapy – data from the eu-cert-icd study C. Sticherling1, *, B. Arendacka2, B. Schaer1, J. Hastrup Svendsen3, S. Wijers4, T. Friede2, J. Stockinger5, G. Schmidt6, B. Merkely7, R. Willems8, A. Lubinski9, M. Scharfe10, M. Zabel11 on behalf of on behalf of the EU-CERT-ICD investigators (1Cardiology, University Hospital Basel, Basel, Switzerland, 2University of Goettingen, Goettingen, Germany, 3Cardiology, Rigshospitalet, Copenhagen, Denmark, 4Cardiology, UMC, Utrecht, Netherlands, 5Cardiology, Universitäts Herzzentrum Bad Krozingen, Bad Krozingen, 6Cardiology, Technical University, Munich, Germany, 7Cardiology, Semmelweiss University, Budapest, Hungary, 8Cardiology, University of Leuven, Leuven, Belgium, 9Cardiology, Medical University of Lodz, Lodz, Poland, 10University Hospital Basel, Basel, Switzerland, 11Cardiology, University of Goettingen, Goettingen, Germany)

* Presenting author

85 Detailed Programme Friday, June 17

Trends of sports-related sudden cardiac death OR96 in Switzerland – an autopsy study B. Asatryan1, *, A. Medeiros-Domingo1, C. Vital1, C. Kellerhals1, C. Gräni2, L. D. Trachsel1, C. M. Schmied2, A. M. Saguner2, S. Bolliger3, K. Michaud4, M. Wilhelm1 on behalf of Swiss Working Group of Sudden Cardiac Death (1Department of Cardiology, Inselspital, Bern, 2University Heart Center, 3Institute of Forensic Medicine, University of Zürich, Zürich, 4Unit of Forensic Medicine, University Center for Legal Medicine, Lausanne, Switzerland)

Electrophysiology study tailored pacemaker OR94 or loop recorder implantation and follow up of patients with left bundle branch block after transcatheter aortic valve implantation A. Mühl1, *, T. Reichlin1, S. Beat1, S. Knecht1, U. Celikyurt1, R. Jeger1, R. Twerenbold1, C. Kaiser1, C. Sticherling1, S. Osswald1, M. Kühne1 (1Kardiologie, Universitätsspital Basel, Basel, Switzerland)

Multi-analysis with oct and vasomotion OR98 in everolimus-eluting synergy coronary stents – the moves trial D. Arroyo1, S. Schukraft1, J.-C. Stauffer1, G. Baeriswyl1, J.-J. Goy1, M. Togni1, S. Puricel1, *, S. Cook1 (1University and Hospital Fribourg, Fribourg, Switzerland)

Diagnostic and prognostic value of the v-index, OR99 a novel ecg marker quantifying spatial hetero- geneity of ventricular repolarization, in patients with symptoms suggestive of acute myocardial infarction R. Abächerli1, *, R. Twerenbold1, J. Boeddinghaus1, I. Strebel1, S. Osswald1, C. Müller1, T. Reichlin1 (1Cardiology, University Hospital Basel, Basel, Switzerland)

Joint Session Room 1C

14:15–15:45 PAH and congenital heart disease 121 Chairs: Matthias Greutmann (Zürich, CH) Jürg Hammer (Basel, CH)

* Presenting author 86 Detailed Programme Friday, June 17

What’s new in the guidelines 121.1 Markus Schwerzmann (Bern, CH)

ASD and PH – close it or not? 121.2 Oliver Kretschmar (Zürich, CH)

The treat and repair approach – 121.3 does it make sense? René Prêtre (Lausanne, CH)

What’s special in Eisenmenger-Syndrome? 121.4 Judith Bouchardy (Geneva, CH)

Main Session Room 5AB

14:15–15:45 Respiratory infections 122 Chairs: Christine Eich (Zürich, CH) Sebastian Ott (Bern, CH)

Lung microbiota: Yin and yang 122.1 Eric Bernasconi (Lausanne, CH)

Non-CF bronchiectasis 122.2 James Chalmers (Dundee, UK)

Guidelines for lower respiratory tract infections 122.3 Tobias Welte (Hannover, DE)

Surgical aspects of infection 122.4 Didier Lardinois (Basel, CH)

Workshop Auditorium B

14:15–15:45 Best swiss articles of the year 2015 123 Chairs: François Mach (Geneva, CH) Francesco Siclari (Lugano, CH) Friedrich Eckstein (Basel, CH) Christian Müller (Basel, CH)

Clinical features and outcomes of takotsubo 123.1 (stress) cardiomyopathy Jelena-Rima Ghadri (Zürich, CH)

87 Detailed Programme Friday, June 17

Misdiagnosis of myocardial infarction related 123.2 to limitations of the current regulatory approach to define clinical decision values for cardiac troponin Maria Ribini Gimenez (Basel, CH)

Persistent spatial clusters of high body mass 123.3 index in a Swiss urban population as revealed by the 5-year GeoCoLaus longitudinal study Idris Guessous (Geneva, CH)

Polymer-free drug-coated coronary stents 123.4 in patients at high bleeding risk Franz Eberli (Zürich, CH)

Transcatheter direct mitral annuloplasty with 123.5 cardioband: feasibility and efficacy trial in an acute preclinical model Maurizio Taramasso (Zürich, CH)

Very late scaffold thrombosis: intracoronary 123.6 imaging and histopathological and spectroscopic findings Lorenz Räber (Bern, CH)

Workshop Room 3C

14:15–15:00 Therapy of hypertension in patients 124 with coronary heart disease Speakers: Roman Brenner (St. Gallen, CH) Yves Allemann (Bern, CH)

88 Posters

All posters need to be displayed from Wednesday, June 15, 2016 10:00 to Friday, June 17, 2016 noon . All posters will be visited during one of the poster sessions from 12:15–13:15 or 14:30–15:30 on Thursday, June 16, 2016 . It is mandatory that the presenting author or one of the co-authors be present during the designated session .

IMPORTANT: Posters not removed after 12:00 on Friday, June 17, 2016 will be disposed of. No possibility of retrieval exists. All the necessary material will be available directly from the Posters help desk located at the entrance of the poster’s area.

Poster Walks

Poster walks will consist of several guided walks around the posters in various categories . During the walks, the poster authors will have the opportunity to present, explain the main results of their work and answer ques tions . Experts in the field of Cardiology and Pneumology will lead groups of up to 12 attendees . Authors are requested to stay close to their posters for flash presentations or questions during the session . Presenting authors are also encouraged to join the tour after their presentation in order to partici- pate in the discussion around other posters on similar subjects .

Meeting point: The tour will start in the poster area at the first poster scheduled on the guided poster walk . The Scientific Committee has organised posters in different walks/topics as follows:

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSC/SSCS 1: Cardiovascular biology (PP-001; PP-012) Poster Walk SSC/SSCS 1: Pacemaker, defibrillator and electrophysiology (PP-022; PP-031) Poster Walk SSC/SSCS 1: Cardiac failure, valvulopathies, cardiomyopathies, pericardiopathies, heart transplantation (PP-042; PP-052) Poster Walk SSC/SSCS 1: Epidemiology, risk factors, rehabilitation, thromboembolic disease (PP-066; PP-073) Poster Walk SSC/SSCS 1: Cardiac imaging, congenital and pediatric cardiology (PP-081; PP-089) Poster Walk SSC/SSCS 1: Clinical cases (PP-099; PP-108) Poster Walk SSP 1: COPD (PP-118; PP-137) Poster Walk SSP 1: Pulmonary Hypertension – Transplantation – Biomarkers (PP-157; PP-171)

89 Posters

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSC/SSCS 2: Pacemaker, defibrillator and electrophysiology (PP-013; PP-022) Poster Walk SSC/SSCS 2: Cardiac failure, valvulopathies, cardiomyopathies, pericardiopathies, heart transplantation (PP-032; PP-041) Poster Walk SSC/SSCS 2: ACS, PCI, CABG (PP-053; PP-065) Poster Walk SSC/SSCS 2: Epidemiology, risk factors, rehabilitation, thromboembolic disease (PP-074; PP-080) Poster Walk SSC/SSCS 2: Cardiac imaging, congenital and pediatric cardiology (PP-090; PP-098) Poster Walk SSC/SSCS 2: Clinical cases (PP-109; PP-117) Poster Walk SSP 2: Sleep disorders – Rehab – Physiology (PP-138; PP-156) Poster Walk SSP 2: Bronchoscopy – Cancer – Tobacco (PP-172; PP-188)

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSC/SSCS 1: (PP-001; PP-012) Cardiovascular biology Chairs: Andrea Banfi (Basel, CH), Stéphane Cook (Fribourg, CH)

Exosomes from human cardiac-resident progenitor cells PP-001 are more cardioprotective than exosomes from bone marrow mesenchymal stem cells via a pregnancy-associated plasma protein-a-dependent mechanism A. Ciullo1, *, L. Barile1, E. Cervio1, V. Biemmi2, V. Lionetti3, G. Milano1, T. Torre4, S. Demertzis4, T. Moccetti4, P. Mauri5, G. Vassalli4 on behalf of Laboratory of Cellular and Molecular Cardiology (1Fondazione Cardiocentro Ticino at SIRM Institute , 2Laboratory of Cellular and Molecular Cardiology, Cardiocentro Ticino Foundation, Lugano, Switzerland, 3Scuola Superiore S. Anna Pisa, Pisa, Italy, 4Fondazione Cardiocentro Ticino, Lugano, Switzerland, 5ITB CNR , Milano, Italy)

The ryanodine receptor type 2 can also cause recessive PP-002 catecholaminergic polymorphic ventricular tachycardia (cpvt) F. Noti1, *, F. Dallèves2, L. Roten1, A. Schaller2, J. Seiler1, H. S. Servatius1, H. Tanner1, N. Tran1, A. Lam1, A. Häberlin1, J. Fuhrer1, A. Medeiros-Domingo1 (1Department of Cardiology, 2DFKE, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland)

* Presenting author

90 Posters

Ticagrelor, but not clopidogrel active metabolite, exerts PP-003 antithrombotic properties on left atrial endocardial cells of patients with atrial fibrillation M. F. F. Reiner1, *, A. Breitenstein2, E. W. Holy3, M. Glanzmann4, H. Amstalden1, S. F. Stämpfli2, N. R. Bonetti1, V. Falk2, S. Keller1, G. Savarese4, S. Benussi5, F. Maisano5, J. H. Beer6, T. F. Lüscher2, J. Steffel2, G. G. Camici4 (1Center for Molecular Cardiology, University of Zurich, Schlieren-Zurich, Switzerland, 2Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland, 3Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland, 4Center for Molecular Cardiology, Universität Zürich, 5Cardiac Surgery, University Heart Center, University Hospital Zurich, Zurich, 6Internal Medicine, Cantonal Hospital Baden, Baden, Switzerland)

Assisted reproductive technologies increases the vaso- PP-004 constrictor responsiveness to angiotensin ll in the aorta T. Meister1, *, R. Soria1, E. Bouillet1, E. Rexhaj1, C. Sartori2, U. Scherrer1, S. F. Rimoldi1 (1Cardiologie, Inselspital, Bern, 2Internal Medicine, CHUV, Lausanne, Switzerland)

Exosomes from human cardiac progenitor cells, but not those PP-005 from patient-matched bone marrow-derived mesenchymal stem cells, improve cardiac function after myocardial infarction in vivo T. Torre1, *, L. Barile1, 2, E. Cervio2, G. Vassalli3, G. Franciosi1, S. Demertzis1 (1Cardiac Surgery, Cardiocentro Ticino, Lugano, 2Cellular and Molecular Cardiology Laboratory , SIRM, Taverne, 3Cardiology Dept., Cardiocentro Ticino, Lugano, Switzerland)

Safety and efficacy improvement of xeno-/allogenic PP-006 cardio-vascular prosthesis by decellularization and pathogen agents inactivation. M. van Steenberghe1, 2, 3, *, T. Schubert3, Y. Guiot4, P. Gianello3, R. Prêtre1, D. Dufrane2 (1Cardiac Surgery Department, CHUV, Lausanne, Switzerland, 2Cellular and Tissular Therapy Unit, 3Experimental Surgery Laboratory, 4Pathology Department, Université Catholique de Louvain, Brussels, Belgium)

* Presenting author

91 Posters

Cardioprotective reperfusion strategies improve recovery PP-007 after normothermic global ischemia in an isolated working rat heart model of donation after circulatory death E. Farine1, *, P. Niederberger1, R. Wyss1, N. Méndez1, T. Carrel1, H. Tevaearai1, S. Longnus1 (1Clinic of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland)

Enalapril, eplerenone or their combination: finding the best PP-008 paradigm to protect against doxorubicin-induced cardiotoxicity D. Martin1, *, M. Metrich1, R. Van Heeswijk2, M. Stuber2, R. Hullin1 (1CHUV-Cardiology, 2CHUV-CIBM, Lausanne, Switzerland)

Neuregulin1 promotes glucose uptake via pi3k/akt in PP-009 neonatal rat cardiomyocytes M. Brink1, *, L. Pentassuglia1, P. Heim2, S. Lebboukh1, C. Morandi1, L. Xu1 (1Department of Biomedicine, University of Basel and Basel University Hospital, Basel, Switzerland, 2Department of Biomedicine, University of Basel and Basel University Hospital, Basel)

A model of platelets in the aging: increased platelet counts PP-010 and – activation are associated with reduced clearance N. Bonetti1, *, S. Stivala1, M. Reiner1, 2, S. Gobbato1, T. Lüscher1, 3, G. Camici1, J.-H. Beer1, 2 (1Center for Molecular Cardiology, University of Zurich, Schlieren- Zurich, Switzerland, 2Internal Medicine, Kantonsspital Baden, Baden, 3Department of Cardiology and Cardiovascular Research, University Heart Center, University of Zurich, Zurich, Switzerland)

Circadian variation of platelets inhibition with ticagrelor PP-011 S. Fournier1, *, F. Guenat1, A. Fournier1, L. Alberio1, D. Bertaggia1, N. Lauriers1, J.-F. Iglesias1, A. Zuffi1, E. Eeckhout1, O. Muller1 (1CHUV, Lausanne, Switzerland)

Cardiac-specific overexpression of jund leads to an enlarged PP-012 infarcts in ischemia/reperfusion model in mouse A. Akhmedov1, *, F. Montecucco2, A. Schaub Clerigué1, G. G. Camici1, F. Mach3, T. F. Lüscher4 (1Center for Molecular Cardiology, University of Zurich, Schlieren-Zurich, Switzerland, 2Department of Internal Medicine, University of Genoa, Genoa, Italy, 3Division of Cardiology, University of Geneva, Geneva, 4Department of Cardiology, University Hospital Zurich, Zurich, Switzerland)

* Presenting author

92 Posters

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSC/SSCS 2: (PP-013; PP-022) Pacemaker, defibrillator and electrophysiology Chairs: Stefano Benussi (Zurich, CH), Peter Ammann (St. Gallen, CH)

The effect of septal versus apical right ventricular pacing PP-013 on left ventricular strain and torsion: a cardiac magnetic resonance imaging study S. Imbach1, P. Dietrich1, *, C. Beynon1, R. Berli2, J. Peter3, R. Maire4, A. Mueller1, R. Zbinden1 (1Kardiologie, Triemlispital, 2Kardiologie, Spital Zollikerberg, Zürich, 3Kardiologie, Kantonsspital Schaffhausen, Schaffhausen, 4Kardiologie, Praxis Dr. Maire, Männedorf, Switzerland)

Adverse effects of elevated testosterone and low estradiol PP-014 serum levels on disease progression in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia D. Akdis1, *, A. Saguner1, K. Shah2, C. Brunckhorst1, T. Lüscher1, H.-S. V. Chen2, F. Duru1 (1Cardiology, University Hospital Zurich, Zurich, Switzerland, 2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States)

Mid-term safety and efficacy of the sub-cutaneous PP-015 implantable cardioverter defibrillator F. Regoli1, *, M. L. Caputo1, G. Conte1, S. Svab1, M. Papa1, T. Moccetti1, A. Auricchio1 (1Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland)

Adaptive harmonic frequency schemes of atrial ecg reveal PP-016 divergent patterns of organization during catheter ablation of persistent atrial fibrillation A. Luca1, *, A. Buttu1, J.-M. Vesin1, P. Pascale2, L. Roten3, C. Sticherling4, E. Pruvot2 (1Swiss Federal Institute of Technology, 2Lausanne University Hospital, Lausanne, 3Inselspital, Bern, 4Basel University Hospital, Basel, Switzerland)

Low incidence of permanent pacemaker implantation PP-017 after surgical aortic valve replacement: an outstanding debate in the tavi era L. Niclauss1, *, R. Pfister1, S. Colombier1, D. Delay1, M. Kirsch1, R. Prêtre1 (1CHUV, Lausanne, Switzerland)

* Presenting author

93 Posters

Long-term results of catheter ablation for paroxysmal atrial PP-018 fibrillation in very young adults – a 5-year follow-up study A. Saguner1, *, T. Maurer1, F. Ouyang1, K.-H. Kuck1, E. Wissner1, A. Metzner1 (1Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany)

Epicardial fibrosis enhances endo-epicardial dissociation PP-019 and breakthrough in an atrial computer model A. Gharaviri1, *, M. Potse1, 2, S. Verheule3, R. Krause1, A. Auricchio1, U. Schotten3 (1Center for Computational Medicine in Cardiology, Università della Svizzera italiana, Lugano, Switzerland, 2Electrophysiology and heart modeling institute LIRYC, Inria Bordeaux Sud-Ouest, Bordeaux, France, 3Physiology, Maastricht University, Maastricht, Netherlands)

Quality of oral anticoagulation using coumarins in daily PP-020 practice – results from a survey in eastern Switzerland M. T. Maeder1, *, T. Freund1, S. Bogdanovic1, I. Schneider1, W. Eugster1, J. Rigger1, S. Kopp1, F. Arquint1, P. Ammann1, H. Rickli1 (1Kantonsspital St. Gallen, St. Gallen, Switzerland)

Safety and efficacy of robotic pulmonary vein isolation PP-021 with a new remote catheter system T. Wolber1, *, A. Saguner1, C. Brunckhorst1, L. Haegeli1, F. Duru1 (1University Heart Center, University Hospital Zurich, Zurich, Switzerland)

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSC/SSCS 1: (PP-022; PP-031) Pacemaker, defibrillator and electrophysiology Chairs: Andreas Müller (Zürich, CH), François Regoli (Lugano, CH)

The value of ajmaline challenge in unmasking subcutaneous PP-022 icd eligibility failure in patients with drug-induced brugada syndrome G. Conte1, *, M. L. Caputo1, F. Regoli1, T. Moccetti1, A. Auricchio1 (1Fondazione Cardiocentro Ticino, Lugano, Switzerland)

Epicardial catheter ablation for ventricular tachycardia PP-023 on uninterrupted warfarin: a safe approach? A. Breitenstein1, *, V. Sawhney2, W. Ullah2, S. Sporton2, M. Earley2, M. Dhinoja2, R. Schilling2, R. Hunter2

* Presenting author

94 Posters

(1Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland, 2Barts Heart Center, London, United Kingdom)

Publication rates and impact factors of accepted abstracts PP-024 presented during the sgk congresses 2011 to 2014 in the field of electrophysiology B. Altermatt1, *, M. Zellweger1, B. Schaer1 (1Universitätsspital Basel, Basel, Switzerland)

First-degree av block is mainly due to intraatrial conduction PP-025 delay in patients with atrial fibrillation, right atrial flutter and supraventricular tachycardia S. Knecht1, *, A. Mühl1, T. Reichlin1, N. Pavlovic2, U. Celikyurt1, B. Schaer1, S. Osswald1, C. Sticherling1, M. Kühne1 (1Cardiology, University Hospital Basel, Basel, Switzerland, 2University Hospital Centre “Sisters of mercy”, Zagreb, Croatia)

Mobile application versus sms alert in out-of-hospital PP-026 cardiac arrest: efficiency and impact on survival M. L. Caputo1, *, R. Burkart2, C. Benvenuti2, S. Muschietti2, F. Regoli1, G. Conte1, R. Mauri2, T. Moccetti1, A. Auricchio1 (1Cardiocentro Ticino, Lugano, 2Fondazione Ticinocuore, Breganzona, Switzerland)

Complications with the micra tps pacemaker system: PP-027 persistent complete heart block and late capture failure N. Holm1, *, A. S. Müller1, R. Zbinden1 (1Klinik für Kardiologie, Stadtspital Triemli, Zürich, Switzerland)

Clinical outcome of high-resolution image integrated PP-028 lava-based vt ablation B. Berte1, *, L. Dang1, D. Maurer1, S. Siebert2, B. Naegeli1, C. Attenhofer Jost1, C. Scharf1 (1Cardiology, 2Radiology, Herzgefässzentrum Klinik Im Park, Zürich, Switzerland)

Application of the concept of competing risk in crt patients PP-029 D. Weber1, M. Koller1, M. Kühne1, T. Reichlin1, *, S. Osswald1, C. Sticherling1, D. Theuns2, B. Schaer1 (1Universitätsspital Basel, Basel, Switzerland, 2Erasmus MC, Rotterdam, Netherlands)

* Presenting author

95 Posters

Leadless transcatheter vvi-pacing (micra) compared PP-030 to standard transvenous vvi-pacing M. Kühne1, *, T. Reichlin1, A. Mühl1, S. Knecht1, U. Celikyurt1, B. Schaer1, S. Osswald1, C. Sticherling1 (1University of Basel, Basel, Switzerland)

High incidence of subsequently newly diagnosed atrial PP-031 fibrillation after cavotricuspid isthmus ablation for atrial flutter U. Celikyurt1, *, S. Knecht1, M. Kuehne1, T. Reichlin1, A. Muehl1, S. Osswald1, C. Sticherling1 (1University Hospital Basel, Basel, Switzerland)

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSC/SSCS 2: (PP-032; PP-041) Cardiac failure, valvulopathies, cardiomyopathies, pericardiopathies, heart transplantation Chairs: Micha Maeder (St. Gallen, CH), Roger Hullin (Lausanne, CH)

Red blood cell distribution width provides incremental PP-032 prognostic value in addition to bnp in advanced heart failure patients M. Zurek1, *, B. Wein1, F. Jordan1, S. Rümmler1, O. Pfister1 (1University Hospital Basel, Basel, Switzerland)

Aortic stiffness affects the kinematics of bioprosthetic PP-033 aortic valves S. E. Jahren1, *, P. P. Heinisch2, J. Wirz3, B. M. Winkler2, T. Carrel2, D. Obrist1 (1ARTORG Center, University of Bern, 2Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland, 3ARTORG Center, University of Bern, Bern, Switzerland)

Assessment of flow patterns and hydrodynamic stresses PP-034 in a novel right heart model U. Gulan1, *, A. Saguner2, D. Akdis2, C. Brunckhorst2, M. Holzner3, F. Duru2 (1UZH, 2USZ, 3ETHZ, Zurich, Switzerland)

3f enable and perceval s: a single centre comparison of two PP-035 bioprosthetic valves for sutureless aortic valve replacement V. Goeber1, *, E. Roost1, D. Reineke1, G. Erdös1, B. Gahl1, C. Huber1, T. Carrel1, L. Englberger1 (1Inselspital Bern, Bern, Switzerland)

* Presenting author

96 Posters

Treatment of severe aortic stenosis with a new generation PP-036 recapturable and repositionable self-expanding transcatheter aortic valve system: a single centre experience of consecutive patients N. Perrin1, *, M. Roffi1, A. Frei1, C. Ellenberger2, H. Mueller1, M. Cikirikcioglu3, A.-L. Hachulla4, M. Licker2, S. Noble1 (1Cardiology, 2Anesthesiology, 3Cardiovascular Surgery, 4Radiology, Hôpitaux Universitaires de Genève, Genève, Switzerland)

Influence of transcatheter aortic valve stent frames on PP-037 coronary perfusion: in vitro study in a left heart flow loop with coronary circulation A. Schwery1, *, D. Hasler1, S. E. Jahren1, S. Stortecky2, S. Windecker2, D. Obrist1 (1ARTORG Center, University of Bern, 2Department of Cardiology, University Hospital Bern, Bern, Switzerland)

Surgical antegrade transcatheter mitral valve implantation PP-038 for symptomatic mitral valve disease and heavily calcified annulus: a case series T. Carrel1, B. Langhammer1, *, S. Stortecky2, A. Weber1, L. Englberger1, E. Roost1, B. Eberle3, P. Wenaweser2, S. Windecker2, C. Huber1 (1Department of Cardiovascular Surgery, 2Department of Cardiology, 3Department of Cardiovascular Anesthesia, Bern University Hospital, Bern, Switzerland)

Long-term progression of cardiac allograft vasculopathy PP-039 a serial quantitative coronary analysis C. Zanchin1, *, K. Yamaji1, C. Rogge1, D. Lesche1, S. Windecker1, P. Mohacsi1, L. Räber1, V. Sigurdardottir1 (1SGK, Bern, Switzerland)

Repair of the aortic valve in case of bicuspid valves PP-040 with insufficiency R. Prêtre1, *, J. Namasivayam1, G. El Khoury1, M. Kirsch1 (1Cardiac Surgery, CHUV, Lausanne, Switzerland)

Experience of minimally invasive mitral valve surgery PP-041 at the university hospital basel M. Grapow1, M. Mytsyk1, *, O. Reutebuch1, P. Matt1, F. Eckstein1 (1Cardiac Surgery, University Hospital of Basel, Basel, Switzerland)

* Presenting author

97 Posters

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSC/SSCS 1: (PP-042; PP-052) Cardiac failure, valvulopathies, cardiomyopathies, pericardiopathies, heart transplantation Chairs: Andreas Flammer (Zurich, CH), Markus Wilhelm (Zurich, CH)

Arrhythmogenic right ventricular cardiomyopathy versus PP-042 dilated cardiomyopathy: implications of next generation sequencing in appropriate diagnosis A. Medeiros Domingo1, *, A. Saguner2, I. Magyar3, A. Bahr3, D. Akdis2, C. Brunckhorst2, F. Duru2, W. Berger3 (1Rhythmologie, Inselspital, Bern, 2Cardiology, University Heart Center Zurich, Zurich, 3Genetics, Institute of Medical Molecular Genetics, University of Zurich, Zurich, Switzerland)

The swiss experience with a swiss valve: 30 day results after PP-043 transfemoral implantation of the acurate neo transcatheter heart valve S. Toggweiler1, *, T. Pilgrim2, P. Biaggi3, F. Cuculi1, P. Wenger Müller1, J. Grünenfelder4, R. Kobza1, S. Windecker5, P. Jamshidi1, R. Corti3, S. Stortecky5 (1Kardiologie, Luzerner Kantonsspital, Luzern, Switzerland, 2Kardiologie, Inselspital Bern, Bern, Switzerland, 3Kardiologie, Herzklinik Hirslanden, Zürich, 4Kardiologie, Herzklinik Hirslanden, Zurich, 5Kardiologie, Inselspital, Bern, Switzerland)

Percutaneous treatment options for high risk patients with PP-044 recurrent mitral valve disease after failed mitral valve surgery D. Bianda1, *, O. Gaemperli2, M. Taramasso2, J. Gruenenfelder3, R. Corti3, F. Maisano2, P. Biaggi3 (1Universität Zürich, Zürich, 2HerzZentrum, UniversitätsSpital Zürich, Zürich, 3HerzKlinik Hirslanden, Zürich, Switzerland)

Local versus general anesthesia for transfemoral PP-045 transcatheter aortic valve implantation S. Stortecky1, *, S. Windecker1, F. Nietlispach2, D. Tüller3, R. Jeger4, M. Taramasso2, L. Räber1, M. Roffi5, J. Grünenfelder6, S. Toggweiler7, E. Ferrari8, S. Noble5, D. Heg9, F. Maisano2, C. Huber1, P. Wenaweser1 (1Bern University Hospital, Bern, 2University Hospital Zurich, 3Department of Cardiology, Triemli Hospital, Zurich, 4University Hospital Basel, Basel, 5University Hospital Geneva, Geneva, 6Herzklinik Hirslanden Zürich, Zürich, 7Kantonsspital Luzern, Luzern, 8Cardiocentro Ticino, Lugano, 9Clinical Trials Unit, Bern, Switzerland)

* Presenting author

98 Posters

Discrepancies between echocardiographic and invasive PP-046 assessment of aortic stenosis in multimorbid elderly patients G. Giannakopoulos1, *, S. Noble1, A. Frei1, H. Müller1 (1Cardiologie, HUG-Hôpitaux Universitaires de Genève, Genève, Switzerland)

The impact of the multidisciplinary team approach PP-047 on early mortality and acute cellular rejection after heart transplantation M. Schmidhauser1, *, J. Regamey1, C. Banfi2, P. Tozzi3, P. Meyer4, R. Hullin1 (1Cardiologie, CHUV, Lausanne, 2Chirurgie cardiaque, HUG, Genève, 3Chirurgie cardiaque , CHUV, Lausanne, 4Cardiologie, HUG, Genève, Switzerland)

Focal hypermetabolic left ventricular cardiomyopathy: PP-048 an underdiagnosed life-threatening arrhythmogenic disease A. P. Porretta1, *, C.-I. Park2, S. Di Bernardo1, L. Bisch1, J. Schlaepfer1, P. Pascale1, G. Buss1, J. Prior1, E. Pruvot1 (1Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, 2La Tour Hospital, Meyrin, Switzerland)

Non-surgery related pericardial effusion is a predictor PP-049 of mortality in heart transplanted patients S. F. Stämpfli1, *, T. Özkartal1, N. Hagenbuch2, S. Bernhart1, A. J. Flammer1, A. Vecchiati1, G. M. Fröhlich1, F. Ruschitzka1, L. Held2, F. C. Tanner1 (1Kardiologie, UniversitätsSpital Zürich, 2Biostatistics, University of Zurich, Zurich, Switzerland)

Cardiac sarcoidosis in the current era: cardiac involvement, PP-050 diagnostic issues and treatment in 32 patients C. H. Attenhofer Jost1, *, D. Maurer1, O. Bertel1, C. Scharf1, B. Naegeli1, W. Amann1 (1HerzGefässZentrum Zürich, Klinik Im Park, Zürich, Switzerland)

Procedural characteristics and outcomes after percutaneous PP-051 double valve interventions S. Toggweiler1, *, F. Praz2, S. Stortecky2, P. Biaggi3, L. Biasco4, R. Jeger5, B. de Boeck1, D. Sürder4, R. Kobza1, M. Moccetti4, G. Pedrazzini4, R. Corti3, S. Windecker2, P. Jamshidi1 (1Kardiologie, Luzerner Kantonsspital, Luzern, 2Kardiologie, Inselspital, Bern, 3Kardiologie, Herzklinik Hirslanden, Zürich, 4Kardiologie, Cardiocentro Ticino, Lugano, 5Kardiologie, Universitätsspital Basel, Basel, Switzerland)

* Presenting author

99 Posters

Morphologic determinants of severe functional mitral PP-052 regurgitation in patients with ischemic and non-ischemic dilated cardiomyopathy P. Monney1, *, M. Agostini1, X. Jeanrenaud1 (1Service de Cardiologie, CHUV, Lausanne, Switzerland)

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSC/SSCS 2: (PP-053; PP-065) ACS, PCI, CABG Chairs: Florim Cuculi (Luzern, CH), Raban Jeger (Basel, CH)

Publication rates and impact factors of accepted abstracts PP-053 presented during the sgk congresses 2011 to 2014 in the field of interventional cardiology B. Altermatt1, *, M. Zellweger1, B. Schaer1 (1Universitätsspital Basel, Basel, Switzerland)

Type 2 myocardial infarction: incidence, presentation, PP-054 treatment and outcome in routine clinical practice D. Radovanovic1, *, T. Pilgrim2, B. Seifert3, P. Urban4, G. Pedrazzini5, P. Erne6 on behalf of AMIS Plus Investigators (1AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, 2Invasive Kardiologie, Universitäts spital, Bern, 3Biostatistic, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, 4Cardiologie interventionnelle, Hôpital de la Tour, Genève, 5Cardiocentro Ticino, Lugano, 6AMIS Plus, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland)

Right- and left transradial approach is feasible PP-055 in the vast majority of all-comers presenting with acute myocardial infarction F. Cuculi1, *, S. Toggweiler1, Z. Sabti1, J. Chronis1, R. Mury1, I. Russi1, R. Kobza1, P. Jamshidi1 (1Herzzentrum, Luzerner Kantonsspital, Luzern, Switzerland)

Minimally invasive robotic coronary revascularization: PP-056 preliminary experience and mid-term follow-up A. Panos1, *, P. Mootoosamy1, P. Myers1 (1Cardiac Surgery, Geneva University Hospitals, Geneva, Switzerland)

* Presenting author

100 Posters

Omitting aspirin in patients requiring oral anticoagulation PP-057 and undergoing percutaneous coronary intervention is safe in an all-comers population V. Praxmarer1, *, S. Toggweiler1, P. Jamshidi1, M. Zbinden1, A. Foell1, V. Weberndoerfer1, Z. Sabti1, I. Russi1, R. Kobza1, F. Cuculi1 on behalf of Working group Acute Coronary Syndrome Central Switzerland (1Herzzentrum, Luzerner Kantonsspital, Luzern, Switzerland)

Very late scaffold thrombosis: a systematic review PP-058 K. Yamaji1, *, K. K. Koskinas1, S. Windecker1, L. Räber1 (1Inselspital, Bern, Switzerland)

Double wall-less cannulas for veno-venous ecmo PP-059 S. Abdel-Sayed1, * (1Department of Surgery, University Hospital, Lausanne, Switzerland)

10 years experience with the cardioplexol™ cardioplegic PP-060 solution at Inselspital H. Tevaearai Stahel1, 2, *, B. Gahl2, E. Roost2, D. Reineke2, B. Winkler2, H. Most2, F. Schoenhoff2, C. Huber2, A. Kadner2, L. Englberger2, T. P. Carrel2 (1CEO, Swiss Cardio Technologies, Stansstad, 2Inselspital, Clinic for Cardiovascular Surgery, Bern, Switzerland)

Immediate treatment and outcome of cancer patients PP-061 with acute myocardial infarction F. Witassek1, *, P. Erne1, S. Rohrmann2, H. Rickli3, D. Radovanovic1 (1AMIS Plus Data Center, 2Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, 3Kardiologie, Kantonsspital, St. Gallen, Switzerland)

Impact of new onset atrial fibrillation in acs patients. PP-062 Insights from the swiss amis plus registry L. Biasco1, *, D. Radovanovic2, H. Rickli3, M. Roffi4, F. Eberli5, R. Jaeger6, T. Moccetti7, M. Moccetti1, P. Erne8, G. Pedrazzini1 (1Horten Cardiac cath lab, Cardiocentro Ticino, Lugano, 2Epidemiology, AMIS Plus Data Center, Zurich, 3Cardiology, Kantonsspital St. Gallen, St. Gallen, 4Cardiology, University Hospital of Geneva, Geneva, 5Cardiology, Stadtspital Triemli, Zurich, 6unknown, 7Cardiology, Cardiocentro Ticino, Lugano, 8Cardiology, Luzerner Kantonsspital, Luzern, Switzerland)

* Presenting author

101 Posters

Absolute neutrophil count is an independent risk predictor PP-063 in patients with acute coronary syndromes – no improvement when added to total leukocyte count, high-sensitive c-reactive protein or high-sensitive troponin t R. Klingenberg1, *, N. Hagenbuch2, A. Wunderlin1, L. Räber3, D. Carballo4, S. Carballo4, B. Gencer4, D. Nanchen5, L. Held2, S. Aghlmandi6, D. Heg6, A. von Eckardstein7, N. Rodondi8, F. Mach4, S. Windecker3, C. M. Matter1, T. F. Lüscher1 on behalf of SPUM-ACS Trial Investigators (1Cardiology, University Hospital Zurich, 2Biostatistics, University of Zurich, Zurich, 3Cardiology, University Hospital Bern, Bern, 4Cardiology, University Hospital Geneva, Geneva, 5Ambulatory Care Medicine, University Hospital Lausanne, Lausanne, 6Biostatistics, CTU, University of Bern, Bern, 7Clinical Chemistry, University Hospital Zurich, Zurich, 8Internal Medicine, University Hospital Bern, Bern, Switzerland)

A novel, low-volume cardioplegia is safe in protecting PP-064 the myocardium during coronary artery bypass surgery S. Tschopp1, *, U. Zenklusen1, U. Schurr1, L. Melly1, F. Rueter1, J. Fassl1, M. Grapow1, O. Reuthebuch1, F. Eckstein1, P. Matt1 (1Universitätsspital Basel, Basel, Switzerland)

Implantation of a modern drug eluting stent over a covered PP-065 stent to treat coronary aneurysms: angiographic and optical coherence tomography follow-up of 3 patients J. Chronis1, *, P. Jamshidi1, F. Cuculi1 (1Herzzentrum, Luzerner Kantonsspital, Luzern, Switzerland)

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSC/SSCS 1: (PP-066; PP-073) Epidemiology, risk factors, rehabilitation, thromboembolic disease Chairs: Matthias Hermann (Wald, CH), Werner Deuel (St. Gallen, CH)

Systemic vascular dysfunction in high-altitude dwellers PP-066 with patent foramen ovale D. Cerny1, *, E. Rexhaj1, T. Meister1, R. Soria1, C. Sartori2, U. Scherrer1, S. Rimoldi1 (1Department of Cardiology, Inselspital, Bern, 2Department of Internal Medicine, CHUV, Lausanne, Switzerland)

* Presenting author

102 Posters

Non-alcoholic fatty liver disease strongly predicts incident PP-067 diabetes in patients with coronary artery disease C. H. Säly1, 2, 3, D. Zanolin1, 3, A. Vonbank1, 2, A. Leiherer1, 3, P. Rein1, 2, A. Mader2, 3, *, H. Drexel1, 2, 3, 4 (1VIVIT-institute, 2Medicine & Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 3Medicine, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein, 4College of Medicine, Drexel University, Philadelphia, United States)

Non alcoholic fatty liver disease in coronary artery disease PP-068 patients - association with impaired glucose metabolism and with future cardiovascular event risk K. Vathie1, D. Zanolin1, 2, A. Vonbank2, 3, A. Leiherer1, 2, P. Rein2, 3, A. Mader1, 3, *, C. H. Säly1, 2, 3, H. Drexel1, 2, 3, 4 (1Medicine, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein, 2VIVIT-institute, 3Medicine & Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 4College of Medicine, Drexel University, Philadelphia, United States)

Does prenatal detection screening influence the incidence PP-069 of congenital heart disease (chd)? L. Rovina1, A. Kadner2, M. Nauwerk3, J.-P. Pfammatter4, L. Rajo5, D. Hutter4, * (1Cardiology, Inselspital, Bern, Switzerland, 2Cardiovascular Surgery, 3Gynacology and Obstetrics, 4Cardiology, Inselspital, Bern, Switzerland, 5Gynacology and Obstetrics, Inselspital, Bern, Switzerland)

Oxidative stress mediated systemic vascular dysfunction PP-070 in offspring of preeclampsia evolve into arterial hypertension and may be prevented by anti-oxidants E. Rexhaj1, *, D. Cerny1, R. Soria1, T. Meister1, C. Sartori2, U. Scherrer1, S. F. Rimoldi1 (1Cardiology, Inselspital, Bern, 2Internal Medicine, CHUV, Lausanne, Switzerland)

* Presenting author

103 Posters

Combining high-sensitive c-reactive protein, high-sensitive PP-071 troponin t and nt-pro b-type natriuretic peptide with the pulmonary embolism severity index risk score marginally improves risk stratification of elderly patients with pulmonary embolism R. Klingenberg1, *, O. Schlager2, A. Limacher3, M. Méan4, N. Vuilleumier5, H.-J. Beer6, D. Staub7, B. Frauchiger8, M. Aschwanden7, J. Cornuz9, B. Lämmle10, M. Righini11, M. Egloff6, J. Osterwalder12, A. Angelillo- Scherrer13, N. Kucher14, M. Banyai15, N. Rodondi4, A. von Eckardstein16, D. Aujesky4, M. Husmann17, C. M. Matter1 on behalf of SWITCO 65+ Trial Investigators (1Cardiology, University Hospital Zurich, Zurich, Switzerland, 2Angiology, Medical University Vienna, Vienna, Austria, 3Biostatistics, CTU, University of Bern, 4General Internal Medicine, University Hospital Bern, Bern, 5Laboratory Medicine, University Hospital Geneva, Geneva, 6Medicine, Cantonal Hospital Baden, Baden, 7Angiology, University Hospital Basel, Basel, 8Internal Medicine, Cantonal Hospital Frauenfeld, Frauenfeld, 9Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, 10Haematology, University Hospital Bern, Bern, 11Angiology and Hemostasis, University Hospital Geneva, Geneva, 12Emergency Medicine, Cantonal Hospital St. Gallen, St. Gallen, 13Service and Central Laboratory of Hematology, University Hospital Lausanne, Lausanne, 14Angiology, University Hospital Bern, Bern, 15Angiology, Cantonal Hospital Lucerne, Lucerne, 16Clinical Chemistry, 17Angiology, University Hospital Zurich, Zurich, Switzerland)

Acceptance of ehealth training as alternative for phase ii PP-072 and phase iii cardiac rehabilitation program B. Schnegg1, *, J. Peterhans1, P. Eser1, M. Wilhelm1 (1Department of Cardiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland)

Single and joint effects of obesity and of the metabolic PP-073 syndrome on the development of diabetes in patients with coronary atherosclerosis C. H. Säly1, 2, 3, A. Vonbank2, 3, D. Zanolin1, 2, A. Leiherer1, 2, P. Rein2, 3, A. Mader1, 3, *, H. Drexel1, 2, 3, 4 (1Medicine, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein, 2VIVIT-institute, 3Medicine & Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 4College of Medicine, Drexel University, Philadelphia, United States)

* Presenting author

104 Posters

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSC/SSCS 2: (PP-074; PP-080) Epidemiology, risk factors, rehabilitation, thromboembolic disease Chairs: Philippe Meyer (Geneva, CH), Augusto Gallino (Bellinzona, CH)

Diastolic rather than systolic or systolic/diastolic PP-074 combined hypertensive response to exercise is more frequently observed in 2,476 consecutive exercise tests in a large tertiary referral center in Switzerland D. Niederseer1, *, A. Brauchlin1, R. Baumberger1, F. Baumann1, C. Schmied1 (1Department of Cardiology, University Hospital Zurich, Zurich, Switzerland)

Remnant cholesterol predicts the development of type 2 PP-075 diabetes mellitus in patients with established coronary artery disease C. H. Säly1, 2, 3, P. Rein2, 3, A. Leiherer1, 2, A. Vonbank2, 3, D. Zanolin1, 2, A. Mader1, 3, *, H. Drexel1, 2, 3, 4 (1Medicine, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein, 2VIVIT-institute, 3Medicine & Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 4College of Medicine, Drexel University, Philadelphia, United States)

Does bronchial artery malperfusion contribute PP-076 to postoperative respiratory complications in patients operated on for acute type a aortic dissection? A. Ponti1, *, R. Prêtre1, M. Kirsch1 (1Chirurgie cardiaque, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland)

Publication rates and impact factors of accepted abstracts PP-077 presented during the sgk congresses 2011 to 2014 in the field of risk factors and epidemiology B. Altermatt1, *, M. Zellweger1, B. Schaer1 (1Universitätsspital Basel, Basel, Switzerland)

* Presenting author

105 Posters

The visceral adiposity index predicts cardiovascular events PP-078 both in coronary artery disease patients with and in coronary artery disease patients without diabetes A. Vonbank1, 2, C. H. Säly1, 2, 3, P. Rein1, 2, A. Leiherer2, 3, D. Zanolin2, 3, A. Mader1, 3, *, H. Drexel1, 2, 3, 4 (1Medicine & Cardiology, 2VIVIT-institute, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 3Medicine, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein, 4College of Medicine, Drexel University, Philadelphia, United States)

Probnp strongly predicts future vascular events in PP-079 angiographied coronary patients with as well as in those without the metabolic syndrome P. Rein1, 2, D. Zanolin1, 3, A. Leiherer1, 3, A. Vonbank1, 2, A. Mader2, 3, *, C. H. Säly1, 2, 3, H. Drexel1, 2, 3, 4 (1VIVIT-institute, 2Medicine & Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 3Medicine, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein, 4College of Medicine, Drexel University, Philadelphia, United States)

The power of thyroid stimulating hormone to predict PP-080 cardiovascular mortality in non-obese patients is significantly modulated by type 2 diabetes A. Vonbank1, 2, D. Zanolin2, 3, A. Leiherer2, 3, P. Rein1, 2, A. Mader1, 3, *, C. H. Säly1, 2, 3, H. Drexel1, 2, 3, 4 (1Medicine & Cardiology, 2VIVIT-institute, Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 3Medicine, Private University of the Principality of Liechtenstein, Triesen, Liechtenstein, 4College of Medicine, Drexel University, Philadelphia, United States)

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSC/SSCS 1: (PP-081; PP-089) Cardiac imaging, congenital and pediatric cardiology Chairs: Peter Burger (Bern, CH), Tobias Rutz (Lausanne, CH)

Safety and efficacy of intracardiac versus transesophageal PP-081 echocardiography for left atrial appendage occlusion with watchman: a comparative single center consecutive cohort study A. H. Frangieh1, J. Alibegovic1, C. Templin1, O. Gaemperli1, S. Obeid1, R. Manka1, E. Holy1, W. Maier1, T. F. Lüscher1, R. Binder1, * (1Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland) * Presenting author

106 Posters

Congenital central alveolar hypoventilation syndrome- PP-082 associated hypoxemia is associated with vascular dysfunction E. Rexhaj1, *, R. Chetany1, S. F. Rimoldi1, R. Soria1, L. Rovina1, U. Scherrer1, D. Hutter1 (1Cardiology, Inselspital, Bern, Switzerland)

Predictors and age of onset of paradoxical embolism PP-083 in ebstein anomaly: an analysis of 982 patients C. H. Attenhofer Jost1, *, C. McLeod2, J. Dearani3, H. M. Connolly2 (1HerzGefässZentrum Zürich, Klinik Im Park, Zürich, Switzerland, 2Division of Cardiovascular Diseases, 3Department of Cardiovascular Surgery, Mayo Clinic, Rochester MN, United States)

Prosthetic pulmonary valve endocarditis: increasingly PP-084 recognized but often with delayed diagnosis D. Babic1, *, B. Santos Lopes1, C. Gruner1, F. Bonassin Tempesta1, C. Attenhofer-Jost1, M. Greutmann1 (1UniversitätsSpital Zürich, Zürich, Switzerland)

Impact of growing cohorts of adults with congenital PP-085 heart disease on clinical workload: a 20-year experience of a tertiary care center M. Padrutt1, *, I. Bracher1, F. Bonassin1, B. Santos Lopes1, C. Gruner1, S. F. Stämpfli1, A. Oxenius1, G. De Pasquale1, T. Seeliger1, T. F. Lüscher1, C. Attenhofer-Jost1, M. Greutmann1 (1UniversitätsSpital Zürich, Zürich, Switzerland)

Patient characteristics and perceived self-efficacy in adult PP-086 patients with congenital heart disease C. Thomet1, *, A. Kovacs2, E. Oechslin2, M. Schwerzmann1 (1Zentrum für angeborene Herzfehler, Kardiologie, Inselspital Bern, Bern, Switzerland, 2Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network and University of Toronto, Toronto, Canada)

Flow pattern and vascular distensibility of the pulmonary PP-087 arteries in patients after repair of tetralogy of fallot. Insights from 4d flow cmr B. Ruecker1, 2, J. Geiger2, 3, M. Makki2, 3, B. Burkhardt1, 2, C. J. Kellenberger2, 3, E. R. Valsangiacomo Buechel1, 2, * (1Paediatric Heart Centre, 2Children’s Research Centre, 3Department of Diagnostic Imaging, University Children´s Hospital Zurich, Zurich, Switzerland)

* Presenting author

107 Posters

Application of a 2d phase contrast measuring method PP-088 to quantify the wall shear stress in the aorta of a small animal model via 17.6 t nmr K. A. Riedl1, *, T. Kampf2, P. Winter2, V. Herold2, W. R. Bauer1 (1Department of Internal Medicine I, University Hospital Würzburg, 2Department of Experimental Physics 5, University of Würzburg, Würzburg, Germany)

Association between hepatic stiffness by elastography PP-089 and liver fibrosis in adult fontan patients B. Santos Lopes1, *, M. Greutmann-Yantiri1, T. Pfammatter1, C. Gubler1, M. Greutmann1 (1UniversitätsSpital Zürich, Zürich, Switzerland)

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSC/SSCS 2: (PP-090; PP-098) Cardiac imaging, congenital and pediatric cardiology Chairs: Kerstin Wustmann (Bern, CH), Simon Koestner (Morges, CH)

Clinical variability of cmr-measurements of right ventricular PP-090 volumes and function in patients with repaired tetralogy of fallot and severe pulmonary regurgitation F. Schwitz1, *, E. Valsangiacomo Buechel2, C. Kellenberger2, B. Santos Lopes3, F. Bonassin3, A. Oxenius3, G. De Pasquale3, T. Seeliger3, T. F. Lüscher3, C. Attenhofer Jost3, M. Greutmann3 (1Kardiologie, Inselspital Bern, Bern, 2Kinderkardiologie, Kinderspital Zürich, 3Kardiologie, USZ, Zürich, Switzerland)

“systolic ventricularization” of the left atrium with bileaflet PP-091 mitral valve prolapse: impact on quantification of mitral regurgitation with cardiac magnetic resonance G. Vincenti1, *, P.-G. Masci1, T. Rutz1, J. De Blois1, J. Schwitter1, P. Monney1 (1Service de Cardiologie, CHUV, Lausanne, Switzerland)

Age-dependent ventricular remodelling: implications for PP-092 normal values of mitral annular plane systolic excursion A. P. Pazhenkottil1, *, R. Said1, M. Wolfrum1, T. Bernasconi1, M. Zuber1, M. Niemann1, F. C. Tanner1 (1Cardiology, University Hospital Zurich, Zurich, Switzerland)

* Presenting author

108 Posters

Impact of stroke volume assessment by three-dimensional PP-093 echocardiography and multi-detector computed tomography on the classification of aortic stenosis severity B. E. Stähli1, *, L. Erhart1, A. Abouelnour1, A. Vecchiati1, S. Hamada2, T. D. L. Nguyen2, R. K. Binder1, R. Manka2, T. Frauenfelder2, R. Jenni1, F. C. Tanner1 (1University Hospital Zürich, University Heart Center, Cardiology, 2University Hospital Zürich, Institute of Diagnostic and Interventional Radiology, Zürich, Switzerland)

Burden and impact of congenital syndromes and comor- PP-094 bidities among adults with congenital heart disease I. Bracher1, *, M. Padrutt1, F. Bonassin1, B. Santos Lopes1, C. Gruner1, S. F. Stämpfli1, A. Oxenius1, G. De Pasquale1, T. Seeliger1, T. F. Lüscher1, C. Attenhofer-Jost1, M. Greutmann1 (1UniversitätsSpital Zürich, Zürich, Switzerland)

Comparison of a novel small-volume, single shot cardioplegia PP-095 to blood cardioplegia in pediatric cardiac surgery B. Langhammer1, *, A. Reist1, M. Veit1, D. Hutter2, B. Gahl1, H. Tevaearai1, F. Schoenhoff1, T. Carrel1, A. Kadner1 (1Department of Cardiovascular Surgery, 2Center for Congenital Heart Disease, Bern University Hospital, Bern, Switzerland)

Late correction of complete atrioventricular septal defect – PP-096 challenging but feasible in selective cases M. Veit1, *, O. Loup1, K. Wustmann2, D. Hutter2, S. Pallivathukal2, M. Pavlovic2, J.-P. Pfammatter2, M. Schwerzmann2, T. Carrel1, A. Kadner1 (1Department of Cardiovascular Surgery, 2Center for Congenital Heart Disease, Bern University Hospital, Bern, Switzerland)

Minimizing radiation and contrast agent exposure in PP-097 coronary computed tomography angiography: first clinical experience on a latest-generation 256-slice scanner D. Benz1, *, C. Gräni1, F. Mikulicic1, R. R. Buechel1, P. A. Kaufmann1 (1Klinik für Nuklearmedizin, UniversitätsSpital Zürich, Zürich, Switzerland)

Total atrioventricular block and pregnancy: analysis PP-098 of management and outcome in 5 women C. H. Attenhofer Jost1, *, M. Schwerzmann2, N. Schwick2, J. Steffel3, F. Bonassin Tempesta4, C. McLeod5, M. Greutmann6

* Presenting author

109 Posters

(1HerzGefässZentrum Zürich, Klinik Im Park, Zürich, 2Division of Cardiology, Inselspital Bern, Bern, 3Division of Cardiology, 4Division of Adult Congenital Heart Disease, University Hospital Zurich, Zurich, Switzerland, 5Division of Cardiovascular Diseases, Mayo Clinic, Rochester MN, United States, 6Division of Adult Congenital Heart Disease, Cardiology, University Hospital Zurich, Zurich, Switzerland)

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSC/SSCS 1: (PP-099; PP-108) Clinical cases Chairs: Tiziano Schepis (Winterthur, CH), Mikael Potocki (Zürich, CH)

Successful epicardial ablation of ventricular tachycardia in a PP-099 patient with arrhythmogenic right ventricular cardiomyopathy D. Akdis1, *, C. Brunckhorst1, F. Duru1, L. Haegeli1 (1Cardiology, University Hospital Zurich, Zurich, Switzerland)

Missing coronary arteries – an extreme variant of an PP-100 anomalous left coronary artery from the pulmonary artery (alcapa) M. O. Schmiady1, *, H. Dave1, J. H. Rüschoff2, K. Steindl3, E. Valsangiacomo- Büchel4, M. Hübler1, M. Schweiger1 (1Department of Congenital Cardiovascular Surgery, University Children’s Hospital Zurich, 2Institute of Surgical Pathology, University Hospital Zurich, 3Institute of Medical Genetics, University Zurich, 4Division of Pediatric Cardiology, University Children`s Hospital Zurich, Zurich, Switzerland)

Emergency assessment of proximal left anterior descending PP-101 coronary stent permeability using transthoracic echocardiography G. Giannakopoulos1, *, J. D. Arroja1, A. Guinand1, H. Müller1 (1Cardiologie, HUG-Hôpitaux Universitaires de Genève, Genève, Switzerland)

Two successful pregnancies in a female with d-tga, prior atrial PP-102 switch (senning), severe muscular subpulmonary outflow tract obstruction and non-sustained ventricular tachycardias C. H. Attenhofer Jost1, *, E. Valsangiacomo Buechel2, F. Krähenmann3, M. Greutmann4 (1HerzGefässZentrum Zürich, Klinik Im Park, Zürich, Switzerland, 2Division of Cardiology, Children’s University Hospital, Zurich, Switzerland, 3Department of Obstetrics and Gynecology, University Hospital Zurich, 4Division of Adult Congenital Heart Disease, Cardiology, University Hospital Zurich, Zurich, Switzerland) * Presenting author

110 Posters

Multimodal imaging of anomalous pulmonary venous PP-103 return in a patient with ventricular tachycardia N. Ehl1, L. Joerg1, *, M. T. Maeder1, D. Weilenmann1 (1Kardiologie, Kardiologie, St. Gallen, Switzerland)

Cladribine treatment for progressive pulmonary langerhans PP-104 cell histiocytosis C. R. Perez Valdes1, *, R. Lazor1, I. Letovanec2, H. Abeidi3, G. Gex4, L. Noirez1, A. Ogna1 (1Pneumologie, 2Pathologie, CHUV, Lausanne, 3Oncologie, 4Pneumologie, Centre Hospitalier du Valais Romand (CHVR) – Sion, Sion, Switzerland)

Mcconnell’s sign and pulmonary embolism PP-105 A. von Düring1, *, S. Mock1, H. Müller1 (1Cardiologie, HUG, Genève, Switzerland)

Spontaneous regression of a large iatrogenic ascending PP-106 aorta intramural hematoma A. Roumy1, *, M. van Steenberghe1, R. Prêtre1, M. Kirsch1, L. Niclauss1 (1CHUV – Service de Chirurgie Cardiaque, Lausanne, Switzerland)

Multimodality imaging evaluation of a mitro-aortic fibrosa PP-107 pseudo-aneurysm fistulizing into both atria J. D. Arroja1, A. L. Hachulla2, C. Ellenberger3, H. Müller1, * (1Cardiology, 2Radiology, 3Anesthesiology, HUG, Geneva, Switzerland)

The first two cases of thoratec heartmate iii implantation PP-108 in Switzerland A. Roumy1, *, A.-R. Hosseinpour1, N. Barras2, R. Hullin2, R. Prêtre1, M. Kirsch1 (1CHUV – Service de Chirurgie Cardiaque, 2CHUV – Service de Cardiologie, Lausanne, Switzerland)

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSC/SSCS 2: (PP-109; PP-117) Clinical cases Chairs: Hansjörg Meier (Zofingen, CH), Felix Tanner (Zurich, CH)

Coronary anomaly: successful challenge for off-pump PP-109 coronary artery bypass grafting with complete revascularisation A. Zientara1, *, M. Gruszczynski1, O. Dzemali1, M. Genoni1 (1Cardiac Surgery, Stadtspital Triemli, Zürich, Switzerland) * Presenting author

111 Posters

Large aneurysm of the right sinus of valsalva PP-110 N. F. Sipahi1, *, C. Mueller1, C. Hagl1, M. Pichlmaier1 (1Cardiac Surgery, University Hospital Munich, Ludwig-Maximilian- University, Munich, Germany)

Norwood stage 1 with surgical ventricular reconstruction PP-111 and mitral valve repair for neonatal idiopathic left ventricular dilated cardiomyopathy P. Myers1, *, T. Sologashvili1, M. Beghetti2, C. Tissot2 (1Cardiac Surgery, 2Pediatric Cardiology, Geneva University Hospitals, Geneva, Switzerland)

Urgent laminectomy and off-pump cabg as salvage manage- PP-112 ment of spontaneous spinal epidural hematoma complicating symptomatic left main coronary subocclusion P. Mootoosamy1, *, T. Sologashvili1, F. Rigamonti2, P. Bijlenga3, P. Myers1, (1Cardiac Surgery, Geneva University Hospitals, Geneva, Switzerland, 2Cardiology, Geneva University Hospitals, Geneva, Switzerland, 3Neurosurgery, Geneva University Hospitals, Geneva, Switzerland)

Pregnancy in pulmonary arterial hypertension: PP-113 illustration of pluridisciplinary management at an expert center D. Lawi1, *, J. Baptista2, M. Beghetti3, 4, K. Bendjelid3, 5, M. Boulvain6, C. Chizzolini3, 7, S. Fau8, O. Kherad2, M.-J. Licker3, 9, S. Noble3, 10, G. Savoldelli9, F. Boroli2, 5, F. Lador1, 3 (1Service de Pneumologie, 2Service de Médecine Interne Général, 3Programme Hypertension Pulmonaire, 4Service de Cardiologie Pédiatrique, 5Service des Soins Intensifs, 6Service d’Obstétrique, 7Service d’Immunologie et Allergologie, 8Service de Néonatologie et Soins Intensifs Pédiatriques, 9Service d’Anesthésiologie, 10Service de Cardiologie, HUG, Genève, Switzerland)

Exclusion of thrombus from the left atrial appendage by PP-114 cardiac magnetic resonance imaging and confirmation with intracardiac echocardiography in a patient after esophagectomy N. Tran1, *, S. De Marchi1, A. Lam1, F. Noti1, J. Seiler1, H. Servatus1, A. Häberlin1, A. Medeiros-Domingo1, L. Roten1, A. Wahl1, H. Tanner1, J. Fuhrer1, K. Wustmann1 (1Department of Cardiology, Inselspital, Bern, Switzerland)

* Presenting author

112 Posters

A full cardiac evaluation in a patient with implanted PP-115 cardioverter defibrillator: how adjustment of bandwidth improves image quality T. Rutz1, *, S. Degrauwe1, G. Vincenti1, J. Schwitter1 (1Service de Cardiologie, Centre hospitalier universitaire vaudois, Lausanne, Switzerland)

Upfront bitherapy with macitentan/tadalafil after mono- PP-116 therapy failure in idiopathic pulmonary arterial hypertension P. Gianella1, 2, *, S. Noble2, 3, P. M. Soccal1, 2, M. Beghetti2, 4, F. Lador1, 2 (1Pneumologie, 2Programme hypertension pulmonaire, 3Cardiologie, 4Cardiologie pédiatrique, HUG, Genève, Switzerland)

Post-operative right ventricular mechanical assistance PP-117 with a heartmate ii device in ebstein’s anomaly A. Nowacka1, *, A.-R. Hosseinpour1, C. Marcucci2, T. Rutz3, R. Hullin3, L. Liaudet4, R. Prêtre1, M. Kirsch1 (1Department of Cardiac Surgery, 2Department of Anesthesiology, 3Department of Cardiology, 4Department of Intensive Care, University Hospital Lausanne, Lausanne, Switzerland)

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSP 1: (PP-118; PP-137) COPD Chairs: Robert Thurnheer (Münsterlingen, CH), Grégoire Gex (Sion, CH)

Flexible bronchoscopy in copd – a case-control study PP-118 P. Grendelmeier1, M. Tamm1, K. Jahn1, E. Pfimlin1, D. Stolz1, * (1Pneumology, University Hospital Basel, Basel, Switzerland)

Effect of hyperoxia on exercise performance in patients PP-119 with copd: a randomized trial S. Ulrich1, *, S. Saxer1, E. Hasler1, M. Furian1, K. E. Bloch1 (1Pneumologie, UniversitätsSpital Zürich, Zürich, Switzerland)

Mortality of patients with long term oxygen therapy due PP-120 to chronic obstructive pulmonary disease - a population based cohort study N. Pavlov1, *, A. Haynes2, A.-K. Brill1, A. Stucki3, P. Jüni4, S. R. Ott1 (1Universitätsklinik für Pneumologie, Inselspital Bern, 2Institute for Social and Preventive Medicine, Bern, 3Department of Internal Medicine, Spital Thun, Thun, Switzerland, 4Applied Health Research Centre, St. Michael’s Hospital, Toronto, Canada) * Presenting author

113 Posters

Postural control in copd patients travelling from 760 m to PP-121 3200 m; a randomized trial evaluating effect of dexamethasone L. Muralt1, *, M. Furian1, M. Lichtblau1, S. S. Aeschbacher1, M. Bisang1, T. D. Latshang1, R. Clark2, A. Aldashev3, T. Sooronbaev4, S. Ulrich1, K. E. Bloch1 (1Pulmonary Division and Sleep Disorders Center, University Hospital of Zurich, Zurich, Switzerland, 2School of Exercise Science, Australian Catholic University, Melbourne, Australia, 3Research Institute for Molecular Biology and Medicine, 4National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyztan)

Effectiveness of the “living well with copd” intervention on PP-122 coping, smoking behavior and exacerbations in patients from swiss primary care: a non-randomized controlled study C. Steurer-Stey1, *, J. Braun2, V. Gaveikaite2, S. Markun1, K. DallaLana1, M. Puhan2 (1Institute of Primary Care, 2Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland)

The impact of case finding on the recruitment yield for copd PP-123 research in general practice: an observational study S. Markun1, *, T. Rosemann1, K. DallaLana1, C. Steurer-Stey1 (1Institute of Primary Care, University of Zurich, Zurich, Switzerland)

Dyspnea is an independent predictor of readmission and death PP-124 in chronic obstructive pulmonary disease patients surviving acute hypercapnic respiratory failure E. Dupuis1, P. M. Social2, J. P. Janssens3, T. Similowski4, D. Adler3, * (1Service de Pneumologie, HUG, Genève, 2HUG, Genève, Switzerland, 3Service de Pneumologie, HUG, Genève, Switzerland, 4Pitié-Salpêtrière, APHP, Paris, France)

Modeling of oxygen uptake kinetics during exercise testing PP-125 in patients with chronic obstructive pulmonary diseases (copd) F. Baty1, *, C. Ritz2, A. van Gestel1, M. Brutsche1, D. Gerhard3 (1Pneumologie, Kantonsspital St. Gallen, St. Gallen, Switzerland, 2Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark, 3School of Mathematics & Statistics, University of Canterbury, Christchurch, New Zealand)

* Presenting author

114 Posters

Mannose-binding lectin protein and its association PP-126 to clinical outcomes in copd: a longitudinal study J. Mandal1, B. Malla1, R. Steffensen2, L. Costa1, A. Egli3, M. Trendlenburg4, F. Blasi5, K. Kostikas6, T. Welte7, A. Torres8, R. Louis9, W. Boersma10, B. Milenkovic11, J. Aerts12, G. G. Rohde13, A. Lacoma14, K. Rentsch15, M. Roth1, D. Stolz16, *, M. Tamm1 (1Clinic for Pulmonary Medicine and Respiratory Cell Research, University Hospital Basel, Basel, Switzerland, 2Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark, 3Infection Disease Department, 4Department of Biomedicine and Division of Internal Medicine, University Hospital Basel, Basel, Switzerland, 5Department of Pathophysiologie and Transplantation, Università degli Studi di Milano, Milano, Italy, 6Pneumology, Thessaly Medical School, Thessaloniki, Greece, 7Pneumology, Medical School Hannover, Hannover, Germany, 8Pneumology, Hospital Clinic, Barcelona, Spain, 9Pneumology, University of Liege, Liege, Belgium, 10Pneumology, Medisch Centrum Alkmaar, Alkmaar, Netherlands, 11Faculty of Medicine, University of Belgrade, Clinic of Pulmonary Disease, Belgrade, Serbia, 12Pneumology, Amphia Hospital/Erasmus MC, Breda, 13Department of Respiratory Medicine, Maastrich University Medical Center, Maastrich, Netherlands, 14Department of Microbiology, Hospital Universitari Germans Trias i Pujol, Baladona, Spain, 15Department of Laboratorial Medicine, 16Pneumology, University Hospital Basel, Basel, Switzerland)

On-line breath analysis of copd patients reveals altered PP-127 metabolic signatures between frequent and non-frequent exacerbators M. T. Gaugg1, *, Y. Nussbaumer-Ochsner2, L. Bregy1, A. Engler2, N. Stebler2, T. Gaisl2, Y. Suter1, P. Martinez-Lozano Sinues1, R. Zenobi1, M. Kohler2, 3, 4 (1D-CHAB, ETH Zürich, 2Department of Pulmonology, 3Centre for Integrative Human Physiology, 4Zurich Centre for Interdisciplinary Sleep Research, UZH, Zurich, Switzerland)

Cerebral tissue oxygenation in lowlanders with copd PP-128 spending a night at 2590m M. Furian1, *, D. Flueck1, P. M. Scheiwiller1, S. Mueller-Mottet1, S. E. Hartmann2, M. Poulin2, B. Osmonov3, L. Urner1, A. Steiner1, M. Kohler1, T. D. Latshang1, S. Ulrich1, K. E. Bloch1

* Presenting author

115 Posters

(1Pulmonary Division and Sleep Disorders Center, University Hospital of Zurich, Zurich, Switzerland, 2Dept of Physiology & Pharmacology and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada, 3National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyztan)

A human in vitro airway epithelial model to study the effects PP-129 of aerosolized multi-walled carbon nanotubes in chronic obstructive pulmonary diseased cells S. Beyeler1, *, S. Chortarea2, B. Rothen-Rutishauser2, A. Petri-Fink2, S. Tschanz3, C. Von Garnier1, F. Blank1 (1Respiratory Medicine, University Hospital, Bern, 2Adolphe Merkle Institute, University of Fribourg, Fribourg, 3Institute of Anatomy, University of Bern, Bern, Switzerland)

Exhaled breath analysis identifies altered metabolic PP-130 signature in chronic obstructive pulmonary disease L. Bregy1,*, Y. Nussbaumer-Ochsner2, D. García-Gómez1, Y. Suter1, T. Gaisl2, N. Stebler2, M. Gaugg1, P. Martinez-Lozano Sinues1, M. Kohler2, R. Zenobi1 (1Department of Chemistry and Applied Biosciences, ETH Zurich, 2Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland)

Management of acute exacerbated copd in three swiss public PP-131 hospitals: room for improvement in key elements of care D. P. Franzen1, *, S. Markun2, S. Beyer3, S. Wieser4, K. DellaLana2, T. Hess3, M. Kohler1, C. Steurer-Stey2 (1Klinik für Pneumologie, UniversitätsSpital Zürich, 2Institut für Hausarztmedizin, Universität Zürich, Zürich, 3Pneumologie, Kantons- spital Winterthur, Winterthur, 4Pneumologie, Stadtspital Waid, Zürich, Switzerland)

Physical activity in copd and its relationship to exercise PP-132 performance and sleep S. Saxer1, *, E. D. Hasler1, M. Furian1, K. E. Bloch1, S. Ulrich1 (1Pneumologie, UniversitätsSpital Zürich, Zürich, Switzerland)

Insights into the recently launched alpha-1 antitrypsin PP-133 registry in Switzerland C. F. Clarenbach1, *, N. A. Sievi1, M. Kohler1 (1Klinik für Pneumologie, UniversitätsSpital Zürich, Zürich, Switzerland)

* Presenting author

116 Posters

Cardiopulmonary- and hemodynamic responses during PP-134 non-invasive positive airway pressure ventilation in patients with chronic obstructive pulmonary disease A. Van Gestel1, M. Hörner1, *, M. Brutsche1, G. Benz1, F. Baty1 (1Pneumology, KSSG, St. Gallen, Switzerland)

Telehealthcare in copd – a feasibility trial PP-135 F. Rassouli1, *, M. Pfister1, F. Baty1, S. Schlotter1, M. Brutsche1 (1Klinik für Pneumologie und Schlafmedizin, Kantonsspital St. Gallen, St. Gallen, Switzerland)

Interferon-lambda-genotype gg and igg2 predict frequent PP-136 copd exacerbations in a swiss multicenter copd cohort study (topdocs) S. Henny1, *, T. Dieterle1, T. Brack2, M. Brutsche3, C. Clarenbach4, A. Egli5, I. Heijnen6, S. Irani7, M. Frey8, N. Sievi4, R. Thurnheer9, M. Trendelenburg10, M. Kohler4, J. Leuppi1 (1University Clinic of Medicine, Kantonsspital Baselland, Liestal, and Medical Faculty University of Basel, Liestal, Switzerland, 2Internal Medicine, Kantonsspital Glarus, Glarus, Switzerland, 3Respiratory Medicine, Kantonsspital St. Gallen, St.Gallen, Switzerland, 4Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland, 5Clinical Microbiology, University Hospital Basel, University of Basel, Switzerland, 6Division of Medical Immunology, Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland, 7Respiratory Medicine, Kantonsspital Aarau, Aarau, Switzerland, 8Respiratory Medicine, Klinik Barmelweid, Barmelweid, Switzerland, 9Respiratroy Medicine, Kantonsspital Münsterlingen, Münsterlingen, Switzerland, 10Division of Internal Medicine and Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland)

Value of clinical characteristics as predictors of frequent PP-137 exacerbations in a swiss multicenter copd cohort study (topdocs) S. Henny1, *, T. Dieterle1, T. Brack2, M. Brutsche3, C. Clarenbach4, S. Irani5, M. Frey6, N. Sievi4, R. Thurnheer7, M. Kohler4, J. Leuppi1 (1University Clinic of Medicine, Kantonsspital Baselland, Liestal, and Medical Faculty University of Basel, Liestal, Switzerland, 2Internal Medicine, Kantonsspital Glarus, Glarus, Switzerland, 3Respiratory Medicine, Kantonsspital St. Gallen, St.Gallen, Switzerland, 4Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland, 5Respiratory Medicine, Kantonsspital Aarau, Aarau, Switzerland, 6Respiratory Medicine, Klinik Barmelweid, Barmelweid, Switzerland, 7Respiratroy Medicine, Kantonsspital Münsterlingen, Münsterlingen, Switzerland)

* Presenting author

117 Posters

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSP 2: (PP-138; PP-156) Sleep disorders – rehab – physiology Chairs: Frédéric Lador (Geneva, CH), Martin Frey (Barmelweid, CH)

Sleep disordered breathing in morbidly obese patients prior PP-138 to bariatric surgery – a retrospective analysis of a single centre cohort C. M. Horvath1, 2, *, J. Jossen1, A.-K. Brill1, P. Nett3, S. R. Ott1 (1Pulmonary Medicine, Inselspital, University Hospital of Bern, Bern, 2Sleep Medicine and Pneumology, Kantonsspital St. Gallen, St. Gallen, 3Visceral Surgery and Medicine, Inselspital, University Hospital of Bern, Bern, Switzerland)

How do patients adhere to chronic treatment of pulmonary PP-139 diseases? Preliminary data from a randomized controlled trial C. Gregoriano1, 2, *, S. Henny-Reinalter1, S. Maier1, A.-L. Flamm1, T. Dieterle1, 3, I. Arnet2, K. E. Hersberger2, J. D. Leuppi1 (1University Department of Medecine, Cantonal Hospital Baselland, Liestal, Liestal, Switzerland, 2Pharmaceutical Care Research Group, 3Faculty of Medicine, University of Basel, Basel, Switzerland)

Determination of coordination patterns in preterm infants PP-140 by esophageal signal recording K. Jost1, M. Thomet2, L. Suter1, S. Schulzke1, A. Haeberlin3, 4, T. Niederhauser2, * (1Department of Neonatology, University of Basel Children’s Hospital (UKBB), Basel, 2Institute for Human Centered Engineering HuCE, Bern University of Applied Sciences, Biel, 3Department of Cardiology, Inselspital, Bern University Hospital, 4ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland)

Effect of continuous positive airway pressure on circadian PP-141 patterns of cardiac repolarization in obstructive sleep apnoea: data from a randomized controlled trial C. Schlatzer1, *, D. J. Bratton1, E. I. Schwarz1, T. Gaisl1, J. C. Pepperell2, J. R. Stradling2, M. Kohler1 (1Klinik für Pneumologie, UniversitätsSpital Zürich, Zürich, Switzerland, 2Oxford Centre for Respiratory Medicine and NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom)

* Presenting author

118 Posters

Resistive work of breathing as target parameter evaluating PP-142 methacholine challenge to assess airway hyperreactivity in comparison to other lung function parameters R. Kraemer1, 2, *, J. Salomon2, M. Gürtler2, S. Minder2 (1Department of Clinical Research, Faculty of Medicine, University of Bern, 2Centre of Pulmonary Medicine, Hirslanden Private Hospital Group, Bern, Switzerland)

Metabolic effects of inhaled salbutamol determined by PP-143 exhaled breath analysis P. M-L Sinues1, *, Y. Nussbaumer-Ochsner2, L. Bregy1, A. Engler2, T. Gaisl2, M. T. Gaugg2, D. Garcia Gomez1, Y. Suter1, R. Zenobi1, M. Kohler2 (1ETH Zurich, 2University Hospital Zurich, Zurich, Switzerland)

Comparison of ventilator-integrated end-tidal co2 PP-144 and transcutaneous co2 monitoring in home-ventilated neuromuscular patients D. Orlikowski1,2, H. Prigent3, F. Lofaso3, A. Ogna2, 4, * (1INSERM CIC 14.29, 2Service de réanimation médicale et Unité de ventilation à domicile, 3Service de Physiologie-Explorations Fonctionnelles, CHU Raymond Poincaré, Garches, France, 4Service de Pneumologie, CHUV, Lausanne, Switzerland)

The prevalence of airway hyperresponsiveness to mannitol PP-145 challenge test among water pipe smoking young adults in Switzerland A. Scherr1, *, J. Schmidlin1, S. Albisser1, A. Meyer1, M. Tamm1, D. Stolz1 (1Pneumology, Universitätsspital Basel, Basel, Switzerland)

Short-term effects of adaptive servo ventilation withdrawal PP-146 on sleep disordered breathing in stable congestive heart failure patients after the serve-hf safety warning A.-K. Brill1, *, J. Pichler Hefti1, T. Geiser1, S. R. Ott1 (1Pulmonary Medicine, University Hospital (Inselspital) and University Bern, Bern, Switzerland)

A descriptive analysis of pulmonary rehabilitation trends PP-147 in Switzerland P.-O. Bridevaux1, 2, *, M. Frey3, A. Turk4 on behalf of Working Group on Pulmonary Rehabilitation and Patient Education of the Swiss Respiratory Society

* Presenting author

119 Posters

(1Service de Pneumologie, Hôpitaux Universitaires de Genève, Genève, 2Service de Pneumologie, Hôpital du Valais, Sion, 3Reha Klinik, Barmelweid, Barmelweid, 4Pneumologie, UniversitätsSpital Zürich, Wald, Switzerland)

Prognostic value of nocturnal hypoventilation in unventilated PP-148 neuromuscular disease patients A. Ogna1, 2, *, H. Prigent3, M. A. Quera Salva4, F. Lofaso3, D. Orlikowski2, 5 (1Service de Pneumologie, CHUV, Lausanne, Switzerland, 2Service de réanimation médicale et Unité de ventilation à domicile, 3Service de Physiologie-Explorations Fonctionnelles, 4Unité du sommeil, 5INSERM CIC 14.29, CHU Raymond Poincaré, Garches, France)

Use of home ventilators for ventilatory support during PP-149 magnetic resonance imaging A. Ogna1, 2, *, X. Ambrosi1, H. Prigent3, D. Orlikowski1, 4, F. Lofaso3 (1Service de réanimation médicale et Unité de ventilation à domicile, CHU Raymond Poincaré, Garches, France, 2Service de Pneumologie, CHUV, Lausanne, Switzerland, 3Service de Physiologie-Explorations Fonctionnelles, 4INSERM CIC 14.29, CHU Raymond Poincaré, Garches, France)

Severe asthma – 5 years of phenotyping patients PP-150 V. Seif1, *, T. Rothe1, L. Grize2 (1Zürcher Rehazentrum Davos, Davos Clavadel, 2Swiss TPH Basel, Basel, Switzerland)

Think primary ciliary dyskinesia in adult patients with PP-151 bronchiectasis S. Filippi 1, *, A. Jung2, M. Hofer1, T. Hess1 (1Pneumologie, Kantonsspital Winterthur, Winterthur, 2Pneumologie, Universitäts-Kinderspital, Zürich, Switzerland)

Light chain deposition disease: a rare cause of multiple PP-152 cystic lung disease A. Lenoir1, E. Clottu1, *, J. Mazza-Stalder1, A. Cairoli2, I. Letovanec3, S. Rotman3, R. Lazor1 (1Service de Pneumologie, 2Service d’Hématologie, 3Institut Universitaire de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland)

* Presenting author

120 Posters

High-altitude climate-therapy in Hochgebirgsklinik Davos – PP-153 an important therapeutical option to treat asthma! H.-W. Duchna1, * (1Hochgebirgsklinik Davos, SGP, Davos, Switzerland)

Raclette-induced dyspnea – a swiss case report PP-154 S. P. Descombes1, *, S. Jegerlehner2, T. Geiser1, M. Funke1 (1Universitätsklinik für Pneumologie, 2Universitätsklinik für Allgemeine Innere Medizin, Inselspital Bern, Bern, Switzerland)

When sleep medicine meets cardiology – unusual first PP-155 manifestation of an arrhythmogenic right ventricular dysplasia (avrc) C. M. Horvath1, *, S. Zbinden2, S. R. Ott1, A.-K. Brill1 (1Department of Pulmonary Medicine, 2Cardiology, University Hospital and University of Bern, Bern, Switzerland)

Oxygen transport at high altitude and effects PP-156 of acclimatization J. Pichler Hefti1, *, T. Merz2 (1Department of Pulmonary Medicine, University and University Hospital, 2Department of Intensive Care Medicine, Inselspital, University and University Hospital Bern, Bern, Switzerland)

Thursday, 16 June 2016 – 13:15–14:15 Poster Walk SSP 1: (PP-157; PP-171) Pulmonary Hypertension – Transplantation – Biomarkers Chairs: Silvia Ulrich (Zurich, CH), Andrea Azzola (Lugano, CH)

Composite clinical worsening endpoint in paediatric pah – PP-157 clinically meaningful and feasible for clinical research M. Beghetti1, *, M. Brand2, R. Berger3, T. Humpl4, J. Wheeler5, D. Ivy6, D. Bonnet7 on behalf of on behalf of the TOPP investigators (1Pediatric Cardiology, University Hospital, Geneva, 2Global Clinical Science, Actelion, Basel, Switzerland, 3Paediatric Cardiology, University of Groningen, Groningen, Netherlands, 4Pediatric Cardiology and Critical Care Medicine, University of Toronto, Toronto, Canada, 5Quanticate, London, United Kingdom, 6Paediatric Cardiology, University of Colorado School of Medicine, Aurora, United States, 7Paediatric Cardiology, Necker Hospital for Sick Children, Paris, France)

* Presenting author

121 Posters

In-hospital disease burden of sarcoidosis in Switzerland PP-158 from 2002 to 2012 S. Pohle1, *, F. Baty1, M. Brutsche1 (1Kantonsspital St. Gallen, St. Gallen, Switzerland)

Nitrogen multiple breath washout for diagnosis PP-159 of bronchiolitis obliterans in patients after allogeneic stem cell transplantation L. Baumeler1, S. Nyilas2, 3, J. Halter4, S. Savic5, A. Meyer1, J. Passweg4, P. Latzin2, 3, D. Stolz1, * (1Pneumology, University Hospital Basel, 2Department of Paediatric Pneumology, University Children’s Hospital Basel (UKBB), Basel, 3Division of Respiratory Medicine, Department of Paediatrics, University Children’s Hospital of Bern, Bern, 4Division of Hematology, 5Institute of Pathology, University Hospital Basel, Basel, Switzerland)

Evaluation of comorbid conditions in lung transplant recipients PP-160 O. Bilat1, *, A. Koutsokera2, J.-P. Antonietti1, M.-F. Derkenne2, P. M. Soccal3, A.-K. Brill4, P. Grendelmeier5, L. P. Nicod2, J.-D. Aubert2 (1Faculté de Biologie et Medecine, Université de Lausanne, 2Service de Pneumologie, CHUV, Lausanne, 3Service de Pneumologie, HUG, Genève, 4Pneumologie Abteilung, Inselspital, Bern, 5Pneumologie Abteilung, Unispital, Basel, Switzerland)

Hyperoxia enhances exercise performance in pulmonary PP-161 arterial and chronic thromboembolic pulmonary hypertension: randomized trial S. Ulrich1, *, H. D. Elisabeth1, S. Saxer1, M. Furian1, S. Müller-Mottet1, S. Keusch1, K. E. Bloch1 (1Pneumologie, UniversitätsSpital Zürich, Zürich, Switzerland)

Heart rate variability in lung transplant recipients PP-162 T. Fontolliet1, *, P. Gianella2, V. Pichot3, P. M. Soccal2, G. Ferretti1, F. Lador2 (1APSI, UNIGE, 2Pneumologie, HUG, Genève, Switzerland, 3UJM, Saint-Etienne, France)

Kinetics of cardiac output at the onset of exercise in PP-163 pre-capillary pulmonary hypertension F. Lador1, 2, *, A. Bringard3, S. Bengueddache2, G. Ferretti3, K. Bendjelid1, 3, P. M. Soccal1, 2, S. Noble1, 4, M. Beghetti1, 5, D. Chemla6, P. Hervé6, O. Sitbon6

* Presenting author

122 Posters

(1Programme Hypertension Pulmonaire, 2Pneumologie, 3APSI, 4Cardiologie, 5Cardiologie pédiatrique, HUG, Genève, Switzerland, 6Pneumologie, Hôpital de Bicêtre, Paris, France)

Platelet-derived growth factor-bb induced fibroblast PP-164 remodeling depends on erk1/2 and stat1 activation which controls protein arginine methyltransferase-1 expression Q. Sun1, 2, *, L. Liu2, J. Mandal3, A. Molino4, D. Stolz3, M. Tamm3, S. Lu2, M. Roth1, 3 (1Biomedicine, University of Basel, Basel, Switzerland, 2Biochemistry and Molecular Biology, Jiaotong University Health Science Center, Xi’an, China, 3Pneumology, University Hospital Basel, Basel, Switzerland, 4Respiratory Diseases, University of Naples, Federico II, Naples, Italy)

Spontaneous flow increase from implantable pump PP-165 for intravenous treprostinil delivery G. Kopp1, 2, *, A.-L. Hachulla3, 4, S. Noble4, 5, P. M. Soccal1, 4, M. Beghetti4, 6, F. Lador1, 4 (1Pneumologie, 2Médecine Interne Générale, 3Radiologie, 4Programme Hypertension Pulmonaire, 5Cardiologie, 6Cardiologie Pédiatrique, HUG, Genève, Switzerland)

Acute complications after lung transplantation: PP-166 radio-pathological correlation C. Habre1, A.-L. Hachulla1, 2, *, J. Gariani1, S. Martin1, L. Lücker3, F. Lador2, 3, J.-C. Pache4, P. M. Soccal2, 3, X. Montet1, 2 (1Division of Radiology, 2Pulmonary Hypertension Program, 3Department of Pneumology, 4Department of Pathology, Hôpitaux Universitaires de Genève, Genève, Switzerland)

Generation of an immortalized functional alveolar epithelial PP-167 cell line from human induced pluripotent stem cells A. Gazdhar1, *, L. Tamo1, Y. Hibaoui2, S. Kallol3, M. Alves4, C. Albrecht3, A. Feki5, T. Geiser1 (1Department of Pulmonary Medicine, University Hospital Bern, Bern, Switzerland, 2Department of Gynecology , University Hospital Geneva, Geneva, Switzerland, 3Department of Molecular Medicine, University of Bern, 4Department of Pediatric Pneumology , University Hospital Bern, Bern, 5Department of Gynecology, Kantonsspital Fribourg, Fribourg, Switzerland)

* Presenting author

123 Posters

Functional pulmonary perfusion with dual-energy ct in PP-168 children with pulmonary hypertension, preliminary results A.-L. Hachulla1, 2, *, F. Lador2, 3, S. Noble2, 4, J. Gariani1, M. Laurent1, X. Montet1, 2, Y. Aggoun5, M. Beghetti2, 5, J.-P. Vallée1, 2 (1Division of Radiology, 2Pulmonary Hypertension Program, 3Department of Pneumology, 4Department of Cardiology, 5Department of Pediatric Cardiology, Hôpitaux Universitaires de Genève, Genève, Switzerland)

Use of macitentan (endothelin receptor antagonist) in children PP-169 D. Hutter1, *, J.-P. Pfammatter1 (1Cardiology, Inselspital, Bern, Switzerland)

Dual energy ct – the new v/q scan for the diagnosis of cteph? PP-170 T. Frauenfelder1, S. Baumüller1, T. Pfammatter1, S. Ulrich2, R. Speich2, M. Kohler2, W. Weder3, I. Opitz3, * (1Institute of Diagnostic and Interventional Radiology, 2Department of Pulmonology, 3Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland)

Dual-energy ct imaging of pulmonary hypertension PP-171 A.-L. Hachulla1, 2, *, F. Lador1, 3, J. Gariani2, P. M. Soccal1, 3, M. Beghetti1, 4, X. Montet1, 2 (1Pulmonary Hypertension Program, 2Division of Radiology, 3Department of Pneumology, 4Department of Pediatric Cardiology, Hôpitaux Universitaires de Genève, Genève, Switzerland)

Thursday, 16 June 2016 – 14:30–15:30 Poster Walk SSP 2: (PP-172; PP-188) Bronchoscopy – Cancer – Tobacco Chairs: Alban Lovis (Lausanne, CH), Michael Tamm (Basel, CH)

Electrospray: a novel method for targeted drug delivery PP-172 P. Ruzgys1, S. Bohringer2, S. Satkauskas3, D. Hradetzky4, T. Geiser1, A. Gazdhar1, * (1Department of Pulmonary Medicine, University Hospital Bern, Bern, Switzerland, 2Institut für Medizinal- und Analysetechnologie, FHNW, Muttenz, Switzerland, 3Department of Biophysics, University of Kaunus, Kaunus , Lithuania, 4Institut für Medizinal- und Analysetechnologie, FHNW, Muttenz, Switzerland)

* Presenting author

124 Posters

Endobronchial coil-spring fiducial markers guiding PP-173 cyberknife® stereotactic radiosurgery for medically inoperable early stage non-small cell lung cancer patients A. Casutt1, *, M. Bernasconi1, A. Durham2, M. Ozsahin2, L. Nicod1, A. Lovis1 (1Pneumology, 2Radiation Oncology, CHUV, Lausanne, Switzerland)

Immunocompromised status is not a risk factor for surgical PP-174 lung biopsy K. Furrer1, *, C. Nebiker2, L. Junker3, S. Lazdinyte1, S. Savic4, K. Hostettler3, D. Schumann1, J. Halter5, M. Tamm3, D. Lardinois1 (1Thoracic Surgery, 2Visceral Surgery, 3Pneumology, 4Pathology, 5Haematology, University Hospital Basel, Basel, Switzerland)

Multiplex bacterial pcr in the bronchoalveolar lavage PP-175 of immunocompromised patients K. Affolter1, M. Tamm2, K. Jahn2, L. Junker2, R. Frei3, A. Egli4, D. Stolz5, * (1Department of Respiratory Medicine, University Hospital Basel, Basel, Switzerland, 2Clinic for Pulmonary Medicine and Respiratory Cell Research, 3Department of Microbiology, 4Infection Disease Department, 5Pneumology, University Hospital Basel, Basel, Switzerland)

Operative stabilisation of chest wall trauma: single center PP-176 report of initial management and longterm outcome C. Michelitsch1, *, Y. P. Acklin2, G. Hässig1, C. Sommer2, M. Furrer1 (1Department of Surgery, Thoracic Unit, 2Department of Surgery, Trauma Unit, Kantonsspital Graubünden, Chur, Switzerland)

24h-blood profile gene expression biomarkers of PP-177 the response to bevacizumab-erlotinib (be) in advanced non-squamous non-small cell lung cancer (nsclc) F. Baty1, *, M. Früh2, M. Jörger2, M. Brutsche1 (1Pneumologie, 2Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland)

Quality of life in octogenarians after thoracic surgery PP-178 W. Moersig1, *, A. Hiebinger1, S. Lazdinyte1, D. Schumann1, D. Lardinois1 (1Thoracic Surgery, University Hospital Basel, Basel, Switzerland)

* Presenting author

125 Posters

Near-infrared fluorescence is useful for identification of the PP-179 intersegmental plane in thoracoscopic lung segmentectomy B. Bédat1, *, S. Guigard1, F. Triponez1, M. Licker2, W. Karenovics1 (1Surgery, 2Anesthesiology, Geneva University Hospitals, Geneva, Switzerland)

Lung volume reduction therapy in chuv: a medico- PP-180 economical assessment of 3 different modalities A. Casutt1, *, R. Bensaker1, A. Koutsokera1, M. Bernasconi1, Y. Perentes2, T. Krueger2, L. Nicod1, M. Gonzalez2, A. Lovis1 (1Pneumology, 2Thoracic Surgery, CHUV, Lausanne, Switzerland)

Tobacco advertising/sponship in Switzerland: outcome of PP-181 15 complaints filed by oxyromandie provide evidence of ineffectiveness of self-regulation by tobacco multinationals R. M. Kaelin1, *, M. Canevascini2, P. Diethelm1 (1Oxyromandie, Geneva, 2Stratégies marketing, Cipret Vaud, Lausanne, Switzerland)

The first case of an extraskeletal myxoid chondrosarkoma PP-182 in the pulmonary artery I. Opitz1, *, H. Klein1, B. Bode2, L. Freitag3, D. Schneiter1, S. Ulrich3, F. Maisano4, W. Weder1 (1Division of Thoracic Surgery, 2Institute of Surgical Pathology, 3Department of Pulmonology, 4Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland)

First experience with a biodegradable endobronchial stent PP-183 in a case of bronchomalcia T. Schneider1, *, F. Baty1, M. Brutsche1 (1Pneumologie, Kantonsspital St. Gallen, St. Gallen, Switzerland)

Safairway: an airway training for pulmonologists performing PP-184 flexible bronchoscopy with non-anaesthesiologist administered propofol sedation. A prospective evaluation D. P. Franzen1, *, M. Schulze2, B. Grande2, M. Kolbe2, 3, S. Kriech3, 4, C. B. Nöthiger2, D. R. Spahn2, M. Kohler1 (1Klinik für Pneumologie, 2Institut für Anästhesiologie, 3Simulations- zentrum, UniversitätsSpital Zürich, 4ETH Zürich, Zürich, Switzerland)

* Presenting author

126 Posters

Hypersensitivity pneumonitis after bronchoscopic lung PP-185 volume reduction with endobronchial valves in a patient with nickel allergy. Coincidence or causality? D. P. Franzen1, *, L. Freitag1, M. Kohler1, P. Schmid-Grendelmeier2 (1Klinik für Pneumologie, 2Allergiestation, Klinik für Dermatologie, UniversitätsSpital Zürich, Zürich, Switzerland)

Multimodal screening of respiratory disease related to tobacco PP-186 consumption: results from a screening day at a tertiary center P. Gianella1, *, D. Adler1, F. Lador1, X. Montet2, P. M. Soccal1 (1Pneumologie, 2Radiologie, HUG, Genève, Switzerland)

A 25-year follow-up of 2 airways stents (gianturco z-stents) PP-187 placed during childhood L. M. Lücker1, *, P. Soccal1, F. Lador1, J. Plojoux1 (1Pneumologie, Hôpitaux Universitaires de Genève, Genève, Switzerland)

Instrumentalisation of academic research by the industry PP-188 to influence swiss tobacco control policies, 1962–2015 R. M. Kaelin1, *, P. Diethelm2 (1Oxyromandie, Geneva, Switzerland, 2Oxyromandie, Geneva, Switzerland)

* Presenting author

127 Moderator List

Moderator Name Page number Moderator Name Page number

Ammann P ...... 53, 93 Ferrari E ...... 64 Aubert J-D ...... 48, 72 Flammer A ...... 50, 63, 98 Azzola A ...... 50, 63, 121 Flammer A ...... 63, 98 Franzen D ...... 51 Banfi A ...... 49, 90 Frey M ...... 54, 78, 118 Barazzone C ...... 74 Fuhrer J ...... 33 Barben J ...... 33 Battegay E ...... 56 Gallino A ...... 54, 105 Baumgartner C ...... 84 Ganière V ...... 69 Beer J ...... 40, 61 Gasche Soccal P ...... 47 Benussi S ...... 53, 78, 93 Geiser T ...... 47, 52 Berdat P ...... 34 Genoni M ...... 26 Bernasconi E ...... 45 Gex G ...... 50 Bernheim A ...... 31 Grendelmeier P ...... 60 Biaggi P ...... 19, 21 Greutmann M ...... 86 Bloch K ...... 38 Gruner C ...... 29 Bouchardy J ...... 35 Györik S ...... 73 Brack T ...... 38 Bridevaux P-O ...... 40, 71 Häberlin A ...... 28 Brutsche M ...... 32, 71 Hammer J ...... 57, 86 Burger P ...... 50, 106 Hermann M ...... 50, 102 Buser P ...... 80 Hess T ...... 78 Horvath E ...... 49 Cattilaz-Langenauer V ...... 64 Huber C ...... 43 Chanez P ...... 84 Hullin R ...... 19, 25, 53, 96 Cook S ...... 20, 49, 90 Costabile S ...... 26 Inderbitzi R ...... 71 Cuculi F ...... 53, 100 Irani S ...... 40

De Pasquale G ...... 26 James R ...... 23 Deuel W ...... 50, 102 Janssens J-P ...... 49 Donner B ...... 81 Jeger R ...... 53, 100 Duru F ...... 33 Jenni H ...... 26 Dzemali O ...... 74 Kadner A ...... 26 Eckstein F ...... 64, 87 Kaiser C ...... 29 Eeckhout E ...... 31 Kaufmann U ...... 30 Egger B ...... 51 Koestner S ...... 54, 108 Eich C ...... 87 Kohler M ...... 82 Englberger L ...... 54 Kraus M ...... 27 Kuster G ...... 43

128 Moderator List

Moderator Name Page number Moderator Name Page number

Lador F ...... 54, 118 Reek S ...... 68 Landolt J ...... 65 Regoli F ...... 49, 94 Latzin P ...... 74 Reichlin T ...... 22, 68 Lazor R ...... 25, 60 Reineke D ...... 21, 79 Leventhal M ...... 38 Reser D ...... 21 Linka A ...... 63 Riesen W ...... 23 Lovis A ...... 54, 124 Ris H-B ...... 73 Lüscher T ...... 31, 51, 80 Rochat I ...... 57, 72 Rochat T ...... 48 Mach F ...... 55, 57, 87 Roffi M ...... 81 Maeder M ...... 53, 96 Rosenblatt N ...... 39 Matter C ...... 39 Rothe T ...... 31 Meier H ...... 54, 111 Röthlisberger C ...... 29 Messerli F ...... 67 Ruschitzka F ...... 57, 68 Meyer P ...... 28, 54, 105 Rutz T ...... 50, 81, 106 Mivelaz Y ...... 58 Möller A ...... 79, 82 Schärli M ...... 64 Monnier P ...... 27 Schepis T ...... 50, 110 Mordasini R ...... 40 Schmid T ...... 25 Moschovitis G ...... 79 Schmidt-Trucksäss A ...... 71 Müller A ...... 49, 94 Schuurmans M ...... 33 Müller C ...... 87 Schwerzmann M ...... 58 Schwitter J ...... 29 Namdar M ...... 22, 28 Siclari F ...... 26, 87 Nanchen D ...... 48, 61 Sologashvili T ...... 77 Nicod L ...... 49, 79 Stämpfli S ...... 32 Noble S ...... 74 Steffel J ...... 76 Noti F ...... 85 Sticherling C ...... 69, 83 Stoffel G ...... 54 Osswald S ...... 73 Stricker H ...... 80 Ott S ...... 55, 87 Suter T ...... 19, 28, 34

Park C-I ...... 47 Tamm M ...... 54, 80, 124 Pascale P ...... 76 Tanner F ...... 54, 111 Pedrazzini G ...... 71 Thurnheer R ...... 50, 63 Pfister O ...... 19, 71 Tozzi P ...... 65 Plass A ...... 66 Triponez F ...... 53 Potocki M ...... 50, 110 Pruvot E ...... 68 Uldry C ...... 37 Ulrich S ...... 50, 121 Quadri F ...... 84

129 Moderator List

Moderator Name Page number

Vogt K ...... 49

Weber A ...... 81 Weber R ...... 35 Weilenmann D ...... 48 Weiss P ...... 66 Wenaweser P ...... 20, 64 Wilhelm M ...... 37, 50 Wilhelm M ...... 50, 98 Windecker S ...... 47, 51 Wustmann K ...... 54, 77, 108

Yerly P ...... 50

Zellweger M ...... 30 Zigan N ...... 38 Zimmerli M ...... 73, 85

130 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Abächerli R ...... OR99 Armato F ...... OR83 Abdel-Sayed S ...... PP-059 Arnet I ...... 116 .2, PP-139 Abeidi H ...... PP-104 Arquint F ...... 86 2,. PP-020 Abouelnour A ...... PP-093 Arranto C ...... OR68 Acklin Y .P ...... PP-176 Arroja J . D ...... PP-101, PP-107 Adler D ...... PP-124, PP-186 Arroyo D ...... OR98 Aebischer P ...... 108 3. Asatryan B ...... OR96 Aerts J .G ...... OR37, PP-126 Aschwanden M ...... PP-071 Aeschbacher S .S . . . . . OR33, OR61, Attenhofer Jost C ...... 17 .3 ...... PP-121 Attenhofer Jost C ...... OR59, Affolter K ...... PP-175 ...... PP-028, PP-050, PP-083, Afoke J ...... 5 .1 ...... PP-090, PP-098, PP-102 Aggoun Y ...... PP-168 Attenhofer-Jost C ...... PP-084, Aggoun Y ...... OR26 ...... PP-085, PP-094 Aghlmandi S ...... OR08, PP-063 Attinger-Toller A ...... OR45 Agostini M ...... PP-052 Aubert J .D ...... 96 Akdis D ...... PP-014, PP-034, Aubert J .D . . . . OR40, OR64, PP-160 ...... PP-042, PP-099 Aubier M ...... 119 .2 Akhmedov A ...... OR18, PP-012 Aubort N ...... OR70 Alberio L ...... PP-011 Auer R ...... OR08 Albisser S ...... PP-145 Augereau C ...... OR70 Albrecht C ...... PP-167 Aujesky D ...... 105 .2, PP-071 Aldashev A . . . OR33, OR61, PP-121 Auricchio A ...... 16 .4, 117 3,. 117 .4, Alerci M ...... OR11 ...... OR91, . PP-015, PP-019, Alibegovic J ...... PP-081 ...... PP-022, PP-026 Alkhadhi H ...... OR85 Allemann P ...... OR16 Babic D ...... PP-084 Allemann Y ...... 124 Baeriswyl G ...... OR98 Altermatt B ...... PP-024, PP-053, Bahr A ...... PP-042 ...... PP-077 Baldinger S .H ...... OR22 Altmann D ...... OR04 Banerjee P ...... OR80 Alves M ...... PP-167 Banfi C ...... PP-047 Amacker M ...... OR42 Banyai M ...... PP-071 Amann W ...... PP-050 Baptista J ...... PP-113 Ambrosi X ...... PP-149 Barbey F ...... 76 .8 Amman F .W ...... OR15 Barile L ...... PP-001, PP-005 Ammann P . . . OR04, OR88, PP-020 Barras N ...... OR23, PP-108 Ammann P ...... 98 .3 Battegay E ...... 73 .1, 73 .7 Amstalden H ...... OR18, PP-003 Baty F . . . . OR60, PP-125, PP-134, Androulakis A ...... OR22 . . . PP-135, PP-158, PP-177, PP-183 Angelillo-Scherrer A . . . . . PP-071 Bauer W .R ...... PP-088 Antonietti J .-P ...... PP-160 Baumann F ...... PP-074 Arendacka B ...... OR95 Baumberger R ...... PP-074

131 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Baumeler L ...... OR37, PP-159 Biemmi V ...... PP-001 Baumüller S ...... PP-170 Biffi M ...... OR88 Bavamian S ...... OR66 Bijlenga P ...... PP-112 Beat S ...... OR94 Bilat O ...... PP-160 Bédat B ...... PP-179 Binder R .K .. . . OR47, PP-081, PP-093 Beer H .-J ...... PP-071 Bingisser R ...... 10 .1 Beer J .H ...... OR18, PP-003 Birkemeyer R ...... OR12 Beer J .-H ...... PP-010 Bisang M .. . . . OR33, OR61, PP-121 Beghetti M . . . . OR26, OR76, OR77, Bisch L . . . OR14, OR16, OR90, PP-048 . . . PP-111, PP-113, PP-116, PP-157, Blanche C ...... 11 .3 . . PP-163, . PP-165, PP-168, PP-171 Blank F ...... OR42, PP-129 Beigelman-Aubry C . . . . 99 .1, OR16 Blasi F ...... OR37, PP-126 Bendjelid K . . . . PP-113, PP-163 Blaüer C ...... 83 .4 Bengueddache S ...... PP-163 Bläuer C ...... OR20 Bensaker R ...... PP-180 Bloch K ...... 24 .3 Benussi S ...... OR86, PP-003 Bloch K E...... OR33, OR61, OR62, Benvenuti C ...... PP-026 ...... PP-119, PP-121, PP-128, Benz D .C ...... OR28, PP-097 ...... PP-132, PP-161 Benz G ...... OR60, PP-134 Blom R .A . M ...... OR42 Benz G ...... 72 .3 Blomström-Lundqvist C . . . 43 .4, 93 .1 Berdajs D ...... OR84 Bode B ...... PP-182 Bereuter L ...... OR89 Boeck L ...... OR34, OR37 Berger R ...... PP-157 Boeddinghaus J ...... OR99 Berger W ...... PP-042 Boersma W ...... OR37, PP-126 Berli R ...... PP-013 Bogdanovic S ...... PP-020 Bernardo A ...... 104 .1 Bogen M ...... OR11 Bernasconi E ...... OR40 Bohringer S ...... PP-172 Bernasconi E ...... 122 .1 Bolliger S ...... OR96 Bernasconi M . . . . . OR64, PP-173, Bonassin F .. . . . 103 2,. OR59, PP-085, ...... PP-180 ...... PP-090, PP-094 Bernasconi T ...... PP-092 Bonassin Tempesta F . . . . . PP-084, Bernhart S ...... PP-049 ...... PP-098 Bertaggia D ...... PP-011 Bonetti N R...... PP-003, PP-010 Berte B ...... OR15, PP-028 Bonnet D ...... PP-157 Bertel O ...... OR21, PP-050 Bonovolias I ...... OR34 Beyeler S ...... PP-129 Boon M ...... OR32 Beyer S ...... PP-131 Boroli F ...... PP-113 Beynon C ...... PP-013 Bouchardy J ...... 121 4,. OR59, Bhuiyan Z . A ...... OR72 ...... OR76, OR77 Biaggi P ...... 1, 1 .4, 4 .3, 4 .6, OR55, Bouillet E ...... PP-004 ...... PP-043, PP-044, PP-051 Boulvain M ...... PP-113 Bianda D ...... PP-044 Bouvaist H ...... 46 .4 Biasco L ...... PP-051, PP-062 Bovet C ...... OR43

132 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Bracher I ...... PP-085, PP-094 Büsching G ...... OR35 Brack T . . . . OR36, PP-136, PP-137 Buser P ...... OR21 Brand M ...... PP-157 Buss G ...... PP-048 Brandtner E .-M ...... OR09 Buttu A ...... PP-016 Brasier N ...... OR12 Bratton D .J ...... PP-141 Cahenzly M ...... OR47 Brauchlin A ...... PP-074 Cairoli A ...... PP-152 Braun J ...... PP-122 Calmy A ...... OR66 Bregy L ...... PP-127, PP-143 Camici G ...... OR18, PP-003, Bregy L ...... PP-130 ...... PP-010, PP-012 Breitenstein A . . . . 108 .2, PP-003, Canevascini M ...... PP-181 ...... PP-023 Cannizzaro V ...... OR81 Bremerich J ...... OR06 Cantatore S ...... OR25 Brenner R ...... 124 Caporali E ...... OR83 Briand S ...... OR18 Caputo M . L ...... OR91, PP-015, Bridevaux P .O ...... 90 .1, 116 .3 ...... PP-022, PP-026 Bridevaux P .-O ...... PP-147 Carballo D ...... 39 .1, PP-063 Brill A .-K ...... PP-120, PP-138, Carballo S ...... PP-063 ...... PP-146, PP-155, PP-160 Carbone F ...... OR08 Bringard A ...... PP-163 Carrel T ...... 82 3,. OR74, OR87, Brink M ...... PP-009 ...... PP-007, PP-033, PP-035, Brunckhorst C .. . . . PP-014, PP-021, ...... PP-038, PP-060, PP-095, ...... PP-034, PP-042, PP-099 ...... PP-096 Bründler S ...... 70 5. Carroz P ...... 98 .4, OR90 Brunner H P...... 34 .4 Casaulta C ...... OR32 Brutsche M . . . . . 44 .4, 61 .4, OR36, Casutt A ...... PP-173, PP-180 ...... OR60, PP-125, PP-134, Cattaneo M ...... OR11 ...... PP-135, PP-136, PP-137, Cavigelli-Brunner A . . . . . OR30, OR81 ...... PP-158, PP-177, PP-183 Celikyurt U . . . . OR04, OR06, OR94, Bubendorf L ...... OR38 ...... PP-025, PP-030, PP-031 Buchaab H ...... 99 .3 Cerny D . . . . . OR69, PP-066, PP-070 Büchel R .R ...... OR28 Cervio E ...... PP-001, PP-005 Buechel R .R ...... PP-097 Chalmers J ...... 122 .2 Bühler S ...... OR92, OR93 Chanez P ...... 107 .3 Burch F ...... OR04 Charakida M ...... OR67 Burkard T ...... OR12, OR68 Charon P ...... OR22 Burkart R ...... PP-026 Chemla D ...... PP-163 Burkhalter H ...... 47 .3 Chen H .-S . V ...... PP-014 Burkhardt B . . . OR27, OR29, PP-087 Chetany R ...... OR65, PP-082 Bürki C ...... OR81 Chiodini A ...... 86 .1 Burnier M ...... 73 .3 Chizzolini C ...... PP-113 Burri H ...... OR88, 117 .1, 117 2. Chortarea S ...... PP-129 Burri H ...... 89 .2, 93 2. Chronis J ...... PP-055, PP-065

133 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Cikirikcioglu M ...... 35 .2, PP-036 de Boeck B ...... PP-051 Ciullo A ...... PP-001 De Chillou C ...... 88 .3 Clair Willi C ...... 45 .1 de Geest S ...... 37 .1 Clarenbach C .F . . . . . OR36, PP-133, de Kerchove L ...... 35 1,35. .5 ...... PP-136, PP-137 De Marchi S ...... PP-114 Clark G ...... 47 2. De Pasquale G . . . . OR59, PP-085, Clark R ...... PP-121 ...... PP-090, PP-094 Clement A ...... OR32 Deanfield J ...... OR67 Clerc O .F ...... OR28 Dearani J ...... PP-083 Clottu E ...... PP-152 Defaye P ...... OR88 Cochard S ...... OR16 Degrauwe S ...... PP-115 Colombier S ...... PP-017 Delabay A ...... 1 .1 Conen D ...... OR12 Delabay A ...... 4 .2 Connolly H .M ...... PP-083 Delacretaz E ...... 98 .2 Conte G ...... OR91, PP-015, Delay D ...... PP-017 ...... PP-022, PP-026 Delhumeau-Cartier C ...... OR66 Cook S ...... 3 .6, 3 .8, OR13, OR90, Dell’Ambrogio M ...... 108 .5 ...... OR98 DellaLana K ...... PP-131 Cornuz J ...... PP-071 Dello Russo A ...... 88 .2 Corsi D ...... OR83 Deluigi C ...... 26 .3 Corti R ...... OR21, OR55, PP-043, Demertzis S . . . . 17 .4, 61 2,. OR10, ...... PP-044, PP-051 ...... OR83, PP-001, PP-005 Coscolla M ...... 48 .1 Derkenne M -F...... PP-160 Costa L ...... PP-126 Descombes S P...... PP-154 Costan C ...... 83 .1 Dhinoja M ...... PP-023 Cowie M ...... 81 3. Di Bernardo S ...... PP-048 Crestani B ...... 27 Di Valentino M ...... OR11 Crisinel V ...... OR14 Diaz-Cañestro C ...... OR18 Crook S ...... OR35 Dieterle T .. . PP-136, PP-137, PP-139 Crowley S ...... OR32 Diethelm P . . . . 30 .1, PP-181, PP-188 Csordas A ...... OR47, OR49 Dietrich P ...... 86 .2, PP-013 Cuculi F . . . . . 18 .3, PP-043, PP-055, Distler O ...... OR62 ...... PP-057, PP-065 Dominichini G ...... 87 .3 Dovifat C ...... OR80 Daccord C ...... OR64 Doytcheva P ...... OR67 DallaLana K . . . . . PP-122, PP-123 Drexel H . . . OR09, PP-067, PP-068, Dallèves F ...... PP-002 ...... PP-073, PP-075, PP-078, D’Ambrosio G ...... OR91 ...... PP-079, PP-080 Dang L ...... OR15, PP-028 Duchna H -W...... PP-153 Dave H ...... PP-100 Dufrane D ...... PP-006 Davies J .C ...... 115 .2, 115 3. Dupuis E ...... PP-124 Dayal N ...... 16 2. Durham A ...... PP-173 De Blois J ...... PP-091 Duru F . . . PP-014, PP-021, PP-034,

134 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

...... PP-042, PP-099 Fechter M ...... OR73 Dzemali O . . . . 35 .1, OR82, OR84, Feki A ...... PP-167 ...... PP-109 Fellmann F ...... OR72 Fellrath J ...... 95 Earley M ...... PP-023 Ferrari E . . . . OR10, OR83, PP-045 Eberle B ...... PP-038 Ferretti G ...... PP-162, PP-163 Eberli F . . . . . 73 .4, 109 2,. PP-062 Filippi S ...... PP-151 Eckstein F . . . . . 82 .2, OR51, OR80, Fink T ...... OR03 ...... PP-041, PP-064 Fischer R ...... 97 Eckstein J ...... OR12 Fischer T ...... OR73 Eeckhout E . . . . 23 .1, 23 .5, PP-011 Fischer U ...... 35 .1 Egger B . . . . 59 .1, 59 .2, 59 .5, 104 .2 Fitting J -W...... OR64 Egli A ...... PP-126, PP-136, Flamm A .-L ...... PP-139 ...... PP-175 Flammer A . J ...... OR25, PP-049 Egloff M ...... PP-071 Flueck D ...... PP-128 Ehl N ...... PP-103 Fodstad H ...... OR72 El Khoury G ...... PP-040 Foell A ...... PP-057 Elisabeth H D...... PP-161 Fontolliet T ...... PP-162 Ellenberger C . . . . . PP-036, PP-107 Fournier A ...... PP-011 Emmert M Y...... OR85 Fournier S ...... PP-011 Emmisberger D ...... 20 Franciosi G ...... OR83, PP-005 Emrich F ...... 5 .2 Frangieh A ...... OR47, PP-081 Engel R ...... OR59 Franzen D . . . . . 59 .1, 59 4,. 59 .5, 59 .6 Englberger L ...... OR87, PP-035, Franzen D .P ...... PP-131, PP-184, ...... PP-038, PP-060 ...... PP-185 Engler A ...... PP-127, PP-143 Frauchiger B ...... PP-071 Enseleit F ...... OR25 Frauenfelder T .. . . . PP-093, PP-170 Erdös G ...... PP-035 Fraunberger P ...... OR09 Erhart L ...... OR24, PP-093 Frei A ...... PP-036, PP-046 Erne P . . . . OR21, PP-054, PP-061, Frei A ...... OR35 ...... PP-062 Frei R ...... PP-175 Eser P ...... PP-072 Freitag L ...... PP-182, PP-185 Eugster W ...... PP-020 Freund T ...... PP-020 Ewert P ...... 103 1,110. 2. Frey M ...... 104 1,. OR36, PP-136, ...... PP-137, PP-147 Faletra F ...... 1 .3, 4 1. Frey S ...... OR89 Falk V ...... PP-003 Friede T ...... OR95 Fan Chung K ...... 107 .2 Fröhlich G .M ...... PP-049 Farine E ...... PP-007 Früh M ...... PP-177 Fassa A ...... 3 .4 Fuchs D ...... OR47 Fassl J ...... OR51, PP-064 Fuchs T .A ...... OR28 Fau S ...... PP-113 Fuhrer J ...... OR01, OR17, OR89, Favre S ...... OR19 ...... PP-114

135 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Fuhrer J . . . . . OR92, OR93, PP-002 Gianella P . . PP-116, PP-162, PP-186 Funke M ...... OR43, PP-154 Gianello P ...... PP-006 Funke-Chambour M ...... 27 Giannakopoulos G . . PP-046, PP-101 Fürholz M ...... OR45 Gimenez M . R ...... 123 .2 Furian M . . . . . OR33, OR61, PP-119, Giostra E ...... OR76 . . . PP-121, PP-128, PP-132, PP-161 Glanzmann M ...... PP-003 Furrer K ...... OR63,PP-174 Gloekler S ...... OR45 Furrer M ...... PP-176 Gobbato S ...... PP-010 Furrer M ...... 90 .4 Goeber V ...... PP-035 Gonzalez M ...... 61 3,. PP-180 Gabor M ...... OR80 Goutaki M ...... OR32 Gaemperli O ...... OR21, PP-044, Goy J .-J ...... OR98 ...... PP-081 Graf D ...... OR13, OR70, OR90 Gahl B ...... OR87, PP-035, Grande B ...... PP-184 ...... PP-060, PP-095 Gräni C . . . . . OR28, OR96, PP-097 Gaisl T ...... PP-127, PP-130, Grapow M .. . . OR51, PP-041, PP-064 ...... PP-141, PP-143 Graves K ...... OR82, OR84 Gallino A ...... OR11 Grego S ...... OR10 Gandjbakhch E ...... OR22 Gregoriano C ...... PP-139 Ganière V ...... 89 .1, 98 4. Grendelmeier P . . . . . PP-118, PP-160 Garcia Gomez D ...... PP-143 Greutmann M .. . . OR24, OR28, OR31, García-Gómez D ...... PP-130 . . .OR59, . PP-084, PP-085, PP-089, Garelli V ...... OR64 . . . PP-090, PP-094, PP-098, PP-102 Gariani J . . . PP-166, PP-168, PP-171 Greutmann-Yantiri M . . . . PP-089 Gasche Soccal P ...... 119 1. Griese M ...... 100 .1 Gaugg M .T . . . . . PP-127, PP-130, Grize L ...... PP-150 ...... PP-143 Gronchi F ...... OR52 Gaveikaite V ...... PP-122 Grossenbacher R ...... OR71 Gazdhar A . . . . OR41, PP-167, PP-172 Gruenenfelder J ...... PP-044 Geiger J .. . . . OR27, OR29, PP-087 Grünenfelder J . . . . . OR21, OR55, Geiser T . . . . . 60 .1, 60 .3, OR41, OR43, ...... PP-043, PP-045 ...... PP-146, PP-154, PP-167, Gruner C ...... OR24, PP-084, ...... PP-172 ...... PP-085, PP-094 Geisler T ...... 23 .4 Gruszczynski M ...... PP-109 Gencer B . . . . 21 .3, 45 .4, OR07, OR08, Gsponer M ...... 104 .1 ...... OR66, PP-063 Gubler C ...... PP-089 Genoni M ...... OR82, OR84, Gubler J ...... OR73 ...... OR85, PP-109 Guedj N ...... OR26 Gerhard D ...... PP-125 Guenat F ...... PP-011 Gex G ...... PP-104 Guerra A ...... OR11 Ghadri J ...... 21 .2 Gugler Y ...... OR89 Gharaviri A ...... PP-019 Guigard S ...... PP-179 Giacalone G ...... OR18 Guinand A ...... PP-101

136 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Guiot Y ...... PP-006 Heinzer R ...... 19, 81 .1 Gulan U ...... PP-034 Held L . . . . . OR24, PP-049, PP-063 Guler S ...... OR43 Henny S ...... PP-136, PP-137 Gürtler M ...... PP-142 Henny-Reinalter S ...... PP-139 Herold V ...... PP-088 Haager P ...... 106 1. Hersberger K E...... PP-139 Haarman E ...... OR32 Herve P ...... 109 .3 Häberlin A ...... PP-002, PP-114 Hervé P ...... PP-163 Habre C ...... PP-166 Herzog B ...... 109 .1 Hachulla A .-L . . . . . OR77, PP-036, Hess T ...... PP-131, PP-151 ...... PP-107, PP-165, PP-166, Hibaoui Y ...... PP-167 ...... PP-168, PP-171 Hiebinger A ...... PP-178 Haeberlin A . . . . OR01, OR17, OR89, Hinchliffe D ...... OR64 ...... OR92, OR93, PP-140 Hirt-Moch B ...... OR28 Haegeli L ...... PP-021, PP-099 Hofer M ...... PP-151 Haeussler A ...... OR84 Hoffelner L ...... OR57 Hafen G ...... 107 1. Höffinghaus T ...... 2 .4 Hagenbuch N . . . . . OR24, PP-049, Hoksch B ...... 29 ...... PP-063 Holm N ...... PP-027 Hagl C ...... OR78, PP-110 Holy E ...... PP-081 Halbeisen F ...... OR32 Holy E W...... OR49, OR53, OR56, Halter J ...... OR63, OR68, PP-159, ...... OR57, PP-003 ...... PP-174 Holzner M ...... PP-034 Hamada S ...... PP-093 Hörner M ...... PP-134 Hamm C ...... OR47 Horvath C .M . . . . . PP-138, PP-155 Hammer J ...... 28,76 3. Hosseinpour A .-R . . . . PP-108, PP-117 Hartmann S E. . .OR33, OR61, PP-128 Hostettler K . . . . . 8, OR63, PP-174 Hasler D ...... PP-037 Hostettler K .E ...... OR41 Hasler E ...... PP-119 Howard L ...... 57 .3 Hasler E .D ...... PP-132 Hradetzky D ...... PP-172 Hässig G ...... PP-176 Huber C ...... 106 .2, OR74, OR87, Hastrup Svendsen J ...... OR95 . . PP-035, PP-038, PP-045, PP-060 Hayashi K ...... OR03 Huber L ...... 107 .4, 115 .3 Haynes A ...... PP-120 Huber L .C ...... OR62 Hayoz D ...... 22 Hübler M ...... 110 3,. OR81, PP-100 Heeger C ...... OR03 Huebner T ...... OR12 Heg D ...... PP-063 Hugli O ...... OR48 Heg D ...... OR08 Hullin R ...... OR23, OR44, OR48, Heg D ...... PP-045 ...... OR52, OR76, PP-008, Heijnen I ...... PP-136 ...... PP-047, PP-108, PP-117 Heim P ...... PP-009 Humbert M ...... 43 .1, 80 .4 Heinisch P ...... 13 .2 Humpl T ...... PP-157 Heinisch P . P . . . OR74, OR87, PP-033 Hunter R ...... PP-023

137 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Hürlimann D ...... 89 .3, OR55 Kamani C ...... 91 .3 Husmann M ...... PP-071 Kampf T ...... PP-088 Hutter D . . . . . 94, OR65, PP-069, Karadag B ...... OR32 ...... PP-082, PP-095, PP-096, Karenovics W ...... 9, PP-179 ...... PP-169 Kaufmann B ...... 34 .3 Kaufmann B .A ...... OR24 Iglesias J .-F ...... PP-011 Kaufmann P .A . .OR28, OR53, PP-097 Imbach S ...... PP-013 Kayser T ...... OR88 Inci I ...... 96 Keim C ...... 70 .4 Irani S . . . . OR36, PP-136, PP-137 Kellenberger C .J ...... OR27, OR29, Iung B ...... 43 .2 ...... PP-087, PP-090 Ivy D ...... PP-157 Keller D ...... OR64 Keller S ...... OR18, PP-003 Jaeger R ...... PP-062 Kellerhals C ...... OR96 Jahn K ...... PP-118, PP-175 Kern L ...... 9 Jahren S . E . . . OR89, PP-033, PP-037 Kettelhack F ...... 76 .3 Jamshidi P .. . . OR21, PP-043, PP-051, Keusch S ...... OR35, PP-161 ...... PP-055, PP-057, PP-065 Khan P ...... OR41 Janssens J . P ...... PP-124 Kherad O ...... PP-113 Janssens J .P ...... 34 2. Kim W .-K ...... OR47 Jeanrenaud X ...... OR14, PP-052 Kinz E ...... OR09 Jeger R . . . . . OR21, OR94, PP-045, Kirsch M ...... PP-017 ...... PP-051 Kirsch M ...... PP-040, PP-076, Jegerlehner S ...... PP-154 ...... PP-106, PP-108, PP-117 Jelusic D ...... OR35 Kirsch M ...... 2 .5 Jenni H .J ...... 70 2. Klein H ...... PP-182 Jenni R ...... OR24, PP-093 Klersy C ...... OR21, OR91 Joerg L ...... PP-103 Klingenberg R .. . . . OR08, PP-063, Jolou J ...... OR77 ...... PP-071 Jordan F ...... OR46, PP-032 Knecht S . . . . OR02, OR04, OR06, Jörger M ...... PP-177 . . . . OR94, PP-025, PP-030, PP-031 Jossen J ...... PP-138 Kobza R .. . . . 16 .5, PP-043, PP-051, Jost K ...... PP-140 ...... PP-055, PP-057 Jung A ...... 76 .7, PP-151 Koerner-Rettberg C ...... OR32 Jüni P ...... OR08, PP-120 Kohler M . . . . OR36, PP-127, PP-128, Junker L . . . . OR63, PP-174, PP-175 . . .PP-130, PP-131, PP-133, PP-141, . . .PP-143, PP-170, PP-184, PP-185 Kadner A .. . . OR87, PP-060, PP-069, Kohler M ...... PP-136, PP-137 ...... PP-095, PP-096 Kohler M ...... 45 .2, 60 .3, 116 .1, Kaelin R .M . . . . . PP-181, PP-188 ...... 116 4,. 116 .5 Kaiser C ...... OR94 Kolbe M ...... PP-184 Kallol S ...... PP-167 Koller M ...... PP-029 Kalman J .M ...... OR22 Kopp G ...... PP-165

138 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Kopp S ...... PP-020 Latshang T ...... 47 .4 Koskinas K .K . . OR45, OR97, PP-058 Latshang T .D ...... OR33, PP-121, Kostikas K ...... OR37, PP-126 ...... PP-128 Koutsokera A . . . . . OR64, PP-160, Latzin P ...... OR32, PP-159 ...... PP-180 Laurent M ...... PP-168 Kovacs A ...... OR100, PP-086 Laurent S ...... OR69 Kozhuharov N ...... OR50 Laures M ...... 47 .1 Kraemer R ...... PP-142 Lauriers N ...... PP-011 Krähenmann F ...... PP-102 Lawi D ...... PP-113 Krause R ...... PP-019 Lazdinyte S . .OR63, PP-174, PP-178 Kretschmar O ...... 121 .2, OR81 Lazor R ...... 8, PP-104, PP-152 Kriech S ...... PP-184 Lebboukh S ...... PP-009 Kröger Y ...... 70 5. Leclercq C ...... OR88 Krueger T ...... PP-180 Lehbert N ...... OR35 Krüger T ...... 46 .3 Leiherer A ...... OR09, PP-067, Kucher N ...... PP-071 ...... PP-068, PP-073, PP-075, Kuck K .-H . . . . OR03, OR05, PP-018 ...... PP-078, PP-079, PP-080 Kuehne M ...... PP-031 Lemes C ...... OR03, OR05 Kuehni C ...... 100 .3, OR32 Lenoir A ...... OR64, PP-152 Kühne M ...... 71 .3, 87 .4, OR02, Leonardi L ...... OR12 ...... OR04, OR06, OR12, OR94, Lerch R ...... 21 .1 ...... PP-025, PP-029, PP-030 Lesche D ...... PP-039 Kullak-Ublick G .A ...... OR18 Leslie N ...... OR64 Külling J ...... OR55 Letovanec I ...... PP-104, PP-152 Külling M ...... OR55 Leuppi J .. . . . 90 .3, OR36, PP-136, Kumar S ...... OR22 ...... PP-137, PP-139 Kurmann R ...... OR71 Liaudet L ...... PP-117 Lichtblau M . . . . OR33, OR61, OR62, Lacoma A ...... OR37, PP-126 ...... PP-121 Lador F ...... 80 .1, OR77, PP-113, Licker M . . . . OR77, PP-036, PP-179 ...... PP-116, PP-162, PP-163, Licker M .-J ...... PP-113 ...... PP-165, PP-166, PP-168, Liebert-Keller Y ...... 83 .3 ...... PP-171, PP-186, PP-187 Liebert-Keller Y ...... OR58 Lahzami S ...... OR64 Liebetrau C ...... OR47 Lakdawala N ...... OR22 Liechti N ...... OR64 Lam A . . .. OR01, OR17, OR89, OR92, Limacher A ...... PP-071 ...... OR93, PP-002, PP-114 Limoni C ...... OR11 Lämmle B ...... PP-071 Lionetti V ...... PP-001 Landmesser U ...... 23 .3, 39 .2 Lisa H ...... OR56 Langhammer B . . . . PP-038, PP-095 Liu L ...... PP-164 Lardinois D . . . . 122 .4, OR41, OR63, Loeblein H ...... OR84 ...... PP-174, PP-178 Lofaso F .. . . PP-144, PP-148, PP-149 Latsang T ...... OR61 Longnus S ...... PP-007

139 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Lopes S ...... 11 .4 Marcucci C ...... OR52 Louis R ...... OR37, PP-126 Mariotti S ...... OR82 Loup O ...... 103 .1, PP-096 Markun S . . PP-122, PP-123, PP-131 Lovis A . . 24 .4, OR64, PP-173, PP-180 Marsland B ...... OR40 Lu S ...... PP-164 Martin D ...... PP-008 Lubinski A ...... OR95 Martin N ...... 118 1,. 118 .2 Luca A ...... PP-016 Martin S ...... PP-166 Lucas J ...... OR32 Martinelli M ...... 2 .7 Lücker L ...... PP-166 Martinez-Lozano Sinues P . . PP-127, Lücker L .M ...... PP-187 ...... PP-130 Luescher T ...... OR49 Maschler I ...... 76 .1 Lüscher T . . . . . OR08, OR47, OR67, Masci P ...... OR54 ...... PP-010, PP-014 Masci P .-G ...... PP-091 Lüscher T .F . . . 23 .2, 58 .1, 58 .5, 108 1,. Maseli A ...... OR12 . . . OR07, OR18, OR56, OR57, OR97, Mathew S ...... OR03 . . .PP-003, PP-012, PP-063, PP-081, Matt P ...... OR80, PP-041, PP-064 ...... PP-085, PP-090, PP-094 Matter C .M . . . . . OR07, OR08, OR97, ...... PP-063, PP-071 Maack C ...... 38 .2 Matter-Ensner S ...... OR82 Mach F ...... 15 .2, 58 .3, 71 .1, 71 2,. Maurer D ...... PP-028, PP-050 . . . . .71 .5, 74 .1, 74 .2, OR07, OR08, Maurer E ...... OR32 ...... OR66, PP-012, PP-063 Maurer T ...... OR03, PP-018 Macintyre C ...... OR22 Mauri P ...... PP-001 Mader A . . . OR09, PP-067, PP-068, Mauri R ...... PP-026 ...... PP-073, PP-075, PP-078, Maury P ...... OR22 ...... PP-079, PP-080 Mazurek H ...... OR32 Maeder M ...... 81 2. Mazza-Stalder J ...... PP-152 Maeder M .T ...... PP-020, PP-103 McLeod C ...... PP-098 Maggiorini M ...... 24 .1 McLeod C ...... PP-083 Magyar I ...... PP-042 Méan M ...... PP-071 Maier S ...... PP-139 Medeiros Domingo A ...... OR01, Maier W ...... OR47, PP-081 ...... OR17, PP-042 Maire R ...... PP-013 Medeiros-Domingo A . . OR89, OR92, Maisano F . . . . . OR21, OR47, OR49, . . . . . OR93, OR96, PP-002, PP-114 . . .OR53, OR56, OR57, OR85, OR86, Meier B ...... OR45 . . . PP-003, PP-044, PP-045, PP-182 Meier C ...... OR66 Makki M ...... PP-087 Meister T . . . PP-004, PP-066, PP-070 Malla B ...... PP-126 Melly L ...... PP-064 Mandal J . . . . . OR38, OR39, PP-126, Menafoglio A ...... 75 ...... PP-164 Méndez N ...... PP-007 Manka R ...... PP-081, PP-093 Merkely B ...... OR95 Manzoni R ...... OR64 Merz T ...... PP-156 Marcucci C ...... PP-117 Messerli F ...... OR69

140 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Métrailler I . R ...... 100 4. Mueller H ...... PP-036 Metrich M ...... PP-008 Mueller-Mottet S ...... PP-128 Metzner A .. . . OR03, OR05, PP-018 Mühl A . . . . . OR02, OR04, OR06, Meyer A ...... PP-145, PP-159 ...... OR94, PP-025, PP-030 Meyer P ...... OR44, OR48, OR76, Müller A .S ...... PP-027 ...... PP-047 Müller C . .. 58 .4, 111 .1, OR50, OR99 Michaud K ...... OR96 Müller H . . . . 82 .1, PP-046, PP-101, Michelitsch C ...... PP-176 ...... PP-105, PP-107 Mihalj M ...... OR74 Muller O . . . . . OR07, OR21, PP-011 Mikulicic F ...... OR28, PP-097 Müller O ...... 3 .3 Milano G ...... OR19, PP-001 Müller S ...... 114 Milenkovic B ...... OR37, PP-126 Müller-Burri A ...... 75 Minder S ...... PP-142 Müller-Mottet S ...... PP-161 Mirrakhimov E ...... OR61 Mündlein A ...... OR09 M-L Sinues P ...... PP-143 Muralt L ...... PP-121 Moccetti M ...... PP-051, PP-062 Mury R ...... PP-055 Moccetti T .. . . OR21, OR91, PP-001, Muschietti S ...... PP-026 . . . PP-015, PP-022, PP-026, PP-062 Muzzarelli S ...... 17 .2 Mock S ...... PP-105 Myers P ...... OR26, OR77, PP-056, Moersig W ...... PP-178 ...... PP-111, PP-112 Mohacsi P ...... PP-039 Mytsyk M ...... PP-041 Molino A ...... PP-164 Möller A ...... 115 1. Naegele M ...... 2 .1, 26 .1, OR25 Möllmann H ...... OR47 Naegeli B . . . . OR21, PP-028, PP-050 Monney P . . . . 1 .5, 4 .4, OR14, OR54, Namasivayam J ...... PP-040 ...... PP-052, PP-091 Nanchen D . . . . OR07, OR08, PP-063 Montecucco F ...... OR08, OR66, Nauwerk M ...... PP-069 ...... PP-012 Nebiker C ...... OR63, PP-174 Montet X ...... PP-166, PP-168, Neri D ...... 58 .2 ...... PP-171, PP-186 Nett P ...... PP-138 Montrasio G ...... 86 .1 Nguyen D . L ...... OR53, OR56 Mootoosamy P . . . . . PP-056, PP-112 Nguyen T . D . L ...... PP-093 Morandi C ...... PP-009 Nguyen-Kim T . D . L ...... OR57 Moreillon P ...... 35 .1 Niclauss L ...... PP-017, PP-106 Morgan L ...... OR32 Nicod L . . . . . 10 4,. 60 3,. OR40, OR64, Moschovitis A ...... OR45, OR97 ...... PP-160, PP-173, PP-180 Moser C ...... OR42 Niederberger P ...... PP-007 Moses Passini C ...... OR70 Niederhauser T ...... PP-140 Most H ...... OR87, PP-060 Niedermann J ...... OR60 Mouraux S ...... OR40 Niederseer D ...... PP-074 Muehl A ...... PP-031 Nielsen K ...... OR32 Mueller A ...... PP-013 Niemann M .. . . OR24, OR53, PP-092 Mueller C ...... OR78, PP-110 Nietlispach F .. . . OR45, OR47, OR49,

141 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

...... OR53, OR56, OR57, PP-045 Pallivathukal S ...... PP-096 Noble S . . . . . 3 .1, 82 .2, OR21, OR77, Panos A ...... PP-056 ...... OR97, PP-036, PP-045, Papa M ...... PP-015 ...... PP-046, PP-113, PP-116, Papachristofilou A ...... 99 .2 ...... PP-163, PP-165, PP-168 Papakonstantinou E . . . . OR34, OR37, Noirez L ...... PP-104 ...... OR38, OR39 Noll G ...... 25, OR55 Park C -I...... PP-048 Nöthiger C .B ...... PP-184 Pascale P ...... OR14, OR16, Noti F . . . . OR01, OR17, OR89, OR92, ...... PP-016, PP-048 ...... OR93, PP-002, PP-114 Pasche A ...... OR64 Nowacka A ...... PP-117 Passweg J ...... PP-159 Nussbaumer-Ochsner Y . . . . . PP-127, Paul M ...... 2 .9 ...... PP-130, PP-143 Pavlov N ...... PP-120 Nyilas S ...... PP-159 Pavlovic M ...... PP-096 Pavlovic N ...... PP-025 Obeid S . . . . . OR49, OR57, PP-081 Pazhenkottil A .P ...... PP-092 Obrist D .. . . OR89, PP-033, PP-037 Pedrazzini G ...... 92 .2 Odavic D ...... OR84 Pedrazzini G B...... OR21, OR97, Odermatt R ...... 37 .3 ...... PP-051, PP-054, PP-062 Oechslin E ...... OR100, PP-086 Pellaton C ...... OR54 Ogna A . . . . OR64, PP-104, PP-144, Pentassuglia L ...... PP-009 ...... PP-148, PP-149 Pepperell J .C ...... PP-141 Omerovic M ...... 37 .4 Perentes Y ...... PP-180 Opitz I ...... PP-170, PP-182 Perez Valdes C .R ...... PP-104 Orlikowski D ...... PP-144, PP-148, Perret Bakhouy S ...... OR64 ...... PP-149 Perrin N ...... OR13, PP-036 Osmonov B ...... PP-128 Peter J ...... PP-013 Osswald S . . . . . OR02, OR04, OR06, Peterhans J ...... PP-072 ...... OR50, OR94, OR99, PP-025, Petitpierre N ...... OR64 ...... PP-029, PP-030, PP-031 Petri-Fink A ...... PP-129 Osterwalder J ...... PP-071 Pfammatter J .-P ...... PP-069, Osto E ...... OR67 ...... PP-096, PP-169 Ott S ...... 72 .1, 72 4. Pfammatter T . . . . PP-089, PP-170 Ott S . R ...... PP-120, PP-138, Pfeffer M ...... 15 .3 ...... PP-146, PP-155 Pfimlin E ...... PP-118 Ouyang F .. . . . OR03, OR05, PP-018 Pfister M ...... PP-135 Oxenius A ...... OR59, PP-085, Pfister O . . 90 .1, OR46, OR68, PP-032 ...... PP-090, PP-094 Pfister R ...... PP-017 Özkartal T ...... PP-049 Piccini D ...... OR44 Ozsahin M ...... PP-173 Pichler Hefti J .. . . . PP-146, PP-156 Pichlmaier M . . . . . OR78, PP-110 Pache J .-C ...... PP-166 Pichot V ...... PP-162 Padrutt M ...... PP-085, PP-094 Pilgrim T . .18 .1, OR45, PP-043, PP-054

142 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Plass A ...... OR85, OR86 Reho I ...... OR55 Plojoux J ...... PP-187 Reibnegger G ...... OR47 Pohle S ...... PP-158 Reichlin T . . . 16 .1, 88 .1, OR02, OR04, Ponti A ...... PP-076 . .OR06, OR50, OR94, OR99, PP-025, Porretta A P...... OR11, PP-048 ...... PP-029, PP-030, PP-031 Possner M ...... OR28, OR53 Rein P . . . . OR09, PP-067, PP-068, Potse M ...... PP-019 ...... PP-073, PP-075, PP-078, Poulin M ...... OR33, PP-128 ...... PP-079, PP-080 Pradella M ...... OR06 Reineke D ...... OR87, PP-035 Praxmarer V ...... PP-057 Reineke D ...... PP-060 Praz F ...... OR74 Reiner M ...... PP-010 Praz F ...... OR21, PP-051 Reiner M . F .F ...... OR18, PP-003 Prella M ...... OR64 Reist A ...... PP-095 Pretre R ...... OR52 Rentsch K ...... PP-126 Prêtre R ...... 103 .2, 121 3,. OR76, Reser D ...... OR86 . . . PP-006, PP-017, PP-040, PP-076, Reutebuch O ...... PP-041 ...... PP-106, PP-108, PP-117 Reuthebuch O . 105. .3, OR51, PP-064 Prigent H . . PP-144, PP-148, PP-149 Rexhaj E . . . OR65, PP-004, PP-066, Prior J ...... PP-048 ...... PP-070,PP-082 . Probst-Hensch N ...... 45 .3 Rey F ...... OR75 Pruvot E . . . .44 .3, 88 .1, OR14, OR16, Richard P ...... OR22 . . . . .OR88, OR90, PP-016, PP-048 Richards D ...... OR70 Puhan M . . . . . 91 .2, OR35, PP-122 Rickli H ...... 82 .3, 108 1,. PP-020, Puricel S ...... OR13, OR98 ...... PP-061, PP-062 Puyal J P...... OR19 Riedl K .A ...... PP-088 Riesen W .F ...... 39 .3 Quera Salva M . A ...... PP-148 Rigamonti F ...... OR75, PP-112 Rigger J ...... PP-020 Raab A ...... 113 Righini M ...... 105 .1, PP-071 Räber L . . . 123 .6, OR08, OR45, OR97, Rimoldi S . . . . . 24 .2, OR65, OR69, . . . PP-039, PP-045, PP-058, PP-063 ...... PP-066 Raccanello O ...... OR70 Rimoldi S .F . . . . . PP-004, PP-070, Radovanovic D . . . . . PP-054, PP-061, ...... PP-082 ...... PP-062 Rindlisbacher B ...... OR43 Radtke T ...... OR35 Ris H B...... 92 .4 Rajo L ...... PP-069 Ritz C ...... PP-125 Rakic J ...... OR34, OR37 Robl J ...... 83 .1 Rassouli F ...... 26 .4, PP-135 Rochat I ...... 76 .4, 94, 100 .2 Reek S ...... 16 .3, 87 1. Rodondi N .. . . . OR07, OR08, PP-063, Regamey J ...... OR23, PP-047 ...... PP-071 Regoli F . . . . OR91, PP-015, PP-022, Rodriguez H ...... OR85 ...... PP-026 Roffi M . . . . . 3 .2, 43 3,. OR79, OR97, Regoli F ...... 89 .4 ...... PP-036, PP-045, PP-062

143 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Rogge C ...... PP-039 ...... PP-073, PP-075, PP-078, Rohde G .G ...... OR37, PP-126 ...... PP-079, PP-080 Rohrmann S ...... PP-061 Salzberger S ...... OR55 Rolin A ...... OR22 Samaja M ...... OR19 Roos G ...... 71 4. Santamaria F ...... OR32 Roost E . . . . OR87, PP-035, PP-038, Santoro F ...... OR03, OR05 ...... PP-060 Santos G ...... OR70 Rosemann T ...... PP-123 Santos Lopes B . . . . . PP-084, PP-085, Roten L . . OR01, OR17, OR89, OR92, ...... PP-089, PP-090, PP-094 . . . . OR93, PP-002, PP-016, PP-114 Sartori C ...... 38 .1, OR65, PP-004, Roth M ...... OR34, OR38, OR39, ...... PP-066, PP-070 ...... OR41, PP-126, PP-164 Satkauskas S ...... PP-172 Rothe T ...... PP-150 Sauty A ...... 97 Rothen-Rutishauser B . . . . . PP-129 Savarese G ...... PP-003 Rotman S ...... OR44, PP-152 Savic S ...... OR38, OR41, OR63, Roumy A ...... PP-106, PP-108 ...... PP-159, PP-174 Roussianos M .-O ...... OR72 Savoldelli G ...... PP-113 Rovina L ...... PP-082 Sawhney V ...... PP-023 Rovina L ...... OR65, PP-069 Saxer S . . . . OR62, PP-119, PP-132, Rubbia-Brandt L ...... OR76 ...... PP-161 Ruchonnet-Metrailler I . . 76 .5, 100 4. Schaer B . . . . . OR02, OR04, OR95, Rücker B ...... OR27, OR29, OR30 ...... PP-024, PP-025, PP-029, Rüdiger J ...... 81 4...... PP-030, PP-053, PP-077 Ruecker B ...... PP-087 Schäfer M ...... OR16 Rueter F ...... PP-064 Schäfer-Keller P ...... OR70 Rümmler S ...... OR46, PP-032 Schaller A ...... PP-002 Ruschitzka F . . . . . 15 .1, 74 .1, 74 .2, Scharf C ...... OR15, PP-028, ...... 87 .5, 87 .6, OR25, PP-049 ...... PP-050 Rüschoff J . H ...... PP-100 Scharfe M ...... OR95 Russi I ...... PP-055, PP-057 Schaub Clerigué A ...... PP-012 Rutz T ...... OR54, OR59, PP-091, Scheiwiller P .M ...... PP-128 ...... PP-115, PP-117 Schenker N ...... OR03 Ruzgys P ...... PP-172 Scherr A . . . . OR34, OR37, PP-145 Scherrer U ...... OR65, PP-004, Sabti Z . . . . OR50, PP-055, PP-057 ...... PP-066, PP-070, PP-082 Sacher F ...... OR22 Schilling R ...... PP-023 Saguner A ...... OR05, PP-014, Schläpfer J ...... 75, PP-048 . . .PP-018, PP-021, PP-034, PP-042 Schlager O ...... PP-071 Saguner A .M ...... OR03, OR96 Schläpfer J ...... OR14, OR72 Said R ...... PP-092 Schlatzer C ...... PP-141 Salfeld P ...... 76 6. Schlotter S ...... PP-135 Salomon J ...... PP-142 Schmiady M ...... 103 2,. OR81 Säly C .H . . . OR09, PP-067, PP-068, Schmiady M O...... PP-100

144 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Schmid J P...... 104 3. Schwitz F ...... 11 .1, PP-090 Schmid-Grendelmeier P .. . . PP-185 Seeck A ...... OR12 Schmidhauser M ...... PP-047 Seeliger T . . . OR59, PP-085, PP-090, Schmidlin J ...... PP-145 ...... PP-094 Schmid-Mohler G ...... 37 .3 Seif V ...... PP-150 Schmidt C ...... 91 1. Seifert B ...... PP-054 Schmidt G ...... OR95 Seiler C ...... OR69, OR71 Schmied C .M ...... OR96 Seiler J . . . . 98 .1, OR01, OR17, OR89, Schmied C ...... PP-074 ...... OR92, OR93, PP-002, Schmitt-Opitz I ...... 46 .1 ...... PP-114 Schnegg B ...... PP-072 Sekarski N ...... OR76 Schneider I ...... PP-020 Sellal J .-M ...... OR22 Schneider T ...... PP-183 Semerano A ...... OR18 Schneiter D ...... PP-182 Servatius H . . . . . OR01, OR17, OR89, Schnepp W ...... OR20 ...... OR92, OR93 Schober W ...... 30 .2 Servatius H S...... PP-002 Schoch O ...... 46 .2 Servatus H ...... PP-114 Schoch O .D ...... OR60 Sessa M ...... OR18 Schoenhoff F . . . . PP-060, PP-095 Shah D ...... 110 .1 Schön T ...... OR12 Shah K ...... PP-014 Schönhoff F ...... OR87 Shakir S ...... OR45 Schotten U ...... PP-019 Shrestha S ...... OR50 Schubert T ...... PP-006 Siebenmann R ...... 35 .1 Schukraft S ...... OR98 Siebert S ...... OR15, PP-028 Schuler M ...... OR35 Sierro C ...... OR54 Schultz K ...... OR35 Sievi N .A ...... OR36, PP-133, Schulze M ...... PP-184 ...... PP-136, PP-137 Schulzke S ...... PP-140 Sigrist T ...... 20, 95 Schumacher C ...... OR50 Sigurdardottir V . . . . 2 .8, PP-039 Schumann D ...... OR63, PP-174, Similowski T ...... PP-124 ...... PP-178 Siniscalchi G ...... OR52 Schurr U ...... PP-064 Sipahi N . F ...... OR78, PP-110 Schwarz E .I ...... PP-141 Sitbon O ...... PP-163 Schweiger M . . . 70 .1, OR81, PP-100 Soccal P ...... 119 .1, PP-187 Schwerk N ...... OR32 Soccal P .M . . . . . PP-116, PP-124, Schwery A ...... PP-037 . . PP-160, PP-162, PP-163, PP-165, Schwerzmann M . . . . 121 .1, OR100, ...... PP-166, PP-171, PP-186 ...... OR31, OR59, PP-086, Sohns C ...... OR05 ...... PP-096, PP-098 Sologashvili T . . . . . OR26, PP-111, Schwick N ...... PP-098 ...... PP-112 Schwitter J ...... PP-091 Sommer C ...... PP-176 Schwitter J ...... OR54 Sooronbaev T ...... OR33,PP-121 Schwitter J ...... OR44, PP-115 Soria R . . . . OR65, PP-004, PP-066,

145 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

...... PP-070, PP-082 ...... OR37, OR38, OR39, PP-118, Soronbaev T ...... OR61 ...... PP-126, PP-145, PP-159, Sotiropoulos K . . . . . OR23, OR48 ...... PP-164, PP-175 Spahn D .R ...... PP-184 Stortecky S ...... OR45, PP-037, Speich R ...... OR62, PP-170 ...... PP-038, PP-043, PP-045, Spirig R ...... OR20 ...... PP-051 Sporton S ...... PP-023 Stradling J R...... PP-141 Stadler T .M ...... OR57 Strebel C ...... OR43 Stähli B ...... OR57 Strebel I ...... OR50, OR99 Stähli B . E ...... OR47 Strobel W ...... 19 Stähli B .E ...... OR24, PP-093 Strömberg A ...... OR70 Stambach D . . . . 103 .1, OR28, OR59 Stuber M ...... PP-008 Stamm A ...... OR62 Stuber M ...... OR44 Stämpfli S ...... 2 .6 Stucki A ...... PP-120 Stämpfli S .F . . . OR24, OR53, PP-049, Sudano I ...... 22, 73 2,. OR25 ...... PP-085, PP-094 Sun Q ...... PP-164 Stämpfli S .F ...... PP-003 Sündermann S H...... OR85 Staub D ...... PP-071 Sürder D ...... OR21, PP-051 Stauber A ...... OR31 Suter L ...... PP-140 Stauffer J .C ...... 3 .7 Suter Y . . . PP-127, PP-130, PP-143 Stauffer J .-C ...... OR98 Svab S ...... OR91, PP-015 Stebler N ...... PP-127, PP-130 Svab S ...... 86 .1 Steffel J ...... 87 .2, 92 .1, PP-003, Sztajzel J ...... OR79 ...... PP-098 Steffensen R ...... PP-126 Tamm M ...... 34 .1, 108 1,. OR34, Stehli J ...... OR28 ...... OR37, OR38, OR39, OR41, Steindl K ...... PP-100 . . . .OR63, PP-118, PP-126, PP-145, Steiner A ...... PP-128 ...... PP-164, PP-174, PP-175 Steurer-Stey C . . . . PP-122, PP-123, Tamo L ...... PP-167 ...... PP-131 Taniwaki M ...... OR97 Stevenson W .G ...... OR22 Tanner F ...... 1 .2,10 .3 Stiasny B ...... OR30, OR81 Tanner F .C . . . . . OR24, OR49, OR53, Sticherling C . . . . . 89 .1, 93 .3, 117 5,...... OR56, OR57,PP-049, . . . 117 .6, OR02, OR04, OR06, OR94, ...... PP-092, PP-093 . . . . OR95, PP-016, PP-025, PP-029, Tanner H . . .26 .2, OR01, OR17, OR89, ...... PP-030, PP-031 ...... OR92, OR93, PP-002, Stieltjes B ...... OR06 ...... PP-114 Stivala S ...... PP-010 Taramasso M . . . 106 4,. 123 5,. OR49, Stockinger J ...... OR95 ...... PP-044, PP-045 Stoffel G ...... OR58 Tedrow U B...... OR22 Stöhr S ...... 90 1. Templin C ...... 21 2,. PP-081 Stoller M ...... OR71 Testuz A ...... 2 .2 Stolz D . . . . 10 .2, 119 .3, 119 .4, OR34, Tevaearai H ...... PP-007, PP-095

146 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Tevaearai Stahel H ...... PP-060 Ulrich S ...... OR33, OR61, OR62, Theuns D ...... PP-029 ...... PP-119, PP-121, PP-128, Thoma J ...... 20 ...... PP-132, PP-161, PP-170, Thomet C ...... OR100, PP-086 ...... PP-182 Thomet M ...... PP-140 Ulrich S ...... OR61 Thompson T ...... OR22 Ulrich S ...... 80 .2 Thurnheer R . . . . . OR36, PP-136, Urban P ...... 18 .2, PP-054 ...... PP-137 Urner L ...... PP-128 Tilz R ...... OR03 Tissot C ...... OR26, PP-111 Vachiéry J .L ...... 57 .2 Tobler D .. . . . 11 .2, OR28, OR31, OR59 Valenti A ...... OR64 Toderi M ...... OR11 Valgimigli M ...... 111 .2 Toggweiler S ...... OR21, PP-043, Valiton V ...... OR90 ...... PP-045, PP-051, PP-055, Vallée J .-P ...... PP-168 ...... PP-057 Valsangiacomo Büchel E . . . . . 109 .4 Togni M ...... 92 .3, OR98 Valsangiacomo Büchel E .R . . . . OR27, Torre T ...... OR83, PP-001, PP-005 ...... OR29 Torre T ...... 35 .4 Valsangiacomo Buechel E . . PP-090, Torres A ...... PP-126 ...... PP-102 Torres A ...... OR37 Valsangiacomo Buechel E .R . PP-087 Tozzi P . . . . 70 .3, OR44, OR52, PP-047 Valsangiacomo E R...... OR30 Trachsel D ...... 29 Valsangiacomo-Büchel E .. . . PP-100 Trachsel L ...... 90 .2 van Dijk R . M ...... OR42 Trachsel L .D ...... OR96 Van Gaal L ...... OR67 Tran N ...... OR17, OR89, PP-002, Van Gestel A . . . . . PP-125, PP-134 ...... PP-114 Van Heeswijk R . . . . . OR44, PP-008 Tran V . N ...... OR92, OR93 van Hemelrijck M ...... OR86 Tran V . N ...... OR01 van Holten K ...... OR58 Trendelenburg M ...... PP-136 van Steenberghe M ...... PP-006 Trendlenburg M ...... PP-126 van Steenberghe M ...... PP-106 Triponez F ...... 61 .1, PP-179 Vassalli G . . . . OR19, PP-001, PP-005 Trunfio R ...... OR10 Vasserot K ...... OR70 Tschannen C ...... OR71 Vathie K ...... PP-068 Tschanz S ...... PP-129 Vecchiati A ...... PP-049, PP-093 Tschopp S ...... PP-064 Veit M ...... PP-095, PP-096 Tüller D ...... PP-045 Veragut-Davies B ...... OR79 Tuor P ...... 112 Verheule S ...... PP-019 Turina M ...... 13 .1 Vesin J .-M ...... PP-016 Turk A ...... 104 .4, PP-147 Vetter C ...... 37 .2 Twerenbold R ...... OR94, OR99 Villeneuve H ...... OR70 Vincenti G ...... OR54, PP-091, Uldry C ...... 72 .2 ...... PP-115 Ullah W ...... PP-023 Vital C ...... OR96

147 Abstract Authors Index

Full Name Prog.-No Full Name Prog.-No

Vogel R ...... OR89 Wildhaber B ...... 28 Vogt P ...... OR23 Wilhelm M . . . OR31, OR96, PP-072 Vohra J ...... OR22 Willems R ...... OR95 von Düring A ...... PP-105 Windecker S ...... OR74 von Eckardstein A . . . PP-063, PP-071 Windecker S . . . . . 58 .1, 58 .5, 111 .3, von Garnier C . . . . . 44 .1, 60 .2, 60 3,...... OR07, OR08, OR21, OR45, ...... OR42, PP-129 ...... OR97, PP-037, PP-038, Von Segesser L . K ...... OR11, OR19 ...... PP-039, PP-043, PP-045, Vona M ...... OR70 ...... PP-051, PP-058, PP-063 Vonbank A ...... OR09, PP-067, Winkler B . . . . OR74, OR87, PP-060 ...... PP-068, PP-073, PP-075, Winkler B .M ...... PP-033 ...... PP-078, PP-079, PP-080 Winter P ...... PP-088 Vontobel J ...... 2 .3, 106 .3, OR28, Winterhalder C ...... OR12 ...... OR53 Wirz J ...... PP-033 Vuilleumier N ...... OR08, OR66, Wissner E ...... OR03, PP-018 ...... PP-071 Witassek F ...... PP-061 Vuilliomenet A ...... OR21 Wittmann M ...... OR35 Vuilliomenet H ...... 35 1. Wolber T ...... PP-021 Wolfrum M ...... PP-092 Wahl A ...... OR31, PP-114 Wuerzner G ...... 25 Waintraub X .D ...... OR22 Wunderlin A ...... PP-063 Wannaz L ...... OR26 Wustmann K ...... OR31, OR59, Weber A ...... OR86, PP-038 ...... PP-096, PP-114 Weber D ...... OR73 Wyss C ...... OR55 Weber D ...... PP-029 Wyss C ...... 4 .5 Weber I ...... 83 2. Wyss R ...... PP-007 Weber K ...... OR73 Wyttenbach R ...... OR11 Weber R ...... OR30 Weber S ...... OR12 Xu L ...... PP-009 Weberndoerfer V ...... PP-057 Weder W . . . . 99 .2, PP-170, PP-182 Yamaji K . . OR97, PP-039, PP-058 Weilenmann D ...... PP-103 Yammine S ...... 76 .2 Wein B ...... OR46, PP-032 Yerly P . . . . OR23, OR48, OR52, OR76 Welte T ...... OR37, PP-126 Yerly P ...... 57 .1, 57 .4, 80 .3 Welte T ...... 122 .3 Yiallouros P ...... OR32 Wenaweser P . . . . . OR45, PP-038, ...... PP-045 Zabel M ...... OR95 Wenaweser P ...... 3 .5, 3 .8 Zanchin C ...... PP-039 Wenger Müller P ...... PP-043 Zanolin D ...... PP-067, PP-068, Wey C ...... OR31 ...... PP-073, PP-075, PP-078, Wheeler J ...... PP-157 ...... PP-079, PP-080 Wieser S ...... PP-131 Zaugg S ...... OR97 Wijers S ...... OR95 Zbinden M ...... PP-057 Abstract Authors Index

Full Name Prog.-No

Zbinden R . . . . . PP-013, PP-027 Zbinden S ...... PP-155 Zellweger M . . . . PP-024, PP-053, ...... PP-077 Zellweger M ...... 44 .2 Zenklusen U ...... PP-064 Zenobi R ...... PP-127, PP-130, ...... PP-143 Zeppenfeld K ...... OR22 Ziaki M ...... OR80 Zientara A .. . . OR82, OR84, PP-109 Zientara A ...... 35 .3 Zindel C ...... OR53 Zuber M ...... OR53, PP-092 Zuber M ...... 17 .1 Zuercher F ...... OR14 Zürcher A ...... 86 .2 Zuffi A ...... PP-011 Zuk G ...... OR87 Zuk K ...... OR87 Zünd G ...... 108 4. Zurbuchen A ...... OR89 Zurek M ...... OR46, PP-032

149 Reviewers List

We would like to thank the following abstract reviewers for their generous support (2016)

Peter Ammann, St . Gallen Phillippe Meyer, Geneva Christine Attenhofer, Zürich Yvan Mivelaz, Lausanne John-David Aubert, Lausanne Patrick Monnier, La Chaux-de-Fonds Andrea Banfi, Basel Olivier Muller, Lausanne Constance Barazzone, Geneva Andreas Müller, Zürich Hansjürg Beer, Baden Stefano Muzzarelli, Lugano Stefano Benussi, Zürich Mehdi Namdar, Geneva Seraina Bischoff, Meiringen David Nanchen, Lausanne Cornelia Bläuer, Basel Ernst Niggli, Bern Konrad Bloch, Schaffhausen Stéphane Noble, Geneva Pierro Bonetti, Chur Georg Noll, Zürich Marijke Brink, Basel Fabian Noti, Bern Peter Burger, Bern Patrizio Pascale, Lausanne Stéphane Cook, Fribourg Jean-Pierre Pfammatter, Bern Florim Cuculi, Luzern Otmar Pfister, Basel Stefano de Marchi, Bern Michael Potocki, Dietikon Gabriella De Pasquale, Zürich Lorenz Räber, Bern Stefano Demertzis, Lugano François Regoli, Lugano Werner Deuel, St . Gallen Tobias Reichlin, Basel Omer Dzemali, Zürich Oliver Reuthebuch, Basel Andreas Flammer, Zürich Walter Riesen, Diessenhofen Ezio Foglia, Massagno Thierry Rochat, Geneva Oliver Gaemperli, Zürich Nathalie Rosenblatt, Lausanne Jürg Grünenfelder, Zürich Christian Röthlisberger, Zürich Christiane Gruner, Zürich Tobias Rutz, Lausanne Eva Horvath, Zürich Tiziano Schepis, St . Gallen Christoph Huber, Bern Otto Schoch, St . Gallen Michael Hübler, Zürich Mario Stalder, Bern Roger Hullin, Lausanne Jan Steffel, Zürich Richard James, Geneva Gaby Stoffel, Binz Raban Jeger, Basel Thomas Suter, Bern Beat Kaufmann, Bern Michael Tamm, Basel Roland Klingenberg, Bad Nauheim Cécile Tissot, Geneva Simon Koestner, Morges Daniel Tobler, Basel Martin Kraus, Weinfelden Arnold von Eckardstein, Zürich Gabriela Kuster, Basel Christophe von Garnier, Bern Jacqueline Landolt, Morges Daniel Weilenmann, St . Gallen Marcia Leventhal, Pfeffingen Philipp Weiss, Basel Micha Maeder, St . Gallen Markus Wilhelm, Zürich Hermann Matthias, Wald Kerstin Wustmann, Bern Hansjörg Meier, Zofingen Nicole Zigan, Lauerz Philippe Meyer, Geneva Marianne Zimmerli, Spiegel

150 Publication and Accreditation

Publication Abstracts submitted in the field of Pneumology are published in Respiration – International Journal of Thoracic Medicine . Abstracts submitted in the field of Cardiology and Cardiac Surgery will be published in Cardiovascular Medi- cine, official journal of the Swiss Society of Cardiology, the Swiss Society of Angiology, the Swiss Society of Hypertension and the Swiss Pediatric Cardi- ology Society . Abstracts are published and made available in open access .

Accreditation The scientific programme is accredited by the following societies: • Schweizerische Gesellschaft für Kardiologie (SGK) / Société Suisse de Cardiologie (SSC) 18 Credits • Schweizerische Gesellschaft für Herz- und thorakale Gefässchirurgie (SGHC) / Société Suisse de Chirurgie Cardiaque et Vasculaire Thoracique (SSCC) 20 Credits • Schweizerische Gesellschaft für Pneumologie (SGP) / Société Suisse de Pneumologie (SSP) 16 Credits • Schweizerische Gesellschaft für Thoraxchirurgie (SGT) / Société Suisse de Chirurgie Thoracique (SSCT) 18 Credits • Swiss Cardiovascular Therapists (SCT) 8 Credits

151 Prizes

The following prizes will be distributed during the meeting:

– Swiss Amgen Cardiology Research Award of the SSC (Wednesday, 18:00-18:20) – Medtronic Young Investigators Award 2016 of the SSCS (Wednesday, 15:00-15:30) – Andreas Grüntzig Lecture of the SSC (Wednesday, 17:30-18:00) – Senning Lecture of the SSCS (Wednesday, 14:15-15:00) – Tuberculosis Research Prize of the SSP (Thursday, 12:30-12:45) – Prizes for best submitted abstracts from all 3 societies . The distribution of prizes will take place during the Networking Event on Thursday evening . – Otto Hess Trainee Awards . The distribution of prizes will take place during the Networking Event on Thursday evening .

152 Information for Authors and Speakers

Schedule Speakers are required to respect the time allocated to them within the sessions.

Projection Your presentation (slides) needs to be in English . You can however present in either German, French or English . All speakers are required to hand in their presentation to the Speaker Pre- view on a memory stick . This should happen no later than 2 hours prior to your presentation or the day before for an early morning presentation . This is even more important if your presentation contains movies . You will still have the possibility to preview and edit your presentation at the Speaker Preview .

Posters All posters need to be displayed from Wednesday, June 15, 2016 10:00 to Friday, June 17, 2016 noon . All posters will be visited during one of the poster sessions from 12:15–13:15 or 14:30–15:30 on Thursday, June 16, 2016 . It is mandatory that the pre senting author or one of the co-authors be present during the designated session . IMPORTANT: Posters not removed after 12:00 on Friday, June 17, 2016 will be disposed of. No possibility of retrieval exists. All the necessary material to affix the posters on the panels will be available directly at the posters help desk located at the entrance of the poster area.

153 General Information

Mobile APP The SSC, SSCS and SSP Joint Annual Meeting 2016 Mobile App can be downloaded from the Apple or Android stores for free . Search for SGK 2016 . This year, additional features like voting options for cer- tain sessions and speaker rating will be available .

Congress Venue SwissTech Convention Centre Quartier Nord de l’EPFL Route Louis-Favre 2, 1024 Ecublens Tel . +41 21 693 42 42 Web: www tstcc. .ch

Administrative SSC/SSCS/SSP 2016 c/o MCI Suisse SA Secretariat 75, rue de Lyon, 1211 Geneva 13 Tel . +41 22 33 99 574 Web: www .swisscardio .ch E: sgk@mci-group .com

Registration and Tuesday 16:00–19:00 Speaker Preview Room Wednesday 06:30–19:15 Opening Times Thursday 06:30–17:30 Friday 07:30–15:45

Congress Languages German, French, English . Translation will only be provided in the Nurses session .

Exhibition The Exhibition is located on the Garden Level of the convention centre . Opening hours are as follows: Wednesday 12:30–17:00 Thursday 07:45–18:00 Friday 07:45–15:00

Congress Fees Category Onsite Fee Members SSP/SSTS, SSC/SSCS, associated Societies (physicians) CHF 100 Non-Members (physicians) CHF 150 Junior Members SSC/SSCS, SSP/SSTS, PhDs, students, Members Nursing and allied professions, Members SCT CHF 50 Physicians in training, Non-Member nurses and allied profes sions, Non-Member therapists CHF 60 Faculty, Press – Selected Workshops CHF 30

154 General Information

Congress Documents All the delegate congress material and vouchers for additional services will be available to registered participants at the registration desk on the Cam- pus Level of the SwissTech .

Coffee Breaks Coffee will be served in the exhibition booths .

Lunch Lunch is included in the registration fee and will be served in the exhibition .

Disclaimer The SSC, SSCS and SSP Joint Annual Meeting 2016 hereby provides notice to conference attendees and anyone else, that the congress makes no warranty of any kind whatsoever, expressed or implied, that any information, materials, techniques or products or anything else presented at this conference is accurate, valid, adequate or fit for any purpose whatsoever . Conference attendees are solely responsible for determining the validity, adequacy and fitness of any information, materials or products or anything else presented at this conference for any and all uses . Statements and descriptions made by the SSC, SSCS and SSP Joint Annual Meeting 2016 at this conference and included in conference literature are informational only and are not made or given as a warranty . The views, opinions and statements made at the conference are solely those of the speakers and may not reflect the views of the SSC, SSCS and SSP Joint Annual Meeting 2016 . Furthermore, speakers may have vested interests in the concepts and products they discuss . It is further understood and agreed that the SSC, SSCS and SSP Joint Annu- al Meeting 2016 shall not be liable whether in contract, in tort, under any warranty, in negligence or otherwise for any kind of claim for loss, damage or expense of any kind arising out of or resulting from the use of any information, materials, products or anything else presented at this conference, and under no circumstances shall the SSC, SSCS and SSP Joint Annual Mee- ting 2016 be liable for special, indirect or consequential damages . The SSC, SSCS and SSP Joint Annual Meeting 2016 and/or its agents have the right to alter or cancel the conference or any of the arrangements, time- tables, plans or other items relating directly or indirectly to the conference without prior notice for any reason beyond their control . The conference and/or its agents shall not be liable for any loss, damage, expenditure or in- convenience caused as a result of such alteration or cancellation .

WIFI WIFI is free at the congress centre . UserID: 2402522307 Password: 2135

155 ULTIBRO® BREEZHALER® Schlagen Sie ein neues Kapitel in der COPD-Therapie auf.*,1, 2

Der erste 1x tägliche duale Bronchodilatator.1

1. ULTIBRO® BREEZHALER® Fachinformation, www.swissmedicinfo.ch (Stand September 2014). 2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management and prevention of COPD. 2015. *Bronchienerweiternde Erhaltungstherapie für COPD-Patienten, welche unter einer tief dosierten LAMA- oder LABA- Monobehandlung symptomatisch bleiben.1 Gekürzte Fachinformation Ultibro® Breezhaler®: Z: Hartkapseln mit 143 µg Indacaterolmaleat entsprechend 110 µg Indacaterol sowie 63 µg Glycopyrroniumbromid entsprechend 50 µg Glycopyrronium. I: Ultibro Breezhaler ist für die bronchienerweiternde Erhaltungstherapie bei symptomatischen Patienten mit chronisch obstruktiver Lungenerkrankung (COPD) angezeigt, bei welchen eine tief dosierte LAMA- oder LABA-Monobehandlung allein nicht genügend ist. D: Erwachsene: Inhalation des Inhalts einer Ultibro Breezhaler-Kapsel 1x täglich mit dem Ultibro Breezhaler-Inhalator. Spezielle Patienten- gruppen: Patienten mit leichter bis moderater Nierenfunktionsstörung in der empfohlenen Dosis, bei schwerer Nierenfunktionsstörung oder bei dialysepfl ichtigen Patienten mit terminaler Niereninsuffi zienz nur, wenn der zu erwartende Nutzen gegenüber dem potenziellen Risiko überwiegt. Patienten mit leichter bis moderater Leberfunktionsstörung in der empfohlenen Dosis. Keine Daten über Patienten mit schwerer Leberfunktionsstörung vorhanden. Darf nicht bei Patienten unter 18 Jahren angewendet werden. Nur orale Inhalation von Ultibro Breezhaler-Kapseln unter Anwendung des Ultibro Breezhaler-Inhalators. Die Kapseln nicht schlucken und jeden Tag zur selben Uhrzeit verabreichen. Wird eine Dosis ausgelassen, so ist diese so bald wie möglich nachzuholen. Nicht mehr als eine Dosis pro Tag einnehmen. Weitere Informationen unter www.swissmedicinfo.ch. KI: Überempfi ndlichkeit gegenüber Indacaterol, Laktose oder einem anderen Inhaltsstoff. VM: Ultibro Breezhaler nicht gleichzeitig mit Präparaten anwenden, die andere langwirkende beta-adrenerge Agonisten oder langwirkende muskarinische Antagonisten enthalten. Nicht bei Asthma anwenden. Langwirksame beta 2-adrenerge Agonisten können, wenn sie zur Behandlung von Asthma eingesetzt werden, das Risiko von Asthma-bedingten schwerwiegenden unerwünschten Ereignissen, inklusive Asthma-bedingtem Tod, erhöhen. Nicht für akute Anwendung bei Bronchospasmus-Episoden. Nach Verabreichung von Indacaterol sind Überempfi ndlichkeitsreaktionen vom Soforttyp aufgetreten. Anwendung kann lebensgefährlichen paradoxen Bronchospasmus auslösen. Bei entsprechenden Anzeichen Behandlung mit Ultibro Breezhaler unverzüglich beenden und Alternativbehandlung einleiten. Wegen anticholinerger Wirkung Vorsicht bei Patienten mit Engwinkelglaukom, mit erhöhtem Risiko für eine Harnretention, mit stark eingeschränkter Nierenfunktion oder mit schweren kardiovaskulären Vorerkrankungen. Bei Patienten mit stark eingeschränkter Nierenfunktion nur anwenden, wenn Nutzen gegenüber potenziellem Risiko überwiegt. Bei Patienten mit Herzkreislauferkrankungen mit Vorsicht einsetzen, vor allem bei Patienten mit Koronarinsuffi zienz, akutem Myokardinfarkt, Herzrhythmusstörungen und Bluthochdruck, sowie bei Epilepsien oder Thyreotoxikose und bei Patienten, die auf beta2-adrenerge Agonisten ungewöhnlich stark ansprechen. Nicht häufi ger bzw. in höheren Dosen als empfohlen anwenden. Wegen Wirkung von beta-adrenergen Agonisten auf Herzkreislaufsystem vor Dauerbehandlung Abklärung von COPD-Patienten hinsichtlich kardiovaskulärer Begleiterkrankungen (EKG zur Abklärung einer QTc-Verlängerung empfohlen). Spezielle Vorsicht bei Patienten mit instabiler koronarer Herzkranheit, Links-Herz-Versagen, kürzlichem Myokardinfarkt, Arrhythmien (ausser Vorhoffl immern) und Verlängerung der QTc-Zeit (Fridericia) oder solchen unter gleichzeitiger Behandlung mit Präparaten, welche eine Verlängerung des QTc-Intervalls bewirken können. Beta-Agonisten können eine ausgeprägte Hypokaliämie verursachen, die unerwünschte kardiovaskuläre Folgeerscheinungen haben kann, vor allem bei schwerer COPD. Inhalation hoher Dosen kann zu einem Anstieg der Plasmaglukose führen, daher bei Diabetikern den Plasmaglukosewert bei Behandlungsbeginn beobachten. Nicht anwenden bei Patienten mit schwerem Lactasemangel oder Galactosämie. Weitere Informationen unter www.swissmedicinfo.ch. IA: Wechselwirkungen bei Anwendung von Ultibro Breezhaler beruhen auf Möglichkeit des Auftretens von Interaktionen bei Anwendung seiner beiden Bestandteile. Beta-adrenerge Blocker können die

Wirkung von beta2-adrenergen Agonisten abschwächen bzw. antagonisieren. Vorsicht bei Anwendung von Ultibro Breezhaler bei Patienten, die mit Mono- aminoxidaseinhibitoren, trizyklischen Antidepressiva oder Arzneimitteln behandelt werden. Gleichzeitige Anwendung von Sympathomimetika könnte die unerwünschten Wirkungen von Indacaterol verstärken. Bei gleichzeitiger Behandlung mit Methylxanthin-Derivaten, Steroiden oder nicht kaliumsparenden Diuretika könnte sich möglicherweise hervorgerufene Hypokaliämie verstärken. Metabolische und transporterbasierte Arzneimittelinteraktionen (CYP3A4 und P-Glykoprotein Inhibitoren) führten zu Anstieg des AUC-Wertes sowie zu Erhöhung des Cmax. Gleichzeitige Anwendung mit inhalativen, Anticholinergika- enthaltenden Präparaten nicht empfohlen. Keine klinisch bedeutsamen Arzneimittelinteraktionen mit Cimetidin oder anderen Inhibitoren des Transports organischer Kationen zu erwarten. Nicht empfohlen während Schwangerschaft und Stillzeit, ausser der zu erwartende Nutzen für die Patienten überwiegt gegenüber einem etwaigen Risiko für den Fetus bzw. Säugling. Weitere Interaktionen s. www.swissmedicinfo.ch. UW: Sehr häufig: Infektionen der oberen Atemwege. Häufig: Nasopharyngitis, Harnwegsinfekt, Sinusitis, Rhinitis, Schwindelgefühl, Kopfschmerzen, Husten, Schmerzen im Mundrachenraum, einschl. Rachenreizung, Dyspepsie, Karies, Schmerzen im Bewegungsapparat, Pyrexie, Schmerzen im Brustkorb. Gelegentlich: Hypersensitivität, Diabetes mellitus, Hyperglykämie, Schlafl osigkeit, Parästhesie, Glaukom, Ischämische Herzkrankheit, Vorhoffl immern, Tachykardie, Palpitationen, Epistaxis, trockener Mund, Pruritus/Hautausschlag, Muskel spas men, Myalgie, Blasenobstruktion, Harnretention, Peripheres Ödem, Müdigkeit. Selten, sehr selten sowie Angaben zu Einzelwirkstoffen s. www.swissmedicinfo.ch. P: Ultibro Breezhaler Indacaterol/ Glycopyrronium 110/50 µg, Hartkapseln mit Pulver zur Inhalation: Packungen mit 30 Hartkapseln und 1 Inhalator und Grosspackung mit 90 (3x30) Hartkapseln und je 1 Inhalator. Verkaufskategorie: 156 B. Weitere Informationen fi nden Sie unter www.swissmedicinfo.ch. Novartis Pharma Schweiz AG,

Risch; Adresse: Suurstofﬁ 14, 6343 Rotkreuz, Tel. 041 763 71 11. Stand 15.07.2014, V1. 27958/05.2015 Society Evenings

Get Together SSP

An informal aperitif will be organized by the SSP on Wednesday, 15 June 2016, at the Starling Hotel from 20:00 – 22:00 . The Starling Hotel is the official congress hotel and it is situated right next to the campus of the EPFL .

Access Route Cantonale 31, 1025 Saint-Sulpice Phone: 021 694 85 85 Dress Code Business Casual Price CHF 50

You are welcome to enquire at the registration desk about availability .

Congress Networking

This year, the networking event of the SSC, SSCS and SSP Joint Annual Meeting 2016 will be held on Thursday, 16 June 2016, starting 19:00 at the Lausanne Palace . This evening will give you the occasion to meet colleagues . A casual atmosphere, great comfort and some highlights will grant you an outstanding evening in Lausanne .

Access Rue du Grand-Chêne 7, 1003 Lausanne Phone: 021 331 31 31 Dress Code Business Casual Price Members and Non-Members CHF 100 Junior Members and Physicians in training CHF 70

You are welcome to enquire at the registration desk about availability .

Animation Reaching normocardia and normotonia through a live comedy intervention . Fabian Unteregger, Comedian

157 Many arrhythmias. One solution.

Join the SATELLITE SYMPOSIUM

Catheter Ablation of Ventricular Arrhythmias: My State of the Art Approach 17:30 - Thursday 16th June - Room 3C

158 Congress Centre Map Auditorium B

159 Posters & Exhibition Layout

160 Piazza Layout

161 List of Exhibitors and Sponsors

COMPANY NAME SUPPORT ABBOTT AG, Abbott Vascular Sponsor & Piazza Space 6 ACTELION PHARMA SCHWEIZ AG Sponsor & Booth 120a AMGEN SWITZERLAND AG Sponsor & Booth 107 Anandic Medical Booth 161 Astrazeneca AG Sponsor & Booth 118 B .BRAUN MEDICAL AG Piazza Space 4 BANK JULIUS BAER & CO . AG Booth 137 Bayer (Schweiz) AG Sponsor & Booth 152 BIOTRONIK Schweiz AG Sponsor & Piazza Space 8 BOEHRINGER INGELHEIM (Schweiz) GmbH Booth 165 Boston Scientific AG Sponsor & Piazza Space 3 BRISTOL-MYERS SQUIBB SA & PFIZER AG Sponsor & Booth 153 CARBAGAS AG Booth 202 CORDIS, A CARDINAL HEALTH COMPANY Piazza Space 10 CSL BEHRING AG Booth 136 Daiichi Sankyo (Schweiz) AG Sponsor & Booth 123 EDWARDS LIFESCIENCES Sponsor & Booth 133 EMH SCHWEIZERISCHER ÄRZTEVERLAG / EMH SWISS MEDICAL PUBLISHERS Booth 221 EUROMED SWISS AG Booth 120b FEHLING INSTRUMENTS GmbH & Co . KG Booth 124 FENIK AG Booth 105 FMH SERVICES Booth 221 FRONTIERS Booth 212 FUMEDICA AG Booth 127 GE MEDICAL SYSTEMS (SCHWEIZ) AG Booth 161 GSK Sponsor & Booth 117 IBSA Institut Biochimique SA Booth 126 JOHNSON&JOHNSON AG Sponsor & Booth 154 LEMAN SURGICAL Booth 103 LIVANOVA – SORIN GROUP INTERNATIONAL SA Sponsor & Piazza Space 7 Loewenstein Medical CH Booth 206 LUZERNER HÖHENKLINIK MONTANA Booth 201 MAQUET AG Piazza Space 5 Marcel Blanc Booth 213 Medela AG Sponsor & Booth 132 MEDICOR AG Booth 204 medi-lan ag Booth 160 Medtronic Sponsor & Booth 142 Menarini AG Sponsor & Booth 116

162 List of Exhibitors and Sponsors

MSD MERCK SHARP & DOHME AG Booth 106 MUNDIPHARMA MEDICAL COMPANY Sponsor & Booth 205 Neurolite AG Booth 203 NOVARTIS PHARMA SCHWEIZ AG Sponsor & Booth 150 NSPIRE Health Booth 130 Olympus Schweiz AG Booth 121 Oprha Swiss Booth 108a ORION PHARMA AG Booth 101 OSCIMED SA Booth 93 PANGAS AG HEALTHCARE Booth 162 PHILIPS AG Booth 119 PHYSICOR Booth 135 PNEUMRX LTD Sponsor & Booth 163 PROCAMED AG Booth 131 PULMONX Sponsor & Booth 122 RESMED SWITZERLAND AG Sponsor & Booth 155 Roche Pharma Booth 108b SANOFI-AVENTIS (SCHWEIZ) AG Sponsor & Booth 109 SCHILLER-REOMED Booth 125 SCHNELL MEDICAL Booth 131 SERVIER SA Sponsor & Booth 151 SIEMENS Healthcare AG Booth 115 SIS MEDICAL AG Sponsor & Piazza Space 9 SOS Oxygene Booth 92 St . Jude Medical (Schweiz) AG Sponsor & Piazza Space 1 Stallergenes Booth 91 Swiss Heart Foundation Booth 220 Swiss Lung Association Booth 222 Swiss Society of Cardiology Booth 214 Symetis SA Booth 164 TERUMO Booth 104 THE MEDICINES COMPANY (Schweiz) GmbH Sponsor & Piazza Space 2 TOMTEC IMAGING SYSTEMS GMBH Booth 140 TOSHIBA MEDICAL SYSTEMS Booth 139 TREIER ENDOSCOPIE AG Booth 211 UNIVERSIMED Cross Media Content GmbH Bag Insert VASCULAR MEDICAL GMBH Booth 102 Vertex Pharmaceuticals (CH) GmbH Sponsor & Booth 141 VIFOR PHARMA Booths 110 & 138 ZOLL CMS GMBH Sponsor & Booth 134

163 Fondation Suisse de Cardiologie Fondation Suisse Active contrede les Cardiologie maladies cardiaques et l’attaque cérébrale

Active contre les maladies cardiaques et l’attaque cérébrale Conférence publique de la Fondation Suisse de ConférenceCardiologie publiqueet de la Ligue de la pulmonaireFondation Suisse suisse de Cardiologie et de la Ligue pulmonaire suisse

Apnées du sommeil et troublestroubles cardiaquescardiaques

Mercredi 15 juin 2016, de 19h00 àà 20h3020h30 (ouverture(ouverture desdes portesportes à à 18h30) 18h30) SwissTech Convention Center, RouteRoute Louis-FavreLouis-Favre 2,2, EcublensEcublens Auditorium BB Le SwissTech Convention Center est situé au nord du campus de l’EPFL. Depuis le centreLe SwissTech de Lausanne, Convention le métro Center m1 estvous situé amène au nord directement du campus en de15 l’EPFL.minutes Depuis devant le le bâtiment,centre de Lausanne,arrêt EPFL le métro m1 vous amène directement en 15 minutes devant le bâtiment, arrêt EPFL 19h00 Allocution de bienvenue 19h00 ChristaAllocution Bächtold, de bienvenue Responsable patients, Fondation Suisse de Cardiologie 19h05 ApnéesChrista Bächtold,du sommeil: Responsable un mal nocturne patients, souvent Fondation méconnu Suisse de Cardiologie Dr Raphaël Heinzer, PD, Médecin chef, Centre d’investigation et de 19h05 rechercheApnées du sur sommeil: le sommeil un mal (CIRS), nocturne CHUV souvent méconnu Dr Raphaël Heinzer, PD, Médecin chef, Centre d’investigation et de 19h25 Apnées du sommeil: le cœur est-il concerné? Drrecherche Philippe sur Meyer, le sommeil PD, Médecin (CIRS), adjointCHUV agrégé, Service de cardiologie 19h25 HôpitauxApnées du Universitaires sommeil: le cœurde Genève est-il concerné?HUG 19h45 VivrDr Philippee avec les Meyer, apnées PD, du Médecin sommeil adjoint agrégé, Service de cardiologie Pierre-AlainHôpitaux Universitaires Bruchez, coordinateur de Genève PASAS,HUG Groupe d‘entraide pour patients atteints du syndrome d‘apnées du sommeil, Neuchâtel 19h45 Vivre avec les apnées du sommeil 20h00 Discussion et questions des auditeurs DanièlePierre-Alain Castle, Bruchez, modération coordinateur PASAS, Groupe d‘entraide pour patients atteints du syndrome d‘apnées du sommeil, Neuchâtel Vous êtes ensuite cordialement invité à un apéritif. Entrée libre sans inscription. Nous20h00 serions heureuxDiscussion de etvous questions accueillir des. auditeurs Danièle Castle, modération Cette manifestation aura lieu dans le cadre de l’Assemblée annuelle de la Société Suisse de Cardiologie, de la Société suisse de chirurgie cardiaque et vasculaireVous êtes ensuitethoracique cordialement et de la Société invité Suisseà un apéritif. de Pneumologie. Entrée libre sans inscription. Nous serions heureux de vous accueillir. www.swissheart.chCette manifestation aura lieu dans le cadre de l’Assembléewww.liguepulmonaire.ch annuelle de la Société Suisse de Cardiologie, de la Société suisse de chirurgie cardiaque et vasculaire thoracique et de la Société Suisse de Pneumologie.

www.swissheart.ch www.liguepulmonaire.ch

164 General Assembly Programme 2016

18:30-19:45 Room 5AB Mitgliederversammlung (Geschäftssitzung) 2016 Assemblée générale (séance administrative) 2016 Traktandenliste / Ordre du jour 1 Traktandenliste Ordre du jour 2 Protokoll vom 10 .06 15. und vom 12 .05 16. Procès-verbal du 10 .06 15. et du 12 .05 16. 3 Jahresbericht des Präsidenten Rapport annuel du président 4 Bericht Kassier bzw . Revisoren sowie Genehmigung Jahresrechnung und des Budgets Rapport du trésorier et des vérificateurs des comptes sur l’exercice annuel écoulé ainsi que l’approbation des comptes et du budget 5 Festsetzung des Jahresbeitrages 2017 Fixation de la cotisation annuelle 2017 6 Wahlen Elections – Bestätigungswahl des Vorstands / Confirmative du comité – Ersatzwahl Hans Rickli / Remplacement de Hans Rickli – Wahl des Vertreters des Inselspitals Universitätsspital Bern / Election du représentant de l’Inselspital Hôpital Universitaire de Berne – Wahl des Vizepräsidenten / Election du vice-président – Wahl des Präsidenten / Election du président – Bestätigungswahl der Revisoren / Confirmation des vérificateurs des comptes 7 Neuaufnahmen Admission de nouveaux membres 8 Bestätigung Delegierte der SGK Confirmation des délégués des la SSC 9 Arbeitsgruppen: SCCP (Swiss Council for Cardiology Practice) Groupes de travail: SCCP (Swiss Council for Cardiology Practice) 10 Statutenänderungen Adaptation des statuts 11 Berichte aus den einzelnen Kommissionen Rapports des différentes commissions – Qualität / qualité – Tarife / tarifs – Weiterbildung / formation continue – Fortbildung / formation post-graduée 12 Nationale Herz- und Gefässkrankheiten, Hirnschlag und Diabetes-Strategie Stratégie nationale des maladies cardiaques, vasculaires, de l’attaque cérébrale et du diabète 13 Gemeinsame Jahrestagung SGK und SGHC mit SGNOR 2017 Assemblée annuelle commune SSC et SSCC avec la SSMUS 2017 14 Varia Divers

Connecting a Global Community in Clinical Chest Medicine

Save the Date Basel Switzerland 7– 9 June 2017

www.chestswitzerland2017.org

166 Notes

Ackermanndruck AG Sägestrasse 73, Postfach 720 Telefon 031 970 10 20 [email protected] 3098 Köniz Fax 031 970 10 29 167www.ackermanndruck.ch

Ackermanndruck_Block_A5_14.indd 1 18.12.14 09:30 Notes

Ackermanndruck AG Sägestrasse 73, Postfach 720 Telefon 031 970 10 20 [email protected] 168 3098 Köniz Fax 031 970 10 29 www.ackermanndruck.ch

Ackermanndruck_Block_A5_14.indd 1 18.12.14 09:30 Plus de puissance.1

Plus d’oxygène.1

dans le traitement symptomatique de l’angor stable3

• Réduction des crises d’angor4 • Meilleure tolérance à l’effort et meilleure résistance physique4 • Neutre au plan hémodynamique3

1) Sossalla S. et al. Inhibition des späten Natriumeinstroms (INa-late) als neuartige kardioprotektive Therapieoption. Kardiologe 2008; 2: 142-148. 2) Hasenfuss G. et al. Mechanism of action of the new anti-ischemia drug ranolazine Clin Res Cardiol 2008; 97(4): 222-6. 3) Information professionnelle en Suisse, www.swissmedicinfo.ch 4) Chaitman B.R. et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. JAMA 2004; 291(3): 309-316.

Ranexa® C: Compr. retard avec 375 mg, 500 mg et 750 mg ranolazine. I: Traitement symptomatique des patients atteints d’angor stable mal contrôlés ou intolérants aux antiangoreux de première intention. P: Posologie initiale: 375 mg bid; titration après 2–4 semaines vers 500 mg bid: dose maximale recommandée de 750 mg bid. CI: Hypersensibilité à la substance active ou à l’un des excipients, insuffisance rénale sévère, insuffisance hépatique modérée ou sévère, co-médication avec des inhibiteurs puissants du CYP3A4 ou avec des antiarythmiques de classe Ia ou III autres que l’amiodarone. PR: Co-médication avec des inhibiteurs modérés du CYP3A4 ou de la P-gp, insuffisance hépatique légère, insuffisance rénale légère à modérée, sujet âgé, patients à faible poids corporel, insuffisance cardiaque congestive modérée à sévère, allongement de l’intervalle QT. IA: Inhibiteurs du CYP3A4 ou de la P-gp, inducteurs du CYP3A4, inhibiteurs du CYP2D6, substrats du CYP2B6, métoprolol, digoxine, simvastatine. Il existe un risque théorique d’interaction pharmacodynamique et d’augmentation du risque potentiel d’arythmie ventriculaire en cas d’association de la ranolazine avec d’autres médicaments connus pour allonger l’intervalle QTc. EI: Vertiges, céphalées, troubles gastro-intestinaux, asthénie, angio-oedème. E: 60, 100. Liste B. Pour les informations détaillées consultez www.swissmedicinfo.ch. V.01. P2987_05/16_f A. Menarini SA, 8052 Zurich, tél. 044 307 40 50, [email protected]

Ranexa_Ins_115x215_20Jahre_fr.indd 2 12.05.16 09:07 NOUVEAU pour les patients atteints d’une maladie cardiovasculaire athérosclérotique (ASCVD) ou d’hypercholestérolémie familiale (HF)1,* Repatha®: Pour une puissante réduction de LDL-C

Chez les patients atteints d’ASCVD ou d’HF jusqu’à DE RÉDUCTION DE LDL-C SUPPLÉMENTAIRE 75s’ajoutant au traitement de base vs placebo2,3

Repatha® – Réduction de LDL-C hautement ef cace grâce au nouveau principe de l’inhibition de PCSK92,3 + Puissante réduction du taux de LDL-C indépendamment de l’âge, du sexe, des valeurs initiales, de l’IMC, du diabète sucré, du type et de la dose de la statine en traitement adjuvant2,3 + Bon pro l de tolérance1 + Simplicité d’emploi : 1 injection s.c. de 140 mg toutes les 2 semaines1,#

*HF hétérozygote sévère ou HF homozygote. #Lors de HFHo la dose peut être augmentée jusqu’à 420 mg s.c. toutes les 2 semaines. LDL-C = cholestérol LDL (LDL : Low-density-Lipoprotein), PCSK9 = proprotéine convertase subtilisine/kexine de type 9. Références : 1. Information professionnelle Repatha®, www.swissmedicinfo.ch 2. Robinson JG, et al. Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia The LAPLACE-2 Randomized Clinical Trial. JAMA. 2014;311(18):1870-1882. 3. Raal FJ, et al. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial; Lancet. 2015;385(9965):331-40. Information professionnelle abrégée Repatha® (evolocumab): Anticorps monoclonal IgG2 humain produit par la technologie de l’ADN recombinant. Indication: Repatha® est indiqué en accompagnement d’un régime alimentaire et en supplément d’une statine à la dose maximale tolérée, avec ou sans autres traitements hypolipémiants, chez l’adulte atteint d’hypercholestérolémie familiale hétérozygote sévère ou chez l’adulte atteint de maladie cardiovasculaire athérosclérotique cliniquement manifeste ou chez l’adulte et l’adolescent à partir de 12 ans atteint d’hypercholestérolémie familiale homozygote nécessitant une réduction supplémentaire des lipoprotéines de basse densité (LDL-C). L’effet de Repatha® sur la morbidité et la mortalité cardiovasculaires n’a pas été établi. Posologie/mode d’emploi: En cas de maladie cardiovasculaire athérosclérotique (ASCVD) clinique chez l’adulte, la dose recommandée est soit de 140 mg toutes les deux semaines, soit de 420 mg une fois par mois. En cas d’hypercholestérolémie familiale hétérozygote sévère chez l’adulte ou d’hypercholestérolémie familiale homozygote chez l’adulte et l’adolescent à partir de 12 ans, la dose initiale recommandée est soit de 140 mg toutes les deux semaines, soit de 420 mg une fois par mois. En l’absence de réponse clinique satisfaisante, la dose peut être augmentée à 420 mg toutes les deux semaines. Aucun ajustement posologique n’est nécessaire chez les patients atteints d’insuf sance rénale légère à modérée. Une diminution de l’exposition à l’evolocumab pouvant réduire la baisse du LDL-C a été constatée chez les patients souffrant d’insuf sance hépatique modérée. Une surveillance étroite de ces patients s’impose. Contre-indications: Hypersensibilité au principe actif ou à l’un des excipients selon la composition. Mises en garde et précautions: Les patients atteints d’insuf sance rénale sévère (dé nie par un DFGe <30 ml/min/1.73 m2) ou d’insuf sance hépatique sévère (Child-Pugh C) n’ont pas été étudiés. Repatha® doit être utilisé avec prudence chez les patients atteints d’insuf sance rénale sévère ou d’insuf sance hépatique sévère. Le capuchon de l’aiguille du stylo prérempli est en caoutchouc naturel sec (un dérivé du latex). Celui-ci peut provoquer des réactions allergiques. Interactions: Aucune étude formelle d’interaction médicamenteuse n’a été réalisée avec Repatha®. Effets indésirables: Fréquents: grippe, rhinopharyngite, infections des voies respiratoires supérieures, bronchite, sinusite, gastroentérite, éruption cutanée, vertiges, céphalées, hypertension, toux, nausées, vomissements, dorsalgies, arthralgies, myalgies, crampes musculaires, douleurs musculo-squelettiques, réactions au site d’injection, fatigue, contusions. Présentation: Boîte de 2 stylos préremplis (SureClick®) à usage unique. Chaque stylo prérempli contient 140 mg d’evolocumab dans 1 ml de solution. Pour de plus amples informations, 170 veuillez consulter l’information professionnelle sur www.swissmedicinfo.ch. Catégorie de vente: B. Titulaire de l’autorisation: Amgen

Switzerland AG, 6301 Zoug. CH-P-145-1215-121437 CH-P-145-1215-120767

Repatha_Inserat_115x215mm_fr.indd 1 14.03.16 14:43